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 “Let food be your medicine and medicine be your food” 
Hippocrates 
“Remember to look up at the stars 
and not down at your feet…And 
however difficult life may seem, there is 
always something you can do, 
and succeed at” 
S.W. Hawking 
“Non ho paura di morire, è un 
compito biologico di ogni essere vivente, 
per lasciare spazio a nuove generazioni. 
Da medico mi appassionano gli studi 
sulla longevità ma il nostro vero obiettivo deve 
essere non solo vivere più a lungo, ma 
godere del tempo guadagnato, in uno 
stato di salute che consenta una vita attiva 
del corpo e soprattutto della mente” 
U. Veronesi
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Abstract of papers produced during PhD course and 
relevant to this thesis 
1. Aiello A, Dara Guccione G, Accardi G, Caruso C. What
olive oil for healthy ageing? Maturitas. 2015;80:117-8.
Excerpt
It is widely accepted that olive oil plays a key role in
explaining part of the health benefits of the Mediterranean
Diet. But, does an olive oil recommended for healthy ageing
exist? Do all olive oils have the same properties? Olive oil is a
complex mixture of over 200 compounds whose composition
depends on many factors, such as geographical origin, weather
and irrigation, and cultivation techniques. To be considered as
extra virgin, an olive oil must have free acidity, expressed as
oleic acid, of no more than 0.8%, and it must be obtained by
mechanical processing, or “cold pressing”, that preserves
polyphenol fraction. Extra virgin is probably the variety of
olive oil to be recommended for healthy ageing due to its
greater amount of polyphenols, with antioxidant and anti-
inflammatory properties, and oleic acid, which is claimed to
increase the resistance of low-density lipoprotein to oxidation
and, consequently, reduces the risk of atherosclerosis.
2. Accardi G, Aiello A, Caruso C. Obesità, microbiota e aging
(Obesity, microbiota, and aging). In “La medicina dell’aging e
dell’anti-aging”. Edra. 2016;251-265.
Excerpt
Obesity is one of the most prevalent health issues of our time.
More and more deaths are caused worldwide by excessive
weight, mainly determined by an imbalance between energy
intake and energy expenditure. While modern eating habits and
ever increasingly sedentary lifestyles are major contributory
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factors, a link has recently emerged between obesity and the 
composition and functionality of gut microorganisms, probably 
because different kinds of diets are associated with differences 
in the composition of gut microbiota. Moreover, several 
research groups demonstrated the contribution of gut microbial 
communities to old people and their role on healthy ageing 
owing to their strong impact on human metabolism and 
immunology. Indeed, changes with age in specific bacterial 
genera and species have been identified, with a considerable 
inter-individual variation that continues into old age.  
3. Accardi G, Aiello A, Gambino CM, Virruso C, Caruso C,
Candore G. Mediterranean nutraceutical foods: Strategy to
improve vascular ageing. Mech Ageing Dev. 2016;S0047-
6374:30011-2.
Abstract
Ageing is characterized by a decline in all systemic functions.
A greater susceptibility to apoptosis and senescence may
contribute to proliferative and functional impairment of
endothelial progenitor cells. These play an important role in
neo-angiogenesis and endothelial repair. Vascular ageing is
associated with changes in the structure and functions of
vessels' walls. There are many possible causes of this damage.
Without doubt, inflammation and oxidative stress play a
fundamental role in the pathogenesis of endothelial
dysfunction, commonly attributed to a reduced availability of
nitric oxide. Inflammageing, the chronic low-grade
inflammation that characterizes elderly people, aggravates
vascular pathology and provokes atherosclerosis, the major
cardiovascular disease. Nutraceutical and molecular biology
represent new insights in this field. Indeed, the first could
represent a possible treatment in the prevention or delay of
vascular ageing; the second could offer new possible targets for
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potential therapeutic interventions. In this review, we pay 
attention to the causes of vascular ageing and on the effects of 
nutraceuticals on it. 
4. Accardi G*, Aiello A*, Gargano V, Gambino CM,
Caracappa S, Marineo S, Vesco G, Carru C, Zinellu A,
Zarcone M, Caruso C, Candore G. Nutraceutical effects of
table green olives: a pilot study with Nocellara del Belice
olives. Immun Ageing.2016;13:11.
Abstract
Background. The aim of this study was to analyse the
nutraceutical properties of table green olives Nocellara del
Belice, a traditional Mediterranean food. The key elements of
the Mediterranean Diet are olives and extra virgin olive oil,
common to all Mediterranean countries. Olive oil is the main
source of fat and can modulate oxidative stress and
inflammation, whereas little is known about the role of olives.
Moreover, emerging evidences underline the association
between gut microbiota and food as the basis of many
phenomena that affect health and delay or avoid the onset of
some age-related chronic diseases.
Methods. In order to show if table green olives have
nutraceutical properties and/or probiotic effect, we performed a
nutritional intervention, administering 12 table green
olives/day for 30 days to 25 healthy subjects (mean age 38.3).
We carried out anthropometric, biochemical, oxidative stress
and cytokine analyses at the beginning of the study and again
at the end. In addition, we also collected fecal samples to
investigate the possible variation of concentration of
Lactobacilli, after the consumption of the olives.
Results. Our results showed a significant variation of one
molecule related to oxidative stress, malondialdehyde,
confirming that Nocellara del Belice green olives could have
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an anti-oxidant effect. In addition, the level of interleukin-6 
decreased significantly, demonstrating how this food could be 
able to modulate the inflammatory response. Moreover, the 
reduction of fat mass with an increase of muscle mass is 
noteworthy, as it suggests a possible effect of long term 
assumption of table olives on body mass variation. No 
statistically significant differences were observed in the 
amount of Lactobacilli, although a trend towards an increased 
concentration of them at the end of the intervention could be 
related to the nutraceutical effects of olives. 
Conclusion. These preliminary results suggest a possible 
nutraceutical effect of daily consumption of green table olives 
Nocellara del Belice. To the best of our knowledge, this is the 
first study performed to assess nutraceutical properties of this 
food. Of course, it is necessary to verify the data in a larger 
sample of individuals to confirm their role as nutraceuticals. 
*contributed equally
5. Aiello A, Accardi G, Candore G, Gambino CM, Mirisola M,
Taormina G, Virruso C, Caruso C. Nutrient sensing pathways
as therapeutic targets for healthy ageing. Expert Opin Ther
Targets. 2017. In revision.
Abstract
Introduction: In the present paper, the authors have discussed
anti-ageing strategies which aim to slow the ageing process and
to delay the onset of age-related diseases, focusing on nutrient
sensing pathways (NSPs) as therapeutic targets. Indeed, several
studies have already demonstrated that both in animal models
and humans, dietary interventions might have a positive impact
on the ageing process through the modulation of these
pathways.
Areas Covered: Achieving healthy ageing is the main
challenge of the 21th century because the lifespan is increasing,
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but not in tandem with good health. The authors have 
illustrated different approaches that can act on NSPs, 
modulating the rate of the ageing process.  
Expert Opinion: Humanity’s lasting dream is to reverse or, at 
least, postpone ageing. In recent years, increasing attention has 
been devoted to anti-ageing therapies. The subject is very 
popular among the general public, whose imagination runs 
wild with all the possible tools to delay ageing and to gain 
immortality. Some approaches discussed in the present review 
should be able to substantially slow down the ageing process, 
extending our productive, youthful lives, without frailty. 
6. Baldassano S, Buscemi S, Aiello A, Accardi G, Caruso C,
Vasto S. β-Glucans and Post Prandial Satiety: the Role of
Intestinal Hormones in Healthy Volunteers. Int J
Immunopathol Pharmacol. Submitted.
Abstract
Summary: Recent interest in intestinal hormones has risen
with the idea that they modulate glucose tolerance and food
intake through a variety of mechanisms, and such hormones
like peptide YY (PYY), ghrelin, glucagon-like peptide (GLP)-1
and 2, and cholecystokinin (CKK) are therefore excellent
therapeutic candidates for the treatment of diabetes and
obesity. Furthermore, in the recent years, multiple studies
suggest that the microbiota is critically important for normal
host functions, while impaired host microbiota interactions
contribute to the pathogenesis of numerous common metabolic
disorders. In this study, we considered the nutraceutical effects
of β-glucans added to pasta at the concentration of 6g\100g.
Ten participants have been recruited and hematochemical
analyses and intestinal hormones tests have been performed
before and after 30 days of pasta intake. Stool specimens have
been studied for Lactobacillus Fermentum, Lactobacillus
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acidophilus, Lactobacillus salivarius, Bifidobacterium longum, 
and Enterococcus faecium presence before and after 30 days of 
nutritional intervention. After 30 days of regular intake of pasta 
enriched by β-glucans results have been evaluated. In 
conclusion, pasta prepared from barley flour enriched with β-
glucans at 6% exhibit promising responses on glucose 
metabolism, on intestinal hormones responses and on 
microbiota modification.  
7. Aiello A, Accardi G, Candore G, Carruba G, Davinelli S,
Passarino G,Scapagnini G, Vasto S, Caruso C.
Nutrigerontology: a key for achieving successful ageing and
longevity. Immun Ageing. 2016;13:17.
Abstract
During the last two centuries the average lifespan has increased
at a rate of approximately 3 months/year in both sexes, hence
the oldest old people are becoming the section of the
population with the fastest growth in Western World. Although
the average life expectancy is increasing dramatically, the
healthy lifespan is not increasing at the same pace. This
underscores the importance of studies on the prevention of age-
related diseases, in order to satisfactorily decrease the medical,
economic and social problems associated to advancing age,
related to an increased number of individuals without
autonomy and affected by invalidating diseases. In particular,
data from experimental studies in model organisms have
consistently shown that nutrient signalling pathways are
involved in longevity, affecting the prevalence of age-related
loss of function, including age-related diseases. Accordingly,
nutrigerontology is defined as the scientific discipline that
studies the impact of nutrients, foods, macronutrient ratios, and
diets on lifespan, ageing process, and age-related diseases. To
discuss the potential relevance of this new science in the
12 
 
attainment of successful ageing and longevity, three original 
studies performed in Sicily with local foods and two reviews 
have been assembled in this series.The data clearly 
demonstrate the positive effects of nutraceuticals, functional 
foods and Mediterranean Diet on several biological parameters. 
Indeed, they could represent a way to prevent many age-related 
diseases, and make possible, if not a solution for this social 
plague, at least a remedy to alleviate the struggles it causes. 
Thus, the possibility to create a dietary pattern, based on the 
combined strategy of the use of both nutraceuticals and 
functional foods should permit us to create a new therapeutic 
strategy, based not only on a specific bioactive molecule or on 
a specific food but on an integrated approach that, starting from 
the local dietary habits, could pave the way for a 
"nutrafunctional diet" applicable worldwide. 
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List of abbreviations 
AGEs advanced glycation end-products  
AMKT AMP-activated protein kinas 
AOP aglicone oleuropein paracetylated 
ARE antioxidant response element  
BMI body mass index  
CALERIE Comprehensive Assessment of the Long-term 
Effects of Reducing Intake of Energy 
CHDs coronary heart diseases  
CLA conjugated linoleic acid 
CR caloric restriction 
CVDs cardiovascular diseases 
DMSO dimethyl sulfoxide  
DR dietary restriction 
EDTA ethylene diamine tetra acetic acid  
EPCs endothelial progenitor cells  
EVOO extra virgin olive oil 
FBS fetal bovine serum  
FMD fasting mimicking diet 
FOXO fork head box O  
GI glycaemic index 
GIT gastro-intestinal tract  
GLP glucagon like peptide  
HDL high density lipoprotein  
HEPES hydroxyethyl-1-piperazineethanesulfonic acid  
HP hydrossytyrosol paracetylated 
IDL intermediate density-lipoprotein  
IF intermittent fasting 
IGF insulin-like growth factor 
IL interleukin  
IMIBIC Instituto Maimónides de Investigación Biomédica de 
Córdoba 
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LDL low-density lipoprotein 
MDA malondialdehyde 
MDP MedDiet pyramid 
MedDiet Mediterranean Diet 
mTOR mammalian target of rapamycin  
MUFA mono unsaturated fatty acid 
NF-κB kappa-light-chain-enhancer of activated B cells 
NO nitric oxide 
Nrf2 nuclear factor-E2-related factor 2  
NSPs nutrient-sensing pathways 
OFI opuntia ficus indica 
PBMCs peripheral blood mononuclear cells 
PF prolonged fasting 
PON paraoxonase 
PR protein restriction  
PSH protein SH 
PUFA poly unsaturated fatty acid  
PYY peptide YY 
ROS radical oxygen species  
RPMI Roswell Park Memorial Institute 
SA successful ageing 
SCFA short-chain fatty acids 
SNPs single nucleotide polymorphisms  
TBARS thiobarbituric acid reactive substances 
TC total cholesterol 
TFs transcription factors 
TNF tumor necrosis factor 
UA unsuccessful ageing 
VLDL very low-density lipoprotein  
WHO world health organization  
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I. Introduction: Healthy eating for healthy ageing
People want to live longer. To date, it is impossible not 
to grow older, but it is desirable to get older in good health, 
avoiding age-related disabilities. To do this, it is necessary to 
have a healthy lifestyle which can limit the damage caused by 
the environmental hazards (radiations, exhaust fumes, heavy 
metals) that face us each day. 
Human beings are always in search of the elixir of long 
life and, in recent years, science has made great strides. The 
ageing studies and, in particular, the research of determinant 
factors for successful ageing and longevity, are steadily 
growing (Longo et al., 2015). However, although life 
expectancy in western countries has increased approximately 3 
months/year in both sexes in the past decade, following 
improved cares and diagnosis, the years lived with disabilities 
and diseases have not decreased (Oeppen et al., 2002). 
Therefore, the continuous increase of lifespan does not go hand 
in hand with the increase of healthy lifespan, the so-called 
“health-span” (Kolovou et al., 2014; Mercken et al., 2012). 
Therefore, the ongoing and future studies ought not only help 
to increase longevity, but also to promote what is known as 
“active life expectancy”, that is the time in later life spent free 
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of disability. This is true also if we are to satisfactorily 
decrease the medical, economic and social problems associated 
with advancing age, related to an increased number of 
individuals without autonomy and affected by invalidating 
diseases (Katz et al., 1983). 
In humans, healthy ageing and longevity are modulated 
by a fortunate interaction between genetic and environmental 
factors (Figure 1). Regarding the latter, physical activity and 
healthy dietary habits are the most important modiﬁable factors 
that can affect the maintenance of a healthy ageing phenotype 
(Dato et al., 2013). In particular, nutrition is a daily process by 
which living organisms get food to gather energy and nutrients 
to live. Good nutrition plays a significant role in determining 
the well-being of older people, and in delaying and reducing 
the risk of contracting diseases. Eating too few fruits and 
vegetables is, for example, responsible for close to three 
million deaths worldwide every year. In addition, the intake of 
dietary fat seems to be associated with various cancers. 
Nutritionally unbalanced diets are often associated with 
diabetes and with the risks of developing coronary heart 
diseases (CHDs). It was seen that children that follow a 
balanced diet with lots of fruits and vegetables are likely to 
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continue eating healthily into adulthood. On the contrary, 
parents who eat too much processed food with high levels of 
salt, sugar and fat tend to pass those habits onto their own 
children (Kiefte-de Jong et al., 2014).  
Nowadays, the findings that diet can improve successful 
ageing have opened new and interesting suggestions for anti-
ageing medicine (Fontana et al., 2010; Partridge et al., 2010). 
Accordingly, a new science, called “nutrigerontology,” was 
born. Nutrigerontology is defined as the scientific discipline 
that studies the impact of nutrients, foods, macronutrient ratios 
and diets on lifespan, the ageing process and molecular 
pathways, and age-related diseases (Aiello et al., 2016a; 
Verburgh, 2015). In fact, when the biogerontologists speak of a 
“healthy diet”, that can slow the ageing process, they are also 
referring to the modulation of intracellular signaling pathways, 
the so-called nutrient-sensing pathways (NSPs), that play a 
fundamental role in healthy ageing and longevity (Davinelli et 
al., 2012). As it will be explained in this thesis, NSPs are 
activated by nutrients, such as carbohydrates or proteins, that 
trigger signals which result in a downstream activation of some 
genes involved in ageing process. An excessive intake of 
nutrients can accelerate these events and increases the risk of 
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age-related diseases. On the contrary, healthy diets (those that 
do not overstimulate NSPs) reduce this risk, promoting 
successful ageing and longevity (Aiello et al., 2016 b. In press). 
Although the complex relationship between nutrition, 
the ageing process and healthy ageing is not completely 
understood in humans, specific dietary changes, such as dietary 
restriction (DR), the reduction of glycaemic and protein intake 
or the elimination of trans and saturated fats, the increased 
intake of omega-3, vitamins, micronutrients and antioxidants, 
can help to minimize the inflammageing, phenomenon that 
characterizes ageing (see I.I). Similarly, appropriate intake of 
specific foods, the so-called “functional foods”, may confer 
health benefits, influencing the maintenance of immune 
homeostasis, and contributing, directly, to the reduction of 
inflammation and metabolic disorders (Dato el al., 2016; 
Kiefte-de Jong et al., 2014) (see I.III.II). 
The majority of the evidence that links nutrition and 
healthy ageing is derived from epidemiological studies. On the 
contrary, nutritional interventions, the typical model 
approaches used to analyse the role of specific foods and diets 
on healthy ageing, are needed to support the development of 
personalised treatment plans. 
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Figure 1. The main characteristics of healthy ageing. 
I.I Ageing process and longevity
The major theories regarding ageing, including those 
involving genes, mitochondria, caloric intake, oxidative stress 
and so on, are all speciﬁc to a particular cause of ageing. These 
provide useful and important insights in the understanding of 
age-related physiological changes. However, the ageing 
process includes several of these mechanisms. So, a global and 
common view is necessary as the process is still obscure in 
some of its aspects.  
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In May 2012, a group of scientists and clinicians met in 
Athens and drafted a consensus statement to highlight the 
features of ageing, different ageing processes, longevity and 
exceptional longevity in human beings. They analysed ageing 
theories taking into account the evolutionary perspective and 
proposed treatments suitable to delay the ageing process. 
According to them, ageing is defined as a physiological and 
ineluctable process, an intrinsic feature of life. It is 
characterised by a gradual decrease of the ability to adapt to 
stress, causing a decline in functional capacity. This event, 
characterised by a progressive loss of physiological integrity of 
many interrelated systems, leads to impaired function and 
increased risk of morbidity and mortality (Avery et al., 2014). 
On the other side, human longevity is a complex 
phenotype influenced by environmental factors (socio-
economic status of parents, education, epigenetics, medical 
assistance, and lifestyle) which accounts for 75%, whilst the 
contribution made by genetics has been estimated to be 25-
30% (Deelen et al., 2013). Among NSPs genes, the 
insulin/insulin-like growth factor (IGF)-1 signaling pathway 
plays a central role in the attainment of longevity. This 
pathway regulates lifespan in various organisms, including 
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mammals. Moreover, mutations that reduce the activity of 
insulin/IGF-1 signaling can extend lifespan in several species 
of organisms (Fontana et al., 2010). 
The ageing process, independent of gender, involves 
organisms at all levels. Some ageing phenotypes such as grey 
air, hearing loss, presbyopia, short-term memory loss, are not 
dangerous for old people. Whereas other like changes in cells, 
tissues and organs (and their progressive reduction of 
function), increase the vulnerability that leads to death (Troen, 
2003). 
As a definition, there are two ways to become old: 
without success (unsuccessful ageing, UA) and with success 
(successful ageing, SA). The first is manifested by people that 
develop one or more age-related diseases, such as 
neurodegenerative (Alzheimer’s or Parkinson’s disease), 
metabolic (metabolic syndrome and type 2 diabetes mellitus) 
and cardiovascular diseases (CVDs), and cancer (Troen, 2003). 
With regards the latter, gerontology distinguished 
between two groups of non-diseased older persons: usual (non-
pathologic but high risk) and successful (low risk and high 
function). SA includes three main related components, amongst 
which are: low probability of disease and disease-related 
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disability, high cognitive and physical functional capacity, and 
active engagement with life. So, SA is more than absence of 
disease or the maintenance of functional capacities, because the 
combination of these components guarantees an active end of 
life, that represents the essential concept of SA (Bülow and 
Söderqvist, 2014) (Figure 2). 
Figure 2. Focus on factors that contribute to SA. 
Centenarians, people that live 100 or more years 
without any significant disease, in good physical and mental 
condition, represent the best model of SA (Avery et al., 2014). 
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They have a favourable genetic background, essential to live 
longer, and a good responsiveness to adverse environmental 
conditions (Balistreri et al., 2012). In particular, our group has 
extensively studied the Sicani Mountains (a small area of 
Sicily) and the dietary habits of their inhabitants, who showed 
a high percentage of centenarians. In 2012, it was demonstrated 
that this area is characterized by a low mortality rate due to 
cancers and CVDs and the centenarians recruited tended to be 
physically active and to have a healthy diet, strictly adherent to 
the Mediterranean dietary pattern (Vasto et al., 2012a; Vasto et 
al., 2012b).  
Likely, the centenary’s ability to reach the age of 100 
(mostly in the westernized countries), in addition to dietary 
pattern, reflects the improvement of hygienic conditions, the 
reduced exposure to infection and inflammation, the 
improvement in general of the quality of life, and the advent of 
therapeutic and preventive medicine (Vasto et al., 2012a). 
The strict adherence to healthy diet can also help to 
reduce the inflammatory status that characterizes ageing, the 
inflammageing. This process consists in the presence of a 
chronic low-grade inflammatory status which contributes to the 
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development of different pathological conditions (Franceschi 
et al., 2000; Cevenini et al., 2013).  
In early life, when natural selection is strong, the 
inflammation should be beneficial because protects the 
organism from harmful conditions and contributes to healing 
process. On the contrary, at a later stage of life, this particular 
inflammatory activity leads to long-term tissue damage and is 
related to mortality risk for all causes. This phenomenon is 
mainly attributed to a continuous antigenic stimulation, not 
foreseen by evolution. 
Principally, inflammageing may derive from age-related 
changes to the immune system, the so-called 
immunosenescence (Franceschi and Cossarizza, 1995; Vasto 
and Caruso, 2004). In line with the remodeling theory of 
ageing, in immunosenescence, innate immunity is largely 
conserved or even up-regulated, while the clonotypic variety 
deteriorates with age. This reduces the ability to clear novel 
pathogens and increases T-cell populations, functionally 
distinct in that the production of pro-inflammatory cytokines is 
amplified (Pawelec, 2012; Caruso and Vasto, 2016). 
Paradoxically, centenarians show high levels of pro-
inflammatory markers, counterbalanced by anti-inflammatories 
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ones (Franceschi et al., 2007). Other causes of inflammageing 
present themselves through damaged macromolecules and the 
endogenous host-derived cell debris that, accumulating with 
age, as a consequence of their increased production and/or 
inadequate elimination, are sources of chronic damage 
(Franceschi et al., 2000). The amount of senescent cells 
increases with age and can have deleterious effects on tissues, 
altering the function of nearby cells. This is due to the 
acquisition of the senescence-associated secretory phenotype 
that induces senescent cells to produce pro-inflammatory 
cytokines (Tchkonia et al., 2013). Visceral obesity is known to 
be associated with a pro-inflammatory status (Balistreri et al., 
2010). Moreover, the autophagy, a self-degradative process, 
important for balancing sources of energy in development and 
in response to nutrient stress, declines with ageing, enhancing 
the inflammageing process. In particular, defects in 
mitochondrial uptake and degradation could increase reactive 
oxygen species (ROS) production and stimulate  the 
inflammatory process (Salminen et al., 2012). Finally, harmful 
metabolites, produced by the human microbiota, likely 
participate in the ageing process, contributing to 
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inflammageing and immunosenescence (Woodmansey, 2007) 
(Figure 3).  
Chronic inflammation negatively impacts on 
physiological functions, causing all age-related disabilities. At 
this regard, current available evidence strongly suggests that an 
anti-inflammatory diet can potentially restrict this condition. 
Indeed, a healthy nutritional pattern can reduce pro-
inflammatory status, offering a unique, nonpharmacological 
approach in treating obesity, metabolic syndrome, diabetes and 
other age-related diseases. Moreover, several important 
bioactive dietary components can exert their effect modulating 
glucose or insulin levels and inflammatory pathways that can 
affect metabolic changes (Santoro et al., 2014). On the 
contrary, physical inactivity and a hypocaloric diet lead to an 
accumulation of visceral fat and to a stimulation of immune-
system, causing an infiltration of pro-inflammatory 
macrophages in adipose tissue (Balistreri et al., 2010).  
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Figure 3. Inflammaging, immunosenescence, and gut microbiota have 
implications for health and lifespan. Emerging evidence has revealed 
extensive crosstalk between microbiota, the immune system, and 
inflammation pathways that influences ageing in humans. This interplay is 
mediated by various genetic and environmental factors such as nutrition and 
lifestyle. 
I.II Excursus on traditional dietary interventions
and their potential impact on human morbidity and 
lifespan 
It is well established that a healthy nutritional pattern 
plays a central role in preventing diseases and promoting 
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health. Dietary regimens that can slow or postpone ageing 
process, promoting long life and healthy old age, continue to 
raise interest among the general public as well as the scientific 
and clinical communities. 
Among these, several types of DR approaches exist. 
DR, defines as “Dietary regimen in which specific food groups 
or micronutrients are reduced or removed from the diet”, was 
first showed about 80 years ago to extend lifespan in rats 
(Mirzaei et al., 2014). Most of these dietary interventions 
provide a significant health-span increase also in humans, 
minimizing adverse effects and increasing longevity (Lee and 
Longo, 2016).  
Caloric restriction (CR), the reduction of total calories 
intake by 20-40% without malnutrition, is the most well-known 
defined dietary intervention to delay ageing in model 
organisms. From unicellular yeast to primates, the effects of 
CR on health-span have been confirmed, suggesting a highly 
conserved role of some common ageing pathways (Fontana et 
al., 2010; Most et al., 2016). The molecular mechanisms that 
mediate the effect of CR are still being investigated and, in all 
models, it was seen that reduced nutrient signaling is associated 
with the downregulation of NSPs, such as insulin and IGF-1, 
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the amino acids targets of rapamycin, and the glucose signaling 
Ras-protein kinase A pathway (Fontana et al., 2008; Speakman 
and Mitchell, 2011; Slack et al., 2015). 
The role of CR in human ageing is difficult to ascertain 
because human lifespan makes long-term investigations and 
there are no universally accepted biomarkers to measure the 
rate of human ageing (Butler et al., 2004). However, some 
epidemiologic and short-term human studies support CR-
related health benefits (Fontana et al., 2010; Heilbronn et al., 
2003; Holloszy et al, 2007; Lee et al., 2001; Walford et al., 
2002). In 2004, a long-term (>30 years) epidemiologic study 
linked CR to human longevity. This study suggested that 
maintaining a modestly low energy intake (mean kcal/day 
1882) in mid-life involves the lowest late-life mortality risk. 
Indeed, a weak trend towards lower all-cause mortality was 
reported in healthy never-smoking Japanese–American men 
whose caloric intake had been reduced by 15% with respect to 
the cohort average (Willcox et al., 2004). Moreover, CALERIE 
(Comprehensive Assessment of the Long-termEffects of 
Reducing Intake of Energy), a controlled randomized study on 
non-obese individuals, reported that a two year 25% CR is 
feasible for humans and provides health benefits, such as 
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reduces inflammatory markers and cardio-metabolic risk 
factors. However, it was seen that in enrolled subjects CR was 
associated with reduced bone mineral density (Ravussin et al., 
2015; Redman et al., 2014). So, considering the results in 
model organisms, more and long-term studies are required on 
healthy human populations in order to understand the 
consequences of CR on ageing and lifespan. 
Another investigated dietary approach is fasting. It is an 
extreme dietary intervention, consisting of a complete lack of 
food or of a 60% or higher food restriction, that has been 
practiced as a treatment for many illnesses since ancient times. 
Only recently have several studies shown the beneficial aspects 
of fasting in adaptive cellular responses. It reduces oxidative 
stress damage and inflammation, optimizing energy 
metabolism and enhancing cellular protection, and results in 
ketogenesis, promoting potent changes in metabolic pathways 
(like lipolysis and autophagy) (Longo et al., 2015).  
The best-characterized form of fasting, evaluated in 
both rodents and human studies, are intermittent (IF) and 
prolonged fasting (PF). Intermittent abstinence from food and 
caloric beverages at least 12 hours (IF) or 48-120 hours (PF), 
improves health effects and protect from age-related 
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disabilities. In humans, IF (e.g., consumption of approximately 
500kcal/day for 2 days a week) has beneficial effects on 
insulin, blood glucose levels, C-reactive protein, and blood 
pressure (Harvie et al., 2011). On the other side, in mice, PF 
cycles, lasting 2 or more days, but separated by a week of 
normal diet, have emerged as a highly effective strategy to 
reduce circulating IGF-1 and glucose levels, and, consequently, 
to down regulate the mammalian target of rapamycin (mTOR) 
pathway. In humans, IF and PF help to reduce obesity, 
hypertension, asthma and rheumatoid arthritis (Lee et al, 2012; 
Longo and Mattson, 2014).  
Nevertheless fasting has the potential to delay ageing 
and has rare and usually reversible side effects, other diets that 
mimic fasting were investigated. In 2014, Longo and Mattson, 
after their studies on Laron syndrome (autosomal recessive 
disorder characterised by an insensitivity to growth hormone) 
tuned a plant-based fasting mimicking diet (FMD), which 
promotes health-span (see Figure 4 for an overview on FMD 
results on models). The authors discovered that, in mice, cycles 
of the FMD lasting 4 days, followed by a standard ad libitum 
diet, determined a decrease of blood glucose and IGF-1 levels, 
and an increase of ketone bodies compared to a control diet 
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group. The results also demonstrated that FMD cycles can have 
profound effects on visceral fats and promote immune system 
regeneration and rejuvenation (Cheng et al., 2014; Longo and 
Mattson, 2014).  
Interesting results have been also demonstrated about 
the role of FMD in murine models in cancer treatment. The 
data indicates that FMD cycles combined with chemotherapy 
can enhance tumor immunogenicity, in part by a heme 
oxygenase 1 dependent mechanism, which promotes the 
recruitment of cytotoxic T cells in the tumor bed (Di Biase et 
al, 2016). In addition, still in mice, FMD reduces 
autoimmunity and multiple sclerosis symptoms and improves 
cognitive performance and multi-system regeneration 
(Brandhorst et al., 2015; Choi et al, 2016). 
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Figure 4. FMD test results. It was demonstrated that a periodic meal 
program that mimics fasting promotes multi-system regeneration, enhanced 
cognitive performance, and health span. Yeast models, deprived of food 
periodically, were shown to have longer life expectancy than yeast fed 
normally. In mice, a specialized diet for four days a month, improved 
metabolism and cognitive function, gradual weight loss and muscle 
rejuvenation, immune system regeneration, and longer average, though not 
absolute, life expectancy. In human beings, after five FMD days for three 
months, results showed that the FMD participants experienced an overall 
improvement of the risk of the main age-relate diseases. 
Recently, Longo and colleagues tested the effects of 
three cycles of low calorie and low protein FMD in a pilot 
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randomized clinical study using 38 healthy subjects, 19 cases 
and 19 controls, with a broad range of ages (19-75). The 
fasting plan was characterised by low carbohydrate and protein 
intake and contained good fatty acids, and was administered for 
5 days per month for each 3 months (3 cycles) (Table 1). At 
the end, the consumer can go back to his normal lifestyle/diet 
for the remaining 25 days of the month. 
Table 1. 5 days of FMD: Calorie and nutrients distribution. 
It was seen that FMD normalizes many metabolic health 
metrics correlated with ageing and health-span. In particular, 
this diet would seem to reduce the levels of fasting blood 
glucose, circulating IGF-1, and C-reactive protein, and to 
increase serum ketone bodies. Moreover, the FMD resulted in a 
3% reduction in body weight together with a positive trend of 
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reduction for fat mass (probably associated with the ketone 
bodies production), and a positive trend of increase for 
mesenchymal stem- and progenitor cells, indicating beneficial 
health effects for regeneration parameters in humans 
(Brandhorst et al., 2015). 
In addition, in studying the benefits attributed to PF or 
IF based strategies as alternatives to CR more deeply, the 
scientists understood that the restriction of specific 
macronutrients, without the restriction of calories, is one of the 
most promising interventions in the promotion of healthy 
ageing in humans. Among these, the restriction of protein 
(protein restriction, PR) or the restriction of particular amino 
acids (amino acid restriction) are the most effective pro-
longevity interventions in multiple model organisms (Mirzaei 
et al., 2014; Grandison et al., 2009). Indeed, these dietary 
patterns are sufficient to reduce IGF-1 concentrations and 
mTOR signalling, more than simple CR (Fontana et al., 2008; 
Soultoukis and Partridge, 2016). In Drosophila melanogaster, 
the effect of CR is lost in the presence of essential amino acids 
(Grandison et al., 2009; Iwasaki et al., 1988). Especially, 
methionine and tryptophan, contained more in animal than in 
plant proteins, seem to have more detrimental effects than other 
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amino acids. Their reduction, in the diet of various model 
organisms, extends lifespan and increases stress resistance, 
with though an unclear molecular mechanism. (Mirzaei e al., 
2014). 
However, few studies were performed on the potential 
benefits of PR on the human ageing process, and one of the 
main limitations of these studies is the age stratification of 
analysed groups. In a case-control study, an association 
between a low protein consumption, a reduction in IGF-1 
levels and cancer in 50-65 years people was demonstrated, but 
not in the older population, suggesting that a higher protein 
intake, mostly from vegetables, should be recommended for 
them (Levine et al., 2014). 
As regards the plant protein effect, a short-term 
randomized clinical trial has shown that high plant protein 
intake was inversely associated with mortality. Plant proteins 
have not been linked with an increase of IGF-1 levels but have 
been linked to lower blood pressure, improved insulin 
sensitivity, reduced low-density lipoprotein (LDL) levels, and 
lowered the incidence of CVDs. Moreover, it was seen that rats 
fed by soy proteins have a higher lifespan than those fed by 
casein (Song et al., 2016). 
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CR and other dietary interventions are not always 
applicable. As just stated, solid evidence for the positive effect 
of efficient high-quality diet on human health, rather than a 
restricted intake, also exists. A close adherence to the 
Mediterranean Diet (MedDiet) or Okinawan one, that also 
include healthy lifestyle and low caloric intake, plays a central 
role in the incidence of age-related disabilities, such as CVDs, 
diabetes mellitus, and cancer, in a large population sample 
(Pallauf et al., 2013).  
Okinawans are the longest-living population in the 
world, according to reports made by the World Health 
Organization (WHO) and Japanese Ministry of Health. They 
seem to have delayed the ageing process and minimized the 
debilitating diseases that accompany the later years, especially 
CHDs. Much of the longevity advantage in Okinawa is related 
to its traditional diet which is low in calories but dense in 
vitamins, minerals, and phytonutrients. It is characterized by 
relatively high consumption of unrefined, low glycemic index 
sugars from vegetables, legumes and fruits, with moderate fish 
and marine food consumption (Willcox et al., 2007). 
Traditional Okinawan cuisine centers on the sweet potato, 
green-leafy or yellow-root vegetables, and soy (e.g. miso soup, 
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tofu or other incarnations of this legume) which accompanied 
almost every meal. Smaller servings of fish, noodles, or lean 
meats flavored with herbs, spices, and cooking oil are often 
associated with the Okinawan dishes (Willcox et al., 2014) (see 
Figure 5 for Okinawa diet pyramid).  
Several studies suggests that other factors play a 
fundamental role in Okinawans longevity including: high 
calcium intake from foods and natural drinking water, high 
flavonoid intake, high vitamin D levels from exposure to 
sunlight and increased physical activity, especially at older 
ages (Suzuki et al., 2001).  
Figure 5. Traditional Okinawa diet food pyramid (Willcox et al., 2014). 
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I.III Mediterranean diet: The most investigated
dietary pattern for achieving successful ageing 
Among the many dietary interventions, the MedDiet has 
received much attention since its beneficial influence on health 
and longevity has been consistently demonstrated (Table 2). 
Several clinical trials and some meta-analyses showed 
significant support for the positive effect of a greater adherence 
to the MedDiet on mortality and morbidity from different 
causes. So, it has been promoted as a model for healthy eating 
and contributes to a favorable health status and to a better 
quality of life (Martinez-Gonzalez et al., 2009; Sofi et al., 
2014; Sofi et al., 2008; Vasto et al., 2014a). 
Table 2. Macronutrient composition of MedDiet compared with other 
dietary interventions. 
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The traditional MedDiet, which more than a diet could 
be defined a lifestyle, is the common dietary pattern adopted by 
inhabitants of countries within Mediterranean basin where the 
olive tree, Olea europaea, is widely cultivated for the 
production of table olives and oil. It involves a set of 
knowledge, rituals, symbols, traditions, and cooking, that 
contribute to healthy lifestyle, reducing the risk of developing 
age-related diseases and disabilities, and promoting healthy 
ageing. Eating together is the foundation of the Mediterranean 
culture and the hospitality, neighborliness, intercultural 
dialogue are some of its fundamental aspects. For all these 
reasons, in 2010, the MedDiet was inscribed on the 
representative list of intangible cultural heritage of humanity 
(UNESCO, 2010). 
MedDiet was ﬁrst deﬁned by Ancel Keys as being low 
in saturated fat and high in vegetable oils, observed in Greece 
and Southern Italy during the 1960s. Keys and his colleagues 
hypothesized that it can have beneﬁcial effects on a range of 
diseases, indicating that it meets several important criteria for a 
healthy diet (Keys et al., 1965). 
A universally defined Mediterranean pattern does not 
exist as within the Mediterranean countries there are many 
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cultural, religious ethnicity, economic development and other 
factors that contribute to the diversity of dietary patterns 
(Trichopoulou 2012). Therefore, the concept of the ‘MedDiet’ 
is more accurate than the concept of a specific diet in 
particular. However, dietary patterns that prevail in the 
Mediterranean regions have many common characteristics such 
as: a high consumption of fruits, vegetables, legumes, and non-
refined cereals, including bread; a high ratio of 
monounsaturated to saturated dietary lipids (mainly olive oil); a 
moderate consumption of milk and dairy products; a low 
consumption of meat and meat products, and alcohol. Fish 
intake is a desirable characteristic of the MedDiet but it has 
depended on the proximity to the sea. Mediterranean lifestyle is 
also characterized by daily physical activities, the consumption 
of particular seasonal foods, and a high intake of β-carotene, 
group B, C, and E vitamins, folic acid, polyphenols and other 
phytochemicals (Trichopoulou A, 2004).  
This diet also consists of a low intake of animal proteins, it is 
hypocaloric, characterized by low amount of cholesterol and 
sugars, and a high content of fibers. Although it is quite 
difficult to define the type of fibers in MedDiet, this term is 
generally used to indicate the plant residues that are resistant to 
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digestion by enzymes from the intestinal lumen. The fibers are 
distinguished as either soluble or insoluble: soluble fibers 
acting mainly in the first part of the digestive tract (stomach 
and small intestine), with the insoluble fibers being more active 
in the terminal part of the digestive tract (large intestine).  
According to the American Diabetes Association, an adequate 
consumption of dietary fiber from a variety of plant foods, 
preserves populations from chronic disease. Indeed, the intake 
of dietary fiber has beneficial effects with regards to risk 
factors for developing several chronic diseases. Epidemiologic 
studies have shown that a suggested consumption of 14 g 
dietary fiber per 1,000 kcal, or 25 g for adult women and 38 g 
for adult men, gives protection against cardiovascular disease 
(Slavin et al., 2008). Moreover, it was highlighted that the 
fibers can promote the colonic health, by stimulating the 
growth of beneficial gut microflora (thus acting as prebiotics) 
(Del Chierico et al., 2014).  
Despite most people in the Mediterranean areas only 
partially adhering to MedDiet guidelines, there is a sufficient 
number of people, especially in some regions, where the 
presence of centenarians is high. This determines the link 
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between the MedDiet and health (Mirzaei at al., 2016; Vasto et 
al., 2014b). 
Nowadays, the data that support the role of  the 
MedDiet on health derive from biochemical, clinical and 
epidemiological research that are great in number and 
availability, and all confirm its association with reduced 
mortality in old age and with success both in improving 
cognitive function and reducing risk of chronic illnesses like 
cancer, metabolic syndrome, neurodegenerative pathologies, 
and, mostly, CVDs (Buckland et al, 2011; Chrysohoou et al., 
2013). This is true not only in Mediterranean basin, but also in 
northern Europe, Australia, Spain, the USA (Kiefte-de Jong et 
al., 2014), and in other countries were the MedDiet is 
widespread. 
For example, Sofi et al., in a meta-analysis, evaluated 
the correlation between a strict adherence to MedDiet and the 
low mortality for CVDs, CHDs and strokes in Mediterranean 
basin. They showed that an increase in MedDiet was inversely 
associated with death by CVDs (Sofi et al., 2014). In that 
regard, it has been established that moderate drinking of red 
wine, a typical Mediterranean beverage, reduces the risk of 
CVDs and CHDs, probably by increasing levels of serum high 
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density lipoprotein (HDL) cholesterol (Rimm et al., 1996). 
Moreover, more important is the intake of monounsaturated 
lipid, mostly from olive oil and olives that directly contributes 
to increased HDL cholesterol levels (Al-Khudairy et al., 2015). 
In addition, benefits attributed to MedDiet have emerged 
comparing the Mediterranean pattern with low-carbohydrate 
and high protein diets, which are often associated with 
metabolic syndrome and cancer (Fung et al., 2010). After all, a 
positive correlation between red and processed meats and risk 
of cancer or other age-related diseases such as diabetes, is 
already known (Wolk, 2016), and, conversely, there is strong 
evidence that the consumption of vegetables and fruits reduces 
the risk of most forms of cancer (Schwingshackl et al., 2016). 
Furthermore, consuming a diet with a high percentage 
of calories coming from added sugars has been linked to 
increased risk of obesity, type 2 diabetes mellitus, dyslipidemia 
and other risk factors for CVDs. In particular, prolonged 
consumption of added sugar is linked to an increase of LDL 
and to a decrease of HDL, and an increase of blood 
inflammatory markers (Malik et al., 2010a and b). 
In summary, as CR evidence on model organisms 
suggest, more beneficial effects of Mediterranean dietary 
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pattern are closely related to low glycaemic index (GI) and low 
animal protein intake. Both of them are able to act directly on 
NSPs. In particular, low glycaemic and protein intake could 
reduce blood glucose levels and therefore insulin release, 
downregulating insulin/IGF-1 and mTOR pathways, and, 
consequently, activating some transcription factors (TFs) 
implicated in the homeostatic gene transcription. It promotes 
longevity, decreases inflammatory status and oxidative stress. 
These beneficial effects could also be attributable to the 
presence of specific Mediterranean nutraceuticals and 
functional foods (see I.III.II).  
So, it is not certain that the MedDiet can fully 
explain the good health of Mediterranean people, but it appears 
unquestionable that it contributes to it preservation. 
I.III.I Focus on Mediterranean pyramid: History
and evolution 
Since 1995, the MedDiet has been popularized using 
a graphical representation of the pyramid, which has been 
updated over the years. The first MedDiet pyramid (MDP), 
created using the current nutrition research of that time, was 
based on the dietary traditions of Crete, Greece and southern 
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Italy in the early 1960s, where the rates of chronic diseases 
among these populations were the lowest in the world. 
This first pyramid was represented using the world 
famous pyramid representation that graphically highlights the 
food groups to be consumed daily, weekly or less frequently. It 
included regular physical activity and moderate consumption 
of wine, and was low in saturated fatty acids. The diet was 
characterized by abundant plant foods and derivatives (fruits, 
vegetables, breads, pasta, rice, polenta, potatoes, beans, nuts, 
and seeds), olive oil as the principal source of fats, and dairy 
products (principally cheese and yogurt). A daily intake of 
these foods was recommended. Fish and poultry were 
consumed in low to moderate amounts, zero to four eggs 
weekly, red meat, and sweets a few times for month (Figure 
6). 
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Figure 6. The traditional healthy MedDiet pyramid in 1960. 
In 2008, after the 15th Anniversary Mediterranean 
Diet Conference, a consensus position on a new revised MDP 
was promoted. The new feature of the MDP update was based 
on the definitive scientific evidence for the healthfulness of 
Mediterranean eating and drinking patterns. Three principal 
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modifications are incorporated in this updated MDP: all plant 
foods (fruits, vegetables, grains, mostly whole, nuts, legumes, 
seeds, olives and olive oil, herbs and spices) are placed in a 
single group at the base of the pyramid, indicating that they 
should be the basis of most meals; the frequency of 
consumption of fish and seafood is increased to at least two 
times per week, indicating their multiple contributions to brain 
and reproductive organ health; herbs and spices are added to 
the pyramid to reflect increased evidence of their health-
promoting characteristics and to contribute to the national 
identities of various Mediterranean cuisines (Figure 7). 
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Figure 7. The MedDiet pyramid in 2008. 
In 2010, after the recognition of the MedDiet as 
intangible cultural heritage of humanity by UNESCO, 
scientists present a third model of pyramid to evidence the 
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contribution of the strict adherence to this dietary pattern to a 
healthy life. The new revised MDP arises from the internal 
dialogues among scientific experts after the conference about 
‘The Mediterranean Diet today, a model of sustainable diet’ in 
Parma (Italy). This pyramid results from the latest research in 
the field of nutrition and health, scientific evidence around the 
healthiness of the Mediterranean dietary pattern, and its role in 
the prevention of many chronic diseases by large 
epidemiological studies. The final design of the MDP today 
provides key elements for the selection of foods, both 
quantitative and qualitative, indicating the relative proportions 
and consumption frequency. Plant-origin foods, that 
represented the heart of the MedDiet, are situated at the base of 
the pyramid, and are responsible for the prevention of many 
chronic diseases and for weight control. Moreover, at the base 
foods that provide a high energy intake are also present, and at 
the upper levels, foods to be eaten in moderate amounts such as 
those of animal origin and/or rich in sugars and fats. The 
pyramid establishes daily, weekly and occasional dietary 
guidelines in order to ensure a constant healthy and balanced 
diet. Among the recommendations regarding the proportion 
and frequency of food consumption, in the 2010 MDP the 
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cultural and lifestyle elements deemed necessary to acquire all 
the benefits from the MedDiet, and to preserve its cultural 
heritage, were incorporated (Bach-Faig et al., 2011) (Figure 
8). 
Figure 8. The MedDiet pyramid in 2010: A lifestyle for today (Bach-Faig 
et al., 2011). 
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I.III.II Mediterranean nutraceuticals and functional
foods: The role on healthy ageing 
In addition to the effects on NSPs, likely attributable 
to low GI and low animal protein intake, the MedDiet is 
renowned to be rich in plant foods and derivatives (fruits, 
vegetables, nuts, seeds, wine, olives and olives oil) which play 
a fundamental role in reducing some risk factors in age-related 
diseases (Vasto et al., 2014b). Recent clinical trials and 
epidemiological studies indicate that the putative beneficial 
effects of a high intake of fruits and vegetable on the risk of 
diseases of ageing may be due to antioxidant compounds. 
However, other non-antioxidant phytochemicals contained in 
plant foods may be equally important. 
In recent years, chemistry research into natural 
products has focused on the identification of biologically active 
secondary metabolites produced by plants, traditionally used as 
medicinal remedies. The most well-known of these being 
vitamins and minerals. Nevertheless, plants contain other 
secondary metabolites which are defined as “nutraceuticals” 
and which are at the center of important scientific studies. 
The term nutraceutical is a portmanteau word, a 
combination of “nutrition” and “pharmaceutical”. It was coined 
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by DeFelice in 1989 and refers to “Naturally derived bioactive 
compounds that are found in foods, dietary supplements and 
herbal products, and have health promoting, disease 
preventing, or medicinal properties” (DeFelice, 2002; Gupta et 
al., 2010). Nutraceuticals have, mainly, antioxidant and anti-
inflammatory effects that confer the MedDiet its anti-ageing 
features. They act on the inflammatory status and on the 
prevention of oxidative reactions, resulting in a significant 
reduction of all risk factors for CVDs. Furthermore, they result 
in the improvement of cognitive function and in the decrease of 
chronic degenerative disorders such as cancers, Alzheimer’s, 
Parkinson’s, and autoimmune diseases (Aruoma, 2003; Santoro 
et al., 2014; Vasto et al., 2014a; Visioli and Galli., 2001). 
Examples of Mediterranean nutraceuticals are: 
polyphenols, terpenoids, flavonoids, alkaloids, sterols, 
pigments, vitamins, and unsaturated fatty acids. All the foods 
that contain these compounds can be considered as “functional 
foods”. Although a universal definition of them does not exist, 
the Functional Food Center defined them as “Natural or 
processed foods that contain known or unknown biologically-
active compounds; which, in defined, effective non-toxic 
amounts, provide a clinically proven and documented health 
54 
benefit for the prevention, management, or treatment of chronic 
disease” (Martirosyan and Singh, 2015). 
Among nutraceuticals, epidemiological studies have 
attributed many of positive effects on wellness to the presence 
of polyphenols, compounds having antioxidant activity. From a 
chemical point of view, they are classified as phenolic acids, 
flavonoids, stilbenes, and lignans, and are widely present in 
fruits and vegetables, including those found in the 
Mediterranean. In plants, they are involved in the defence 
against pathogen attacks or stress induced by chemical and 
physical damage. Flavonoids, such as flavones, anthocyanins, 
flavans, isoflavones, and so on, contained in fruits, vegetable 
and legumes, act as protection against diseases such as cancer 
and CVDs in humans. They also possess anti-allergic, anti-
inflammatory, antiviral, anti-proliferative, and anti-
carcinogenic properties (Prior and Cao, 2000). Catechins and 
procyanidins, contained in the seeds and skins of grapes, are 
the major constituents of red wine, along with resveratrol 
(Greca and Zarrelli, 2012). They are also found in chocolate, 
other fruits, and vegetables. Their importance has been 
extensively demonstrated in literature and, in particular, their 
role as an inhibitor of cancer cells, in the reduction of 
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atherosclerotic plaques, and in the prevention of CVDs 
(increasing HDL and lowering LDL blood levels, and 
inhibiting LDL oxidation) is particularly interesting (Ruidavets 
al., 2000). Anthocyanins, another group of flavonoids, like 
quercetin, are present in fruits with purple skins such as red 
grapes, blueberries and strawberries, and are correlated with a 
minor risk of type 2 diabetes mellitus (Muraki et al., 2013; 
Wedick et al., 2012). Anthocyanins too have interesting 
antioxidant and anti-inflammatory power which is explicated in 
cardio-protective effects, principally through the action on 
LDL blood levels. Additionally, resveratrol, an antioxidant non 
flavonoid polyphenol (mainly found in red grapes and red 
wine), lycopene and other carotenoids (pigments found in 
tomatoes and in other yellow and orange fruits and vegetables), 
and folic acid, in general, can alleviate the inflammation in the 
cardiovascular degenerative processes, such as atherosclerosis, 
improving nitric oxide (NO) release and the endothelial 
function (Accardi et al., 2016a). 
These natural substances, consumed as fresh foods or 
fresh extracts, are always more active than other preparations 
because of the absence of deterioration due to the processing, 
and have a greater intestinal absorbability. 
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Most likely, some polyphenols carry out their 
antioxidant effects by reducing the expression of some TFs, 
like kappa-light-chain-enhancer of activated B cells (NF-κB), 
implicated in the inflammatory process, and by enhancing the 
activation of proteins, like sirtuins, that also by inhibiting NF-
κB, can reduce the cellular stress response (Vasto et al., 
2014a). Moreover, new data have suggested that a small 
amount of polyphenols is able to promote other cellular stress 
response pathways, for example the nuclear factor erythroid 2-
related factor 2 (Nrf2) that activates genes encoding 
antioxidant enzymes. 
Another class of nutraceuticals with anti-inflammatory 
effects are mono/poly unsaturated fatty acids (MUFA and 
PUFA), like oleic acid, omega-3 and omega-6. Numerous 
studies have demonstrated that the ingestion of fats rich in 
omega-6 and omega-3 fatty acids suppress de novo hepatic 
fatty acid biosynthesis, triglyceride production and triglyceride 
secretion, while they enhance hepatic and skeletal muscle fatty 
acid oxidation (Clarke et al., 2002). In addition, regulating 
lipid metabolism, unsaturated fatty acids may improve insulin 
sensitivity and increase non-oxidative glucose metabolism. 
Moreover, they are important for governing the rate of 
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conversion of dietary carbohydrate to fatty acids and 
triglycerides. It can be speculated that a diet rich in olive oil, 
abundant in MUFA, combined with a balance of dietary fat 
derived from marine and vegetable lipids, rich in PUFA, may 
reduce the risks associated with excessive tissue triglyceride 
accumulation, which in turn may delay the onset of obesity and 
type 2 diabetes mellitus (Vasto et al., 2014a). 
So, nutraceutics is the science that deals with the study 
of foods, or parts of those foods, that have particular beneficial, 
preventative and therapeutic effects on human health. Often the 
word nutraceutical is compared to the adjective “functional” 
even if a functional food is not necessarily said to be a 
nutraceutical. A food is therefore considered to be functional 
when it is used as for its ability to prevent or treat specific 
diseases. 
Functional foods are: yoghurt, some fruits and 
vegetables rich in antioxidants, such as broccoli, olives, 
Opuntia Ficus Indica (OFI), olive oil, nuts, and foods enriched 
with nutraceutical extracts or with fibers. Several careful 
studies on Mediterranean populations, whose traditional diets 
consist largely in these foods, show low incidences of certain 
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chronic diseases and long life expectancies (Ortega, 2006) (see 
Figure 9 for the main Mediterranean functional foods). 
Growing evidence suggests that extra virgin olive oil 
(EVOO), the main source of fat for Mediterranean people, 
must play a key role in explaining the health benefits of the 
MedDiet.  
It is the juice of olives obtained by a mechanical procedure and 
consumed after washing, filtration, and decantation, or 
centrifugation, and under controlled temperatures that will not 
harm the oil (Virruso et al., 2014). It is used for cooking and as 
a dressing and its nutraceutical properties derive from the 
presence of a complex mixture of about 200 bioactive 
compounds. EVOO composition depends on many factors 
which include geographical origin, weather and irrigation, 
ripening and processing after harvesting. The main constituents 
of olive oil are triglycerides, the so-called “saponifable 
fraction” (98–99%). The three main fatty acids in the 
triglyceride fraction are: a MUFA (oleic acid), a saturated fatty 
acid (palmitic acid) and a PUFA (linoleic acid). The remaining 
“unsaponifable fraction” (1-2%) contains about 230 bioactive 
molecules. These include: lipophilic phenols (tocopherols) 
whose levels fall as olives mature; sterols; color pigments, 
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mainly chlorophylls and carotenoids (the most important being 
beta-carotene); alcohols; waxes, aldehydes, esters, and ketones; 
and phenolic compounds (hydrophilic phenols). Their quantity 
is strongly influenced by the variety and the geographical 
origin of the olives. For example, Greek Koroneiki olives have 
a very high level of polyphenols, while the polyphenol content 
of the Spanish Arbequina variety is low, and the polyphenol 
content of Sicilian Nocellara is medium-high (Aiello et al., 
2015). 
Evidence shows that EVOO decreases the pro-
inflammatory environment, induced by oxidized LDL, both in 
experimental models and in humans, also reducing the C- 
reactive protein, a powerful marker of inflammation, and the 
interleukin (IL)-6 levels, as shown in dietary interventions 
(Schwingshackl et al, 2015). With its high content of MUFAs 
and polyphenols, EVOO might exert beneficial effects on the 
development and progression of age-related diseases. Oleic 
acid is the main MUFA and is claimed to decrease LDL 
oxidation. It has also been suggested that MUFA can decrease 
all-cause (11%) and cardiovascular mortality (12%), 
cardiovascular events (9%), as well as strokes (17%) 
(Schwingshackl et al, 2015). Moreover, oleic acid suppresses 
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cytotoxic function of natural killer cells and consequently the 
anti-inflammatory effect (Yaqoob et al., 1994). In general, 
unsaturated fatty acids improve endothelial function, 
decreasing intercellular adhesion molecule-1 production by 
endothelial cells, and reducing leukocyte adhesion (Bemelmans 
et al., 2002). In fact, both in vitro and in vivo studies, 
demonstrated the endothelium-protective properties of these 
molecules (Accardi et al., 2016a; Schwingshackl et al, 2015; 
Virruso et al., 2014). Different trials showed that polyphenol 
EVOO intake has been associated with low mortality rates 
caused by CHDs (Saita et al., 2015). Indeed, these compounds 
are able to bind LDL, increasing resistance to oxidation and 
acting as radical scavengers (Gimeno et al., 2007). Moreover, it 
was seen that the consumption of polyphenol-rich olive oil can 
decrease blood pressure and improve endothelial function in 
young women with high-normal blood pressure (Moreno-Luna 
et al, 2012). Generally, polyphenols inhibit NF-B pathway 
that lead to the expression of pro-inflammatory genes. In 
particular, hydroxytyrosol and oleocanthal have ibuprofen-like 
activity, inhibiting cyclooxygenases 1 and 2, responsible for 
prostaglandin production (Virruso et al., 2014). 
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Several health claims for EVOO and its derivatives 
have been assessed but only one was authorized in Europe. It 
relates to the impact of olive phenolic compounds on the 
protection of blood lipids from oxidative stress: “A daily intake 
of 20 g of olive oil, which contains at least 5 mg of 
hydroxytyrosol and its derivatives (e.g., oleuropein and tyrosol) 
provides the expected beneficial effects” (European 
Community, 2007). 
Moreover, our pilot study demonstrated that daily 
consumption of green table olives Nocellara del Belice is likely 
linked to a decrease in IL-6 and malondialdehyde (MDA) 
levels (Accardi et al., 2016b). MDA is the main product of the 
PUFA peroxidation and is an important index of oxidative 
stress (Czerska et al., 2015). It is worth noting that our study 
highlighted a reduction of fat mass with an increase of muscle 
mass of subjects recruited for the nutritional intervention. The 
possible explanation could be linked to the capacity of 
conjugated linoleic acid (CLA) to reduce the body fat levels, 
strictly linked with the production of adipokines (pro-
inflammatory cytokines) (Lehnen et al., 2015). CLA is present 
both in EVOO and table olives, and can also be produced 
during their digestion. In experimental models, acting as 
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signalling mediators, CLA inhibits lipogenesis, increases fat 
oxidation, and reduces adipocytes size (Fazzari et al., 2014; 
Wang et al., 2004) (see VI.). 
Furthermore, pasta is another traditional food of 
MedDiet. The possibility to enrich it with fibers, that lower the 
GI, make pasta a product eligible to be a processed functional 
food (Bjork et al., 2000; Tudorica et al., 2002). In particular, it 
is known that (1-3, 1-4)-β-D-glucans, commonly referred to as 
β-D-glucans, are one of the most abundant forms of 
polysaccharides found in the cell wall of yeasts, fungi, some 
bacteria, algae and cereals. They are soluble fibers, contained 
from 1% in wheat grains, to 3-7% in oats, and 5-11% in barley 
(Skendi et al., 2003). These soluble dietary fibers have 
hypocholesterolemic effects, which improve glycemic control 
(Jenkins et al., 2000). The effect on cholesterol depends on the 
ability to form a viscous layer on the surface of the small 
intestine. The higher viscosity reduces the intestinal absorption 
of cholesterol and the reabsorption of bile acids. The inhibition 
of the reabsorption of bile acids can increase the synthesis of 
bile acids from endogenous cholesterol, and reduces the 
circulation of cholesterol LDL by about 8 % (Othman et al., 
2011). A minimum dose of 3 g/day of β-glucans has been 
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suggested to reduce the levels of cholesterol in the blood and 
decrease the risk of cardiovascular diseases. In a recent pilot 
study, our group demonstrated that after 30 days of intake of 
pasta with 6% of β-glucans, there was a significant decrease of 
LDL-cholesterol, IL-6 and advanced glycation end-products 
(AGEs), confirming the capacity of β-glucans intake to lower 
oxidative stress and inflammatory status (Barera et al., 2016). 
Successively, we showed that the same pasta was able to 
increase endogenous levels of some gut hormones such as 
glucagon like peptide (GLP)-1 and  peptide YY (PYY), 
implicated in the modulation of glucose tolerance and food 
intake. This intervention also showed a promising effect on gut 
microbiota changes (see VII.). 
Finally, the increased prevalence of obesity and 
metabolic syndrome has led the proliferation of various 
supplements on market with varying claims of effectiveness. 
Some of these supplements consist of OFI extracts, a typical 
and widespread plant of the Mediterranean basin (Onakpoya et 
al., 2015).  
OFI is a domesticated cactus plant and its fruits were often 
investigated for their antioxidant and anti-inflammatory 
properties. Its leaves, the cladodes, contain mainly pectins, 
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carotenotenoids, polysaccharides, polyphenols, vitamins, 
polyunsaturated fatty and amino acids, and their extracts, rich 
in fibers, have health positive effects. The identified natural 
OFI compounds and derivatives were shown to have 
biologically relevant activities including hypoglycemic, 
antimicrobial and neuroprotective properties (El-Mostafa et al., 
2014). In humans, the consumption of OFI seems to confer 
protection against peptic ulcers and to improve platelet 
function, and it represents a natural remedy for 
gastroesophageal reflux. Randomized and nonrandomized 
human studies have shown that OFI could attenuate 
postprandial hyperglycemia by stimulating glucose uptake in 
the peripheral tissues, and reduce total cholesterol (TC), LDL 
levels, and triacylglycerols in patients with dyslipidemias, 
though unknown mechanisms (Alecci et al., 2016; Onakpoya et 
al., 2015). 
These promising evidence has stimulated our group to 
study the actual properties and effects of a pasta made with 
OFI cladode extracts on hematochemical, anti-inflammatory, 
antioxidant and anthropometric parameters, to test its potential 
hypoglycemic, hypocholesterolemic and weight loss properties 
and its possible modulator action on gut microbiota (see VIII.). 
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Figure 9. The main Mediterranean functional foods and their health 
benefits. Among the functional food present in the MedDiet are fruits and 
vegetables, nuts, olives and olive oil, as the prevalent fats for dressing, fish, 
as the main source of protein and polyunsaturated/saturated fats. The health 
benefits coming from the food of the Mediterranean diet resides on the 
presence of bioactive compounds such as polyphenols, carotenoids, 
phytosterols, fibers, MUFA and PUFA, displaying antioxidant activity, 
protection from cancer and hypertension, and improvement of the intestinal 
functions. 
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II. Aim of the thesis: Different approaches to
investigate the role of functional foods on human healthy 
ageing 
The interventions to slow or postpone ageing, favoring 
the health-span, represent the new challenges in ageing 
investigation (Longo et al., 2015). Some mechanisms that 
delay and prevent the onset of ageing disabilities have been 
identified and lifestyle, nutrition and pharmacological 
approaches have emerged.  
In particular, as it is clear from this thesis work, eating 
habits represents the most concrete way to act on the ageing 
process, extending our productive lives, without frailty. 
Thus, the aim of my PhD research was to investigate 
the role of Mediterranean functional foods on health, focusing 
the attention on their anti-inflammatory and antioxidant effects, 
and on the possible action on microbiota alterations. 
At first, we explored the literature to summarize the 
existing data regarding the beneficial properties of the MedDiet 
on healthy ageing and on the molecular pathways that are the 
basis of these effects. So, we have identified some foods with 
nutraceutical capacities, and we have tested them through in 
vivo nutritional interventions. In particular, we analyzed three 
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Mediterranean functional foods: table green olives Nocellara 
del Belice, a pasta enriched with 6% of β-glucans, and a pasta 
with 3% of OFI cladode extracts added. After, we decided to 
test some EVOO extracts on peripheral blood mononuclear 
cells (PBMCs, ex vivo interventions), obtained from volunteer 
recruitment.  
II.I In vivo studies: the nutritional intervention
A nutritional intervention is a clinical study involving 
human volunteers, also called participants, who have 
conscientiously decided to lend themselves to the service of 
science. During the intervention, the participants are subjected 
to a specific diet or to require to consume specific food, or part 
of this, with the aim to analyze its action on some health 
parameters. To date, these trials represent the best model to 
study the consequence of nutrition in humans.  
We performed three nutritional interventions to evaluate 
the effect of table green olives, pasta with β-glucans, and pasta 
with OFI cladode extracts, on clinical and biological 
parameters of engaged individuals. In the first case, we 
recruited 25 randomized volunteers, both men and women. The 
subjects included were: healthy, aged between 18 and 65, and 
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Caucasian. The trial consisted in the consumption of 12 
olives/day for 30 days. The green olives belonged to the variety 
Nocellara del Belice, and were processed in salt solution 
without any chemical additives. At baseline (T0) and at the end 
of the intervention (T1), hematochemical tests, oxidative stress 
and cytokine analyses, anthropometric measurements, and 
microbiological analyses on feces, were carried out (see VI.) 
The second nutritional intervention consisted of the 
consumption of 100 g of pasta supplemented with β-glucans, 4 
times a week, for 30 days. We enrolled 10 overweight 
participants, selected between young volunteers. Before and 
after 30 days of pasta intake, hematochemical analysis have 
been performed, and some gut hormones, linked to the food 
intake and glucose tolerance, have been measured. Stool 
specimens have been studied for the study of microbiota 
alterations after the trial (see VII.).  
During the third study, we recruited 41 randomized 
volunteers with metabolic syndrome, both men and women, 
with an average age of 47.5. The subjects had to consume 500 
g/week of pasta with Opuntia, for 30 days. At T0, and after 30 
days (T1), anthropometric measurements, hematochemical, 
oxidative stress and cytokines analyses were performed. 
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Further molecular analyses, using qPCR assays, were 
conducted on total faecal DNA, to measure the variation of its 
amount. (see VIII.). See Figure 10 for the flow-chart of the 
three studies. 
 
 
 
Figure 10. Flow-chart of the nutritional interventions. 
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II.II Ex vivo studies: Cell culture of peripheral blood
mononuclear cells 
During the second year of my PhD research activity, I 
spent three months at the Instituto Maimónides de 
Investigación Biomédica de Córdoba (IMIBIC), in Spain, for 
an Erasmus plus traineeship. In this period, I learned how to set 
up conveniently treated cell culture of PBMCs.  
So, in collaboration with University of Magna Graecia 
of Catanzaro, our group decided to test the antioxidant and 
anti-inflammatory activities of oleuropein, hydroxytyrosol and 
their paracetylated derivates on PBMCs, using an ex vivo 
cellular screening system. The cells were extracted from 14 
whole blood samples of volunteers subjects (age 23-65), 
cultured and incubated with the above mentioned extracts. See 
IX. for the experimental protocol.
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III. What olive oil for healthy
ageing? 
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The olive tree originated in Asia Minor around 6000 years ago
nd then spread toall theMediterraneanbasin.Oliveoil is extracted
rom the pulp of its fruits [1–3]. Many studies show that the nutri-
ionalpatternof the so-calledMediterraneanDiet is associatedwith
lower incidence of age-related diseases related to inﬂammation
nd oxidative stress, such as cardiovascular disease, Parkinson’s
isease, Alzheimer’s disease and cancer [4–7]. It is now clear that
live oil, as a main source of fat, must play a key role in explaining
he health beneﬁts of the Mediterranean Diet.
So what is in olive oil? It is a complex mixture of over 200
ompounds. The composition depends on many factors which
nclude geographical origin, weather and irrigation, ripening and
rocessing after harvesting. Thus all olive oils are not all the same.
he main constituents of olive oil are triglycerides, the so-called
he saponifable fraction (98–99%). The three main fatty acids in
he triglyceride fraction are a monounsaturated fatty acid (oleic
cid), a saturated fatty acid (palmitic acid) and a polyunsaturated
atty acid (linoleic acid) [1–3]. The remaining unsaponifable frac-
ion (1–2%) contains about 230 components. These include: (i)
ipophilic phenols (tocopherols) whose levels fall as olives mature;
ii) sterols the main sterol being beta-sitosterol; (iii) colour pig-
ents, mainly chlorophylls and carotenoids (the most important is
eta-carotene); (iv) alcohols; (v)waxes, aldehydes, esters, ketones;
nd (vi) phenolic compounds (hydrophilic phenols). The phenolic
raction of olive oil are polyphenols of which there are 7 differ-
nt subfamilies: anthocyanins, ﬂavonoids, ﬂavones, phenolic acids,
henolic alcohols, acids and secoiridoids. Their amount is strongly
nﬂuenced by the variety and the geographical origin of the olives.
reek Koroneiki olives have a very high level of polyphenols, while
he polyphenol content of the Spanish Arbequina variety is low
nd the polyphenol content of SicilianNocellara ismedium-high. In
ddition oil produced fromgreen olives containsmore polyphenols
han that obtained from more mature fruit. Furthermore heating,
ethod of extraction, or long processing times and inappropriate
torage and packaging can result in polyphenol loss.
This variation in composition has led to an EU directive 2568/91
lassifying olive oil (OO) according to quality and purity criteria:
i) virgin olive oil (extra virgin olive oil -EVOO-, virgin olive oil r
ttp://dx.doi.org/10.1016/j.maturitas.2014.10.016
378-5122/© 2014 Published by Elsevier Ireland Ltd.VOO- and lampante olive oil -LOO-), (ii) reﬁned olive oil -ROO-
nd (iii) olive oil -OO- (4,5). EVOO (free acidity, expressed as oleic
cid, not more than 0.8%) is obtained by mechanical processing,
r “cold pressing”, that preserves polyphenols. VOO (free acid-
ty, expressed as oleic acid, not more than 0.2%) is also obtained
y processes that include washing olives with water, milling,
old pressing and centrifugation. VOO maintains relatively high
mounts of unsaponiﬁable compounds and a large amount of phe-
olic fractions or tocopherols, but during reﬁning, the majority of
olyphenols are subsequently lost [5]. LOO is the virgin olive oil
hich has a free acidity, expressed as oleic acid, more than 2%.
owever it is not suitable as food because of its high acidity, poor
avour and unpleasant smell unless it is reﬁned. It is a poor quality
il. ROO (free acidity, expressed as oleic acid, not more than 0.3%) is
btained from virgin olive oils by reﬁning methods such as ﬁltering
ith charcoal or other chemical or physical ﬁlters. This leads to a
eduction in polyphenols [5]. OO is a mix of reﬁned and virgin oil
other than lampante olive oil; free acidity, expressed as oleic acid,
otmore than0.1%). The term indicates anOOobtainedbyblending
eﬁned olive oil and virgin olive oil other than lampante olive oil.
But, what olive oil is recommended for healthy ageing? As dis-
ussed below, the positive effects mostly depend on polyphenols,
nd EVOO should represent the best choice for healthy ageing.
any studies now support this idea.
Oleic acid represents the topmost monounsaturated fatty acid
MUFA) provided in the diet (∼90% of all MUFA) and is the main
onounsaturated fatty acid of olive oil. In South-Europe it ismostly
rovided by olive oil, whereas in the other Western countries it is
rovidedbymeatandmeatproducts, added fats, anddairyproducts
8]. Oleic acid is claimed to increase the resistance of low-density
ipoprotein (LDL) tooxidationand, consequently, reduces the riskof
therosclerosis. It has also been suggested thatMUFAoffers protec-
ion from age-related cognitive decline and might be responsible
or the hypotensive effects of OO [4,6–8]. However the source of
UFA seems to be important as shown by a recent meta-analysis.
t found an overall risk reduction of all-cause mortality (11%), car-
iovascular mortality (12%), cardiovascular events (9%), and stroke
17%) when comparing the top versus bottom third of MUFA, olive
il, oleic acid, and MUFA: saturated fatty acid ratio. MUFA of mixed
nimal and vegetable sources per se did not yield any signiﬁcant
ffects on these outcomeparameters.However, only olive oil seems
o be associated with reduced risk. When focusing on virgin olive
il consumption, the inverse correlation between olive oil and CVD
isk found in the meta-analysis is consistent with the fact that olive
tas 80
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oil is not just a source of MUFA but also of other biologically active
components [8].
OO also contains phenolic compounds (hydroxytyrosol, oleu-
ropein) which have antioxidant, anti-inﬂammatory and anti-
microbial properties. [4,9]. These are thought to reduce atheroscle-
rotic plaque formation and to be neuroprotective [10–12]. There
is a European Food Safety Authority (EFSA) approved health claim
on olive oil polyphenols (Commission Regulation (EU) 432/2012):
‘Olive oil polyphenols contribute to the protection of blood lipids
from oxidative stress. The claim may be used only for olive oil,
containing at least 5mg of hydroxytyrosol and its derivatives (e.g.
oleuropeincomplexand tyrosol)per20gofoliveoil. Inorder tobear
the claim information shall be given to the consumer that the ben-
eﬁcial effect is obtained with a daily intake of 20g of olive oil [13].’
Identiﬁcation of the best olive oil for healthy aging remains a
complex issue dependent not only on the polyphenol content but
also on the amount consumed. Extra virgin oil with the highest
polyphenol content seems to offer the most beneﬁts.
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a b s t r a c t
Ageing is characterized by a decline in all systemic functions. A greater susceptibility to apoptosis and
senescence may contribute to proliferative and functional impairment of endothelial progenitor cells.
Theyplay an important role inneo-angiogenesis andendothelial repair. Vascular ageing is associatedwith
changes in the structure and functions of vessels’ wall. There are many possible causes of this damage.
For sure, inﬂammation and oxidative stress play a fundamental role in the pathogenesis of endothelial
dysfunction, commonly attributed to a reduced availability of nitric oxide. Inﬂammageing, the chronic
low-grade inﬂammation that characterizes elderly people, aggravates vascular pathology and provokes
atherosclerosis, the major cardiovascular disease. Nutraceutical and molecular biology represent new
insights in this ﬁeld. In fact, the ﬁrst could represent a possible treatment in the prevention or delay ofutraceuticals vascular ageing; the second could offer new possible targets for potential therapeutic interventions. In
this review, we pay attention on the causes of vascular ageing and on the effects of nutraceuticals on it.
© 2016 Elsevier Ireland Ltd. All rights reserved.
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As quoted in Lim and Townsend, (2009), “Longevity is a vascular
uestion, which has been well expressed in the axiom that man is only
s old as his arteries” (Sir William Osler, 1891).
Many experimental evidences have shown that advancing age
s the major risk factor for the development of vascular endothelial
ysfunction that, in turn, increases the riskof developing cardiovas-
ular diseases (CVDs), themain cause of death inWestern countries
Ras et al., 2013).
In the last decades, vascular endotheliumhas conquered impor-
ance because of extraordinary versatility of its functions. It plays
crucial role in homeostasis by the regulation of vascular tone,
lood cell trafﬁcking, immune response, and physiological vascular
tructure.
Blood vessels are composed of three layers: an intimal mono-
ayer of endothelial cells (ECs), medial vascular smooth muscle
nd the adventitia or tunica externa. Vascular ECs synthesize and
elease a wide array of biologically active molecules which act
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047-6374/© 2016 Elsevier Ireland Ltd. All rights reserved.n autocrine or paracrine manner to modulate arterial structure
nd vasodilatory, thrombolytic and vasoprotective functions. The
ediators released from them in response to biochemical and
echanical stimuli induceanalterationof endothelium-dependent
asodilation, deﬁned as endothelial dysfunction. This condition
eﬂects a disrupted balance between endothelial injury and repair
echanisms and is correlated with several disorders present in
geing, such as CVDs, renal dysfunction, Alzheimer’s disease or
etinopathy (Coleman et al., 2008; Csiszar et al., 2007; Price et al.,
004). Recent works focused on endothelial progenitor cells (EPCs)
s an important contributor to endogenous vascular repair, par-
icipating in new vessel formation and endothelial regeneration
Balistreri et al., 2015; Kim et al., 2010).
EPCs are a subset of mononuclear cells derived from heman-
ioblast cells in the bone marrow that have the ability to
ifferentiate into mature ECs. Since their discovery, about a decade
go, a plethora of evidences has supported their existence, ori-
ins, and contribution in new blood vessel formation. Circulating
PCs are recruited to endothelial tissues, suffering from hypoxia,
nd attend to both blood vessel formation and repair, in affected
issues (Yoder, 2012). They can be identiﬁed by cellular morphol-
gy, including speciﬁc cell surface proteins, and by examining the
xpression of genes encoding surface markers (Balistreri et al.,
015). In the bone marrow or immediately after their migration
nto the systemic circulation, early EPCs are positive for CD133,
eing a64 G. Accardi et al. / Mechanisms of Ag
CD34, and vascular endothelial growth factor (VEGF) receptor-2,
whereas mature circulating EPCs show a high expression of CD34,
VEGF receptor-2, VE-cadherin, and von Willebrand factor. These
data suggest that the loss of CD133 may explain the transformation
of circulating EPCs into mature endothelial-like cells. However, it
is unclear when they lose CD133 (Harraz et al., 2001).
Clinically, vascular ECs are involved in all cardinal signs of
inﬂammation, such as vasodilatation and increased endothelial
permeability.
Nowadays, there is a substantial interest in the potential pro-
tective effect of lifestyle in vascular damage. The adherence to
Mediterranean diet (MD) reduces oxidative stress and acts posi-
tively on inﬂammatory state (Santoro et al., 2014). Moreover, it
improves the regenerative capacity of the endothelium, increasing
the number of EPCs (Marin et al., 2011). These effects are mediated
bynutraceuticals, present inmanyMediterranean foods. TheWorld
Health Organization deﬁnes them as “naturally derived bioactive
compounds that are found in foods, dietary supplements andherbal
products, andhavehealthpromoting, diseasepreventing, ormedic-
inal properties”. The term, coming from the conjunction between
nutrition and pharmaceutics, was coined in 1989 by Stephen De
Felice.
In this review, we have focused on the causes of vascular ageing
andhowMediterraneannutraceutical foodsmay improveendothe-
lial damage that, ultimately, represents a balance between the
magnitude of injury and the capacity for repair. The criteria used
to select the mentioned studies depended on the interests and the
relevance of the papers with the studies conducted by the authors.
Principally, we focused on human data.
2. Role of nitric oxide in vascular endothelium
Inﬂammation and oxidative stress play a fundamental role in
the pathogenesis of endothelial dysfunction, which is commonly
attributed to a reduced availability of nitric oxide (NO).
NO is essential for a functional endothelium. In ECs, it regulates
the degree of contraction of vascular smooth muscle cells, platelet
aggregation, leukocyte adhesion, and endothelial junctional per-
meability. These functions are mediated by the stimulation of
soluble guanylyl cyclase to produce cyclic guanosine monophos-
phate (cGMP). cGMP activates the cGMP-dependent protein kinase
(PKG), which mediates most of NO physiological effects. The
NO/cGMP/PKGsignalingpathway is dysregulated in several inﬂam-
matory diseases, such as Diabetes Mellitus (DM) (Huynh et al.,
2014). A new role for the NO/cGMP/PKG pathway has been sug-
gested in vascular endothelium. It was observed that NO inhibits
endothelial gene expressionof transforminggrowth factor (TGF)-,
which conducts amajor role in the vascular response to injury.Mice
deﬁcient in TGF- die in utero because of vascular defects. Con-
versely, blood vessels that overexpress TGF- develop neointimal
formation (Saura et al., 2005).
Some researchers have suggested that the reduction of
NO bioavailability associated with endothelial dysfunction may
increase TGF- responses, contributing to the pathogenesis of
some vascular diseases. NO is produced by three isoforms of
NO synthase (NOS), endothelial (eNOS), neuronal, and inducible
(iNOS). In endothelial cells, the latter is under control of tran-
scription factors, which are activated by inﬂammatory cytokines.
Moreover, it is capable of increasing overall NO production, far
beyond the levels produced by eNOS. All three NOS isozymes have
regulatory functions in the cardiovascular system. A common fea-
ture of aged vessels is the reduced bioavailability of NO and the
increased production of reactive oxygen species (ROS), which lead
to endothelium dysfunction (Morris and Billiar, 1994). Further-
more, it was observed that diminished NO bioavailability reducesnd Development 159 (2016) 63–70
the mobilization of EPCs, impairing endogenous vascular repair
mechanisms (Aicher et al., 2003).
3. Inﬂammageing: the role in endothelial dysfunction
In last century, prevalenceofCVD is signiﬁcantly increased in the
olderpopulation.Apossible linkbetweenCVDandageingprocess is
represented by chronic low-grade inﬂammation that characterizes
elderly people, termed “inﬂammageing” by Franceschi et al. (2000).
It is known that systemic inﬂammation linked to inﬂammageing
aggravates the vascular pathology and provokes atherosclerosis
(Bonetti et al., 2003; Incalcaterra et al., 2013).
Inﬂammageing is an important risk factor for both morbidity
and mortality in the elderly. It appears to be involved in the patho-
genesis of all age-related diseases, such as atherosclerosis, CVDs,
type 2 diabetes, metabolic syndrome, sarcopenia, osteoporosis,
cognitive decline and frailty, giving rise to the so-called “diseasome
of inﬂammageing” (Franceschi and Campisi, 2014).
An increased expression of genes involved in inﬂammation and
immune responses, higher level of pro-inﬂammatory cytokines in
serum, as well as the activation of Nuclear Factor kappa B (NF-B)
transcription factor signaling, are characteristicmarkers of the pro-
inﬂammatory phenotype in aged mammals (Wu et al., 2015).
The most important role in this pro-inﬂammatory state seems
to be played by chronic antigenic stress. However, the trigger of
the age-related inﬂammatory diseases is the interaction between
chronic antigenic stress, genetic background and environmen-
tal factors. In addition, other important stressors are ROS and
additional products of oxidativemetabolism.Asknown,ROShyper-
production and accumulation induce tissue damage, acting on
important cellular components, such as lipid membranes, enzy-
matic and structural proteins and nucleic acids. Consequently to
inﬂammageing and increased ROS production, older persons dis-
play a global reduction in the capability to cope to stressors.
Moreover, they show a concomitant increase in pro-inﬂammatory
markers and acute phase proteins. The gene expression of these
inﬂammatory markers is modulated by NF-B, which is acti-
vated by the Inhibitor of NF-B Kinase/NF-B inducing Kinase and
Mitogen-activated Protein Kinase pathways. NF-B appears to be
the major intracellular signaling peptide, mediating the increased
expression of endothelial adhesion molecules. In addition, it was
observedamarkedactivationof inﬂammatorypathways, especially
NF-B, into the vascular wall of DM subjects suggesting its role in
the development of endothelial dysfunction (Huynh et al., 2014).
As above discussed, vascular endothelium plays a key role in
regulating function and health of arteries. Several researches sug-
gested that with progressive ageing ECs and smooth muscle cells
undergo to changes leading arterial stiffness. Arterial endothelial
dysfunction refers to functional alterations in the normal endothe-
lial phenotype of arteries that may contribute to the development
of atherosclerosis and other vascular disorders (Widlansky et al.,
2003). In particular, during ageing inﬂammatory responses, ECs are
phenotypically converted into an activated state that can lead to
vasoconstriction, coagulation, and inﬂammation.
Recent studieshaveclearly indicated that the increasedROSpro-
duction can induce the activation of inﬂammasomes, in particular
Nod like receptor 3 (NLRP3). It is an intracellularmultiprotein com-
plex that recognizes pathogen-associated molecular patterns and
activates caspase 1, promoting the release of the pro-inﬂammatory
cytokines interleukin (IL)-1 and IL-18 in macrophages. These
cytokines provoke a low-grade inﬂammation in several tissues and,
in that way, accelerate ageing process by inhibiting autophagy.
Interestingly, NF-B signaling is a crucial inducer of NLRP3 expres-
sion (Salminen et al., 2012).
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Autophagy is an ancient housekeeping mechanism, which con-
rols the turnover of cellular organelles and proteins. Accumulating
vidences have clearly indicated that autophagy can suppress
nﬂammatory reactions. Ageing is associated with a decline in
utophagy, which impairs cellular housekeeping. This alteration
eads to protein aggregation and accumulation of dysfunctional
itochondria, which provoke ROS production and oxidative stress.
Genetic studies showed that disturbed interplay between
utophagy and the inﬂammasomes could be a link between inﬂam-
ageing and vascular pathologies. It was demonstrated that the
oss of autophagy proteins, such as Atg16L1, potentiates the pro-
uction of IL-1 (Saitoh et al., 2008; Wu et al., 2015).
. Senescence and vascular ageing
The process of cellular senescence can be an important addi-
ional contributor to inﬂammageing, since senescent cells acquire
phenotype named senescence-associated secretory phenotype
SASP). It is characterized by the enhanced secretion of many
nﬂammatory modulators that modify the tissue microenviron-
ent and alter the function of nearby cells. Interestingly, this
henotype was observed not only in cells of immune system, such
s macrophages, but also in ﬁbroblast and ECs (Coleman et al.,
013).
The age-related changes of immune system functions are
omplex phenomena incompletely understood. According to the
emodeling theory of ageing, immunosenescence is the result of a
emodeling of immune system cellular pool. This complex scenario
s characterized by a deterioration of adaptive immunity, while
nnate immunity is largely conserved or even up-regulated with
ge (Candore et al., 2010; Franceschi et al., 2000). Immunosenes-
ence of the innate immune system is primarily characterized by
educed cellular production and capability of phagocytosis. A num-
er of reports have provided experimental evidences of the altered
unction of neutrophils and macrophages in mice and humans.
ranceschi et al. (2000) supposed that inﬂammageing is the result
f chronic activation of macrophages termed “macroph-aging”.
gedmacrophages showan impaired respiratoryburst and reactive
itrogen intermediate production that lead to damage of endothe-
ium.
Several authors demonstrated that the acquisition of SASP
educes endothelial regenerative properties, which, in turn, con-
ribute to the development of pro-inﬂammatory pathological
onditions (Freund et al., 2010).
The cellular senescence also implies the impairment of the pool
f stem cells, so of the EPCs. This event leads to the loss of repar-
tive capacity and vascular homeostasis, determining the onset of
VDs and atherosclerosis. In fact, EPCs may contribute to the main-
enance of the endothelium by replacing injured mature ECs. The
PC number has been shown to be reduced in patients with CDVs,
M, and multiple coronary risk factors (Imanishi et al., 2008).
Rehman et al. (2003) showed that circulating EPCs promote vas-
ular repair or angiogenesis, activating resident endothelial cells
y releasing paracrine factors, such as VEGF or hepatocyte growth
actor, rather than by supplying of new endothelial cells.
Recently, it was demonstrated a paracrine action mediated
y EC-derived microparticles (EMPs). EMPs are small membrane
ragments released from activated or apoptotic ECs after injury.
hey contain DNA, RNA or microRNA (miRNA), which can induce
ndothelial regeneration by promoting proliferation of mature ECs
Deregibus et al., 2007).
Jansen et al. (2013) showed a protective effect of EMPs in
urine models. It was demonstrated that injected EMPs acceleratendothelial repair after electric endothelial denudation of carotid
rtery.
n
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. Nutraceutical effects in vascular ageing
Several studies have already demonstrated that both in animal
odels and in humans, dietary intervention can positively modu-
ate ageing process, affecting parameters related to inﬂammageing
Santoro et al., 2014). Also EPCs seem to be inﬂuenced by diet,
lthough, it is not clearly explored.
The CVDs are mostly attributable to lifestyle. In Western world,
t is often sedentary, including a diet rich in saturated fat and sug-
rs, with an altered omega-3 or omega-6 fatty acids ratio, fruits,
egetables and ﬁbers (Vasto et al., 2014). On the contrary, a reduc-
ion in the onset of CVDs is observed in Southern Europe. This event
ould be attributable to health-promoting dietary patterns, such as
D, rich in nutraceuticals (Estruch et al., 2013).
These molecules, mainly, have antioxidant and anti-
nﬂammatory properties that confer to MD anti-ageing features
Vasto et al., 2014; Visioli and Galli, 2001). Resveratrol has anti-
nﬂammatory effects; oleic acid, lycopene, quercetin, anthocyanins
nd catechins, all powerful antioxidants, are able to reduce the
xidation of low density lipoprotein (LDL) or, more generally, to
ave cardioprotective effects (Estruch et al., 2013) (see Table 1).
The main and common food in Mediterranean basin is the extra
irgin olive oil (EVOO), subject matter of many researches thanks
o its strong nutraceutical properties (Aiello et al., 2015; Virruso
t al., 2014).
A large intervention trial showed that a diet rich in EVOO or in
uts could reduce the risk of CVDs by 30%, compared to the low fat
ounterparts (Perez-Martinez et al., 2007). This means that a diet
ich in unsatured fat is healthier than a low fat one.
A systematic review showed that the adherence to MD is asso-
iated with positive effects in endothelial function as well as in
nﬂammation (West, 2001). The explanation is a decrease of oxida-
ive stress due to the antioxidant foods, mainly EVOO (Visioli and
alli, 2001).
Moreover, our pilot study on table green olives, conducted on
ealthyvolunteers, demonstratedadecreaseofoxidative stress and
n anti-inﬂammatory effect, highlighted by a reduction of malon-
ialdehyde and IL-6 levels, respectively (Accardi et al., in press).
Data show that EVOO decreases the pro-inﬂammatory envi-
onment, induced by oxidized LDL in ECs. With its high content
n monounsaturated fatty acids (MUFA) and polyphenols, EVOO
ight exert beneﬁcial effects in the development and progression
f age-related diseases. In fact, its non-saponiﬁable portion (1–2%)
ontains about 230 bioactive components, such as carotenoids,
ainly lycopene, sterols; and the phenolic compounds, such as
leoeuropein, oleocanthal, hydroxytyrosol and tyrosolwith antiox-
dant and anti-inﬂammatory properties (Aiello et al., 2015; Virruso
t al., 2014). Both in vitro and in vivo studies demonstrated the
ndothelium-protective properties of these molecules (Frankel,
011; Martín et al., 2010; Moreno-Luna et al., 2012; Schwingshackl
t al., 2015; Virruso et al., 2014). Different trials showed that
olyphenol intake has been associated with low mortality rates
aused by coronary heart disease (Hertog et al., 1995; Horn et al.,
014). These compounds are able to bind LDL, increasing resistance
o oxidation and acting as radical scavenger (Gimeno et al., 2007).
oreover, it was seen that the consumption of polyphenol-rich
live oil can decrease blood pressure (BP) and improve endothelial
unction inyoungwomenwithhigh-normalBP (Moreno-Lunaet al.,
012). The C Reactive Protein and IL-6 levels, as well as the ones of
ow-mediated dilatation andE-Selectin that characterize endothe-
ial function are positively modulated after dietary interventions
ith EVOO (Schwingshackl and Hoffmann, 2014).
About its anti-inﬂammatory properties, hydroxytyrosol and
leocanthal have ibuprofen-like activity, inhibiting the cyclooxyge-
ases 1 and 2, responsible for prostaglandin production. Moreover,
olyphenols inhibit NF-B pathway that leads to the expression
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Table 1
Nutraceuticals and their functions. This table shows the main nutraceuticals present in Mediterranean foods. The principal sources are red fruits and vegetables, as well as
olives  and extra virgin olive oil.
Molecule Origin Function Family Ref.
Resveratrol Grape skin,
blackberry,
blueberry, nut,
dark chocolate
Cardiovascular
protection;
antioxidant by
activation of
NRF-2;
anti-inﬂammatory;
increase eNO
production;
reduction of oxLDL
and systolic and
diastolic BP
Polyphenol Ndiaye et al.
(2003); Ungvari
et al. (2010)
Lycopene Tomato, red carrot,
strawberry, cherry,
asparagus, olive,
watermelon
Anti-inﬂammatory
in atherosclerosis
process;
antioxidant; BP
reduction;
reduction of oxLDL
Carotenoid Burton-Freeman
et al. (2012); Paran
et al. (2009)
Oleic acid Olive, nut, green
olive
Reduction of oxLDL Lipid Schwingshackl and
Hoffmann, (2014)
Quercetin Apple, red onion,
caper
Antioxidant Flavonoid Horn et al. (2014);
Malavolta et al.
(2015)
Catechin Green tea, cocoa Antioxidant Flavonoid Camargo et al.
(2012); Hertog
et al. (1995); Horn
et al. (2014)
Anthocyanin Red-purple fruit
and vegetables
Antioxidant;
cardioprotective;
neuroprotective;
photoprotective
Flavonoid Horn et al. (2014);
Malavolta et al.
(2015)
Oleuropein Olive, EVOO Radical scavenger,
blocking the LDL
oxidation
Polyphenol Gimeno et al.
(2007)
Hydrossityrosol Olive, EVOO Inhibition of COX-1
and COX-2
Polyphenol Martín et al. (2010)
Oleocanthal Olive, EVOO Inhibition of COX-1
and COX-2
Polyphenol Virruso et al.
(2014)of pro-inﬂammatory genes (Beauchamp et al., 2005; Romier et al.,
2008; Zhang et al., 2009).
Another potential health-promoting component of EVOO is oleic
acid. It is the main MUFA of EVOO and is claimed to increase the
resistance of LDL to oxidation. It has also been suggested that MUFA
can decrease all-cause (11%) and cardiovascular mortality (12%),
cardiovascular events (9%), as well as stroke (17%) (Schwingshackl
et al., 2015).
Moreover, oleic acid suppresses cytotoxic function of natural
killer cells with a consequent anti-inﬂammatory effect (Yaqoob
et al., 1994). In general, unsaturated fatty acids improve endothe-
lial function decreasing intercellular adhesion molecule (ICAM)-1
production by ECs and reducing leukocyte adhesion (Bemelmans
et al., 2002).
But, not only EVOO has to take into account as healthy food. In
fact, many antioxidants, not necessary belonging to MD,  have been
studied, showing cardioprotective properties.
New interesting effects were proposed about quercetin, a
ﬂavonoid that is ubiquitously present in MD,  in a variety of fruits
and vegetables. It has been traditionally viewed as a potent antiox-
idant and anti-inﬂammatory molecule. In addition, the hypothesis
is that in pre-senescent and senescent human cells, this bioactive
molecule has senolytic effects. Its action provides a sort of rejuve-
nation of cells because promotes the selective killing of senescent
cells, while permits the expansion of younger cells, lacking senes-
cent markers (Malavolta et al., 2015). In vivo studies on mice
demonstrated a possible effect of the combination of quercetin
with the anti-tumor drug desatinib in the improvement of vas-cular endothelium damage, representing a possible therapeutic
approach to ameliorate cardiovascular function (Zhu et al., 2015).
Further, ﬂavonoids, such as anthoxanthins, especially ﬂavones
and ﬂavonols, present in red wine, vegetables and fruit, as well as
in tea, soy and cocoa, have antioxidant properties. They exert the
cardioprotective effect, mediating vascular relaxation (Kyaw et al.,
2004).
Flavonols present in cocoa can improve endothelial function,
as well as can lower the level of markers of endothelial integrity,
vascular cell adhesion molecule (VCAM)-1 and ﬂow mediated
dilatation, in healthy subjects and patients with coronary artery
disease (Hertog et al., 1995; Horn et al., 2014). The ﬂavonoids act on
AMP-activated protein kinase (AMPK) pathway, which is activated
when intracellular ATP levels decrease. This signaling is phyloge-
netically conserved and is the guardian of systemic and cellular
energy status. Vascular AMPK seems to be involved in the regula-
tion of vascular tone. In case of hypoxia, it can induce relaxation
of big vessels. In fact, its activation phosphorilates eNOS, acting as
regulator of blood stream (Davis et al., 2006).
The resveratrol, polyphenol found in grape skins so in red wine,
other grape skin derived products, lycopene and carotenoids in
general, can alleviate the inﬂammation in cardiovascular degen-
erative processes, such as atherosclerosis. They and cocoa also
have antioxidant effects, increasing the NO endothelial release by
the activation of NOS, including the production of smooth mus-
cle relaxation through GMP-mediated pathway with a reduction
of systolic and diastolic BP. In addition, in vitro and in vivo studies
have suggested that resveratrol has effects on the modulation of the
EPC levels. This molecule seems to modulate the nuclear factor-
G. Accardi et al. / Mechanisms of Ageing a
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Fig. 1. Effect of nutraceutical foods on vascular endothelium. Nutraceutical foods
may reduce inﬂammageing because their high content in anti-inﬂammatory and
anti-oxidant molecules. Consequently, inﬂammageing lowers its effect on endothe-
lium, delaying the vessels’ ageing process by increasing nitric oxide bioavailability
with a positive effect of vasorelaxation on the wall and diminishing ROS hyperpro-
duction so reducing LDL oxidation. ROS: reactive oxigen species; NO: nitric oxide;
oxLDL: oxidized low density lipoprotein.
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a2-related factor 2 (Nrf2)-antioxidant response element (ARE)
ignalingpathway In thecellularnucleus, it binds theAREsequence,
ermitting the expression of antioxidant enzymes, such as NQO1-
ADPH quinine oxidoreductase 1 and hemeoxigenase 1.Moreover,
t controls the expression of gamma glutamyl cysteine synthetase,
nzyme involved in the synthesis of glutathione. The conse-
uence is an endothelial protective effect, dependent on a dose
resumably achievable in human by resveratrol supplementation
Ungvari et al., 2010, 2008).
Furthermore, the consumption of tomato extract, containing
ycopene and beta-carotene, results in a decrease of LDL oxidation,
nducedbyhigh-fatmeal and theoneof IL-6 (Burton-Freemanet al.,
012; Camargo et al., 2012; Ndiaye et al., 2003; Paran et al., 2009).
he reduced oxidation of LDL also is an effect of ﬂavonoids. They
etermine an inhibition of lectin-like oxidized receptor-1 (LOX-
) that binds oxidized LDL. LOX-1 is expressed in pro-atherogenic
ettings, such as hypertension or hyperlipidemia, and is accumu-
ated in the atherosclerotic lesions. It reduces the release of NO
nd increases the expression of adhesion molecules and inﬂamma-
ory cytokines. So, its inhibition results in vasorelaxation and in a
ossible prevention or treatment of CVDs (Nishizuka et al., 2011).
See Fig. 1 for an overview.
. New insights in vascular ageing
The effect of MD on vascular ageing is not only due to bioactive
ompounds, since the low animal proteins intake of the diet could
ontribute to the protection of endothelium (Vasto et al., 2014).
In general, meat is a source, and sometimes, the main source
f proteins in different diets worldwide. Nevertheless, many stud-
es demonstrated that its great consumption is correlated with
VDs, type 2 diabetes and cancer, in particular the colorectal one
Rohrmann et al., 2013).
Protein restriction (5% to 15% intake) increases life span in
odentsup toone thirdcompared toahigh-proteindiet (50% intake)
Solon-Biet et al., 2014). The molecular reason was explained, tak-
ng into account their actionon themechanistic target of rapamycin
mTOR) pathway downregulation. mTOR is a serine-threonine
rotein kinase, belonging to the phosphatidylinositol-3OH kinase
elated family. This kinase is a nutrient/hormone-sensing molecule
hat regulates cellular growth and metabolism, with mitogenic
ffects due to the promotion of protein synthesis and mRNA trans-
ation. Its down-regulation, possibly related to dietary restriction,
n terms of calories and animal proteins intake, leads tomTOR com-
t
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lex 1 inhibition, favoring longevity. Thus, high proteins intake is
possible responsible of accelerated ageing in model organisms.
owever, recent studies demonstrated that an aminoacids restric-
ion is powerful in life-span extension, more than a total protein
estriction. In fact,Mirisola et al. (2014) demonstrated that in yeast,
he threonine and thevaline, inparticular, promote ageing viaTor-1
ctivation, the orthologue of mTOR in yeast. The main responsible
minoacid involved in ageing damages seems to be the methio-
ine. Rats fedwith a highmethionine diet (2%) comparedwith ones
ed with high-protein diet (50%) showed accelerated vascular age-
ng. They had decreased aortic wall elasticity so they were more
rone to hypertensive consequences. Their aorta smooth muscle
ells were degenerate and with necrosis and they were replaced
y chondroid cells and foci of ﬁbrosis. Methionine, in particular,
ould be the explanation for the damages induced by red meats.
n fact, vegetable proteins are less rich of methionine and sulfur
minoacids, in general, than the animal ones (Fauet al., 1988; Longo
t al., 2015).
Comparing the consumption of red meat with one of poultry
nd dairy products, as well as nuts, it was demonstrated a higher
ate of stroke in the ﬁrst case. The same was observed for coronary
eart disease (Bernstein et al., 2012; Bernstein et al., 2010).
Moreover, many studies provide evidences about the effects of
iRNAs, likely able to regulate endothelial function and inﬂam-
ation. miRNAs are small endogenous non-coding genes present
n animals and plants. They modulate mRNA gene expression in
post-transcriptional manner. miR-146a plays a role in inﬂamma-
ion, cell senescence and ageing. It seems to block Toll-like receptor
and cytokines production and could represent a possible marker
f senescence-associated pro-inﬂammatory status in cell involved
n vascular remodeling (Brudecki et al., 2013; Olivieri et al., 2013;
asa-Nicotera et al., 2011).
In addition, a number of studies investigated whether miRNAs
an be modulated by food.
In a PREDIMED trial, it was shown a novel association between
iRNA and stroke incidence by the modulation of triglyceride lev-
ls (Corella and Ordovás, 2014).
The anti-inﬂammatory properties of some polyphenolic com-
ounds have shown effects on them in vitro. miRNA126, selectively
xpressed in ECs, decreases the mRNA expression of VCAM-1
Harris et al., 2008). This effect was conﬁrmed in a study on
uman Umbilical Vein Endothelial Cells (HUVEC), stimulated with
ipopolysaccharide and treated with a polyphenol extracted from
rape (Noratto et al., 2011). Conversely, another study in HUVEC,
reated with curcuminoids, showed that their anti-inﬂammatory
ffects modulate VCAM-1 expression, but it did not involve miRNA
26 (Angel-Morales et al., 2012).
Moreover, the expression of miR-221 and 181 seems to be mod-
lated by ﬂavanol-metabolites in ECs (Milenkovic, 2014).
So, although it is not completely clear the exact role of miR-
As in vascular ageing, they represent a new interesting insight in
ascular ageing process. They represent new ﬁeld of research with
nteresting implications in human development and diseases.
Some evidences demonstrated the interrelationship between
iRNA expression, DNA methylation, and histone modiﬁcations,
o molecular biology techniques, such as over-expression or selec-
ive knockout of some miRNAs could represent a therapy in the
reatment of CDVs (Corella and Ordovás, 2014).
. Conclusions
During life, different stimuli, such as drugs, oxidative stress and
general functional decline of physiological processes, can reducehe regenerative capacities of EPCs and can induce an impair-
ent of endothelial function, creating a negative feedback loop
eing a68 G. Accardi et al. / Mechanisms of Ag
for ageing. Since these progenitors preserve vascular endothe-
lium homeostasis and participate to re-endothelialization and
neo-vascularization, they can represent a possible target in the
treatment of vascular ageing.
Thepossibility tomodulate thenumber and the functional activ-
ity of EPCs by nutritional therapy, could be useful in the treatment
and in the prevention of age-related diseases, such as CVDs. Nowa-
days, several studies focused on beneﬁcial effects of nutraceuticals.
The presence of these bioactive molecules in foods typical of MD,
confers healthy properties to this nutritional pattern. MD fruits
and vegetables, increasing antioxidant state, improve endothelial
function and modulate inﬂammation. Thus, they may enhance the
regenerative capacityof theendothelium. In fact, thisdietdecreases
ROS production and, so, reduces endothelial damage, determining
lower apoptosis rate in ECs and protecting them from senescence.
Furthermore, MD induces NO release, resulting in a vasorelaxation,
and ameliorate endothelial function. This seems to be associ-
ated with a greater regeneration capacity and with an increase
of circulating EPCs. Moreover, in vitro studies demonstrated that
antioxidant bioactive molecules from olive oil may decrease oxida-
tive stress by the modulation of Nrf2-heme oxygenase-1 pathway
that restore the EPCs function and reduce the number of senescent
cells.
Thus, nutraceuticals act not only direct by their antioxidant or
anti-inﬂammatory properties but also indirectly, via the modula-
tion on molecular pathways that improve the expression of genes
involved in anti-ageing mechanisms.
In conclusion, it is possible to speculate that the key of the
healthy effect of MD on EPCs is not narrow in a single component
or in a single food but in a synergic or additive effect of the overall
dietary pattern. Therefore, further studies need to be carried out to
fully understand the speciﬁc role of Mediterranean nutraceutical
foods played on vascular ageing.
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Nutrient sensing pathways as therapeutic targets for healthy ageing 
Abstract 
Introduction: In the present paper, the authors have discussed anti-ageing strategies which aim to 
slow the ageing process and to delay the onset of age-related diseases, focusing on nutrient sensing 
pathways (NSPs) as therapeutic targets. Indeed, several studies have already demonstrated that both 
in animal models and humans, dietary interventions might have a positive impact on the ageing 
process through the modulation of these pathways.  
Areas Covered: Achieving healthy ageing is the main challenge of the 21th century because 
lifespan is increasing, but not in tandem with good health. The authors have illustrated different 
approaches that can act on NSPs, modulating the rate of the ageing process.  
Expert Opinion: Humanity’s lasting dream is to reverse or, at least, postpone ageing. In recent 
years, increasing attention has been devoted to anti-ageing therapies. The subject is very popular 
among the general public, whose imagination runs wild with all the possible tools to delay ageing 
and to gain immortality. Some approaches discussed in the present review should be able to 
substantially slow down the ageing process, extending our productive, youthful lives, without 
frailty.
Keywords: Ageing; anti-ageing approaches; dietary patterns; nutraceuticals; nutrient sensing 
pathways 
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1. Introduction: overview of the ageing process 
Healthy ageing is the main challenge of the 21th century both in Western and developing 
countries.[1] To develop preventive and therapeutic measures that can support healthy lifespan, an 
integrative approach is needed.[2] To do it, it is important to change daily habits, and diet is, 
probably, the most important one.[3,4]  
Ageing is a complex process which decreases the ability to adapt to stress, causing a decline 
in functional capacity. This event, characterized by a progressive loss of the physiological integrity 
of many interrelated systems, leading to impaired function and increased vulnerability to disease
and likelihood of death. In May 2012, a group of scientists and clinicians developed a consensus 
statement to highlight the importance of a common view on ageing and healthy lifespan. As 
reported in the panel: “Ageing processes are defined as those that amplify the vulnerability of 
subjects, as they became older, to the factors that finally lead to death. Individuals with the same 
chronological age may have different rate of ageing and different biological age”.[5]  
Ageing is a physiological and ineluctable process, characterized by many processes and 
molecular dysfunctions, whose burden falls into two different phenotypes: successful and unsuccessful. 
The latter is manifested by those that develop one or more age-related diseases after reaching 65 
years of age. Conversely, successful ageing involves avoidance or delayed onset of pathologies, 
including cardiovascular diseases, which are the main cause of death, and other organ specific 
diseases, in addition to disability, preservation of desirable cognitive, physical function and social 
activities throughout the lifespan.[5,6] 
Ageing is accompanied by a chronic low grade inflammatory state, known as 
inflammageing, a term derived from a combination of inflammation and ageing.[7,8] In general, 
inflammation is not a negative response because it serves to protect the organism from harmful 
conditions and contributes to healing process. On the contrary, at a later stage of life, the chronic 
inflammatory stimuli can lead to detrimental phenomena that increase the risk of diseases and 
death. According to the theory of antagonistic pleiotropy, in early life, when natural selection is 
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strong, the inflammation should be beneficial but becomes dangerous during ageing when selection 
is weak.[9] 
A wide range of different stimuli contribute to develop inflammageing, however some 
factors can impact inflammageing, counteracting it, such as an anti-inflammatory diet and physical 
activity (see Figure 1).[3,10,11]  
Increased inflammation is mainly attributed to a chronic lifelong antigenic stimulation, 
unforeseen by evolution. So, inflammageing may derive from age-related changes to the immune 
system, so-called immunosenescence. In line with the remodelling theory of ageing [12], in 
immunosenescence, innate immunity is largely conserved or even up-regulated, while clonotypic 
immunity deteriorates with age. This causes reduced ability to clear novel pathogens and T-cell 
populations, responsible for the production of pro-inflammatory cytokines, are amplified.[13,14]  
Paradoxically, centenarians show high levels of pro-inflammatory markers, counterbalanced 
however by anti-inflammatory ones.[15]  
Other causes of inflammageing can be represented by damaged macromolecules and 
endogenous host-derived cell debris that, accumulating with age, as a consequence of their 
increased production and/or inadequate elimination, are sources of chronic damage.[7] The amount 
of senescent cells increases with age and can have deleterious effects on tissues, altering the 
function of nearby cells. This is due to the acquisition of the senescence-associated secretory 
phenotype (SASP) that induces senescent cells to produce pro-inflammatory mediators.[16] 
Furthermore, visceral obesity is known to be associated with a pro-inflammatory status.[17] 
Moreover, harmful metabolites, produced by the microbiota, likely participate in the ageing 
process. Although the intestinal microbiota is relatively stable throughout adulthood, age-related 
changes in the gastro-intestinal tract, as well as changes in diet and host immunity reactivity, inevitably 
affect the composition of bacterial populations. In the gut, prolonged retention time leads to an 
increase in bacterial protein fermentation and consequently putrefactive processes with a greater 
susceptibility to inflammatory diseases.[18].  
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Changes with age in specific bacterial genera and species have been identified, with a 
considerable inter-individual variation that continues into old age. Many studies have demonstrated 
a decline, with age, in both the total number and in the species diversity of Bacteroides and 
Bifidobacteria. High fat consumption produces a decrease in the number of Bifidobacteria. This 
group of bacteria has been shown to reduce lipopolysaccharide (LPS) levels in mice and to improve 
the mucosal barrier function. Interestingly, Bifidobacteria do not degrade intestinal mucous 
glycoproteins like other pathogenic bacteria do. This effect promotes a healthier microvillus 
environment by preventing permeability and bacterial translocation. Some studies provide evidence 
that the processes involved in the development of endotoxemia that causes  low-grade inflammation and 
the corresponding metabolic disorders in response to high fat consumption are associated with an 
increased intestinal permeability, reducing the expression of genes coding for tight junction proteins 
(see Figure 1).[19-22]  
In addition, age-related changes in microbial populations would lead to a decline in the 
production of short chain fatty acids (SCFAs). In non-aged people, fibres present in vegetables, 
fruits, whole cereals, and other fermentable foods are converted ,in the colon, into SCFAs by 
microbiota, with the production of acetate, propionate and butyrate, that have positive effects on 
health.[23] It was speculated that this reduction of SCFAs in elderly faeces, likely related to the 
reduction of Bacteroides and Bifidobacteria, might contribute to an adverse effect on immune 
function.[18] In fact, the decrease of Bifidobacteria observed in elderly was associated with a 
decreased inhibition of the growth of some pathogens and, potentially, with an increase in  
susceptibility to infection.[24] However, it is noteworthy that, on the basis of studies in both 
animals and humans, dietary intake appears to be a major short  and long term regulator of the 
structure and function of gut microbiota.[25] 
Inflammageing, with its close links to the oxidative stress that increases the release of 
inflammatory mediators, represents one of the most important triggers of age-related diseases, like 
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Alzheimers, cardiovascular diseases, type 2 diabetes mellitus (T2DM), sarcopenia, cancer, 
metabolic syndrome, and frailty.[10] 
Moreover, currently available evidence suggests that anabolic signalling accelerates ageing 
and age-related diseases, whereas decreased nutrient signalling extends survival and longevity. The 
process is, at least in part, linked to the modulation of downstream nutrient sensing pathways 
(NSPs), such as the activation of forkhead box O (FOXO) 3A or the inhibition of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB). The activation of the former counteracts 
the oxidative stress through the transcriptional activation of homeostatic genes. The inhibition of the 
latter one switches off the transcription of inflammatory genes, thus slowing down the 
inflammaging process.[2,26-29] 
2. NSPs: key role in healthy ageing
For many years, biogerontologists have investigated possible interventions to slow the rate 
of ageing and increase lifespan. Nowadays, the findings that diet can contribute to successful ageing 
has created new and interesting possibilities for anti-ageing medicine.[4,11,30]  
In the present paper, we do not need to distinguish between ageing and age-related diseases 
because, as discussed by Blagosklonny, in protected environments, humans and animals die from 
age-related diseases, which are a manifestation of ageing. [31,32] Since human longevity is limited 
by death from age-related diseases, a true anti-ageing drug must delay the onset of age-related 
diseases. In other words, unless a drug delays age-related diseases, it will not extend lifespan. And 
vice versa, if a drug prevents age-related diseases, it must extend lifespan. See, however, 
Blumenthal for a comprehensive critical review of the relationship between ageing and disease.[33] 
Several studies have suggested that both in animal models and humans, dietary intervention 
can prevent or decrease various age-related diseases, by positively regulating ageing process 
through the modulation of NSPs such as the insulin/insulin-like growth factor (IGF)-1, the 
mechanistic (previously referred to as mammalian) target of rapamycin (mTOR) and the sirtuin 
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pathways.[34-37] These are activated by nutrients, such as carbohydrates or proteins that trigger 
signals which result in a downstream activation of genes involved in ageing process. An excessive 
intake of nutrients however can accelerate these events and increase the risk of unsuccessful ageing. 
In fact, the activation of these metabolic pathways is characterized by inflammation and 
mitochondrial dysfunction, with an increase of oxidative stress and a reduction of autophagy. This 
is a self-degradative process, important for the balance of sources of energy in development and in 
the response to nutrient stress [26] that, in case of reduction, promote inflammageing and 
unsuccessful ageing. 
Through the downregulation of IGF-1 and mTOR cascade or the up-regulation of sirtuins 
one can extend lifespan in various model organisms, including mammals.[26] These effects are also 
obtained by the presence of specific single nucleotide polymorphisms (SNPs) in genes encoding 
proteins involved in NSPs, such as IGF-1 receptor (IGF-1R) and FOXO3A.[38] 
Thus, dietary and pharmacological interventions relating to these pathways might delay or 
prevent age-related pathologies and improve the quality of life during ageing. 
2.1 Insulin/IGF-1 pathway  
The Insulin/IGF-1 pathway is evolutionarily conserved (although with an obvious increase 
in its complexity from yeast to human) and multiple genetic manipulations, that attenuate signalling 
intensity at different levels of the pathway, seem to extend the lifespan of model animals.[26]  
The insulin/IGF-1 signalling cascade starts from the binding of insulin or IGF-1 to the 
insulin or IGF-1 receptors. Consequently, the intracellular substrate proteins, known as insulin 
responsive substrates (IRSs), act as mediators, binding specific Src-homology-2 domain proteins. 
These include enzymes, such as phosphatidylinositol 3-kinase (PI3K) and other intracellular 
signalling molecules, such as the adaptor protein growth factor receptor-bound protein 2, which is 
connected with the Rat sarcoma protein pathway, a mitosis stimulating proto-oncogene. PI3K 
activates via the second messenger phosphatidyl inositol 3-phosphate, leading to the activation of 
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protein kinase B (PKB, also known as AKT), that acts on glycogen synthase kinase 3 involved in 
cellular glucose uptake. Moreover, it stimulates the NF-κB pathway, involved in immune-
inflammatory processes. In addition, this pathway, through the kinases PI3K and AKT, activates 
mTOR complex.[39,40]  
Downstream, the insulin/IGF-1 pathway modulates the expression of transcription factors, 
like FOXO3A, extensively studied for its role in ageing and longevity. It is one of the orthologue of 
daf-16 in Caenorhabditis (C.) elegans and is involved in stress resistance and survival, through its 
action on homeostatic genes.[26] Some FOXO3A SNPs were associated with longevity in different 
populations. This highlights the role of FOXO3A in successful ageing, probably due to an increased 
expression of FOXO3A.[38,41] In humans, ageing is associated with lower levels of circulating 
IGF-1, and in long-lived people IGF-1R was correlated with modulation of lifespan through the 
attenuation of its signalling.[38,41] However, growth hormone (GH) and IGF-1 levels decline both 
in successful and unsuccessful ageing, whereas in models such as nematodes and mice, a 
constitutively decreased signalling pathway extends longevity. It has been suggested that a 
constitutively reduced signalling implies a lower rate of cell growth and metabolism, hence a lower 
rates of cellular damage. On the other hand, extremely low levels of signalling are incompatible 
with life, as shown by embryonic death of mice with null mutation in genes downstream in the 
pathway.[42]  
GH is secreted from the anterior pituitary gland in response to stimulation by GH releasing 
hormone, ghrelin, and dietary components such as proteins, whereas its secretion is inhibited by 
IGF-1, somatostatin and insulin. GH stimulates the hepatic production of IGF-1, and acts on 
insulin/IGF-1 pathway, modulating insulin sensitivity.[27] Moreover, it does not directly interact 
with the insulin receptor but, in experimental models, it was seen that an excess of GH might be 
associated with hyperinsulinemia. On the contrary, the GH deficiency is associated with increased 
insulin sensitivity and decreased insulin secretion and fasting blood glucose concentration. GH and 
IGF-1 (i.e., the somatotropic axis), synergistically, act on carbohydrate metabolism and their 
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signals, although the sequence of molecular events has not clarified, converge with that of insulin. 
In particular, GH stimulates lipolysis and inhibits insulin-induced suppression of hepatic 
gluconeogenesis. These counteract insulin action and reduce the need for a dietary source of 
carbohydrates. IGF-I plays an important role in carbohydrate metabolism, maintaining a balance 
between the actions of insulin and GH. IGF-I also participates in the control of insulin sensitivity 
and action and plays an important role in the hormonal balance between GH and insulin in addition 
to its effect on reducing circulating GH levels.[43]  
People with impaired GH receptor (Laron Syndrome) have very low incidence of age-related 
diseases. It was shown that humans with GH receptor deficiency are characterized by a reduction of 
IGF-1 and insulin levels in serum, displaying no diabetes mortality.[44,45]  
So, continuous activation of these anabolic pathways by nutrients, i.e., proteins (GH and 
IGF-1) and sugars (insulin) with high glycaemic index (GI), is responsible for accelerating ageing 
and age-related diseases, such as cancer, stimulating inflammation and cell proliferation, and 
decreasing homeostatic responses (see Figure 1). 
However, the criticism of a recent review, according to which, available data do not support 
the hypothesis of the role of somatotropic axis in modulating ageing and longevity in humans, 
should be taken into account. The article argues that, because the life-history strategies of humans 
are very different from those of models, this hypothesis is unwarranted.[46]  
2.2 mTOR pathway  
TOR is a serine/threonine kinase belonging to the phosphatidylinositol kinase-related family 
and it is structurally as well as functionally highly conserved throughout eukaryotes. 
Yeast, in contrast to higher eukaryotes, which have a single TOR gene (mTOR), has two 
TOR genes: TOR1 and TOR2.[47,48] Two different TOR containing complexes are present in yeast 
cells: the rapamycin-sensitive (for the pharmacological use of rapamycin see paragraph 3.3) TOR 
complex 1 (TORC1) and the rapamycin-insensitive TOR complex 2 (TORC2).[49] These 
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9
complexes respond to nutrients, especially some amino acids, such as methionine, glutamine, 
threonine and valine as crucial activators of TOR signalling. Mutations in genes relevant to 
glutamine metabolism alter TOR activity and valine/threonine restriction impairs phosphorylation 
of the major TOR target, Sch9 kinase, increasing lifespan.[50,51] 
However, TORC1 and TORC2 have non-overlapping cellular functions. TORC1 mainly 
regulates growth, metabolism, and stress response through regulation of transcription, translation 
and autophagy. TORC2 mainly regulates actin cytoskeletal remodelling.[52] Decreased activity of 
the TORC1 signalling pathway due to mutations, drugs or amino acids depletion, increases 
chronological lifespan in yeast and improves resistance to stresses through relocalization of 
transcription factors. Genetic down-regulation of TORC1 activity in yeast, as well as in worms and 
flies, extends longevity.[50,51]  
In mammals, mTOR participates to the formation of mTORC1 and mTORC2. mTORC1 
promotes anabolic processes and blocks catabolism and autophagy, and its best  known target is 70-
kDa ribosomal protein S6 kinase 1 (p70S6K). Reduced growth factor signalling suppresses 
mTORC1 activity, leading to down-regulation of metabolism and promotion of survival, during 
starvation or intermittent fasting.[53] mTORC2 phosphorylates and activates PKB, suggesting a 
regulation on mTORC1.[54] 
Stress conditions such as hypoxia and osmotic stress can also inhibit mTOR activity.[55,56] 
Instead, nutrients, especially amino acids and growth factors, such as IGF-1, activate mTOR 
pathway.[57]  
Low cellular ATP levels or a high AMP/ATP ratio activates the cellular energy sensor 5' 
adenosine monophosphate-activated protein kinase (AMPK), also activated by caloric restriction 
(CR, see paragraph 3.1). AMPK, in turn, inhibits mTORC1, as well as creating genotoxic stress via 
p53, oxidizing agents, cigarette smoke and glucocorticoids that act via the induction of the hypoxia-
inducible factor (HIF) DNA damage response 1.[57,58] Moreover, mTORC1 inhibits autophagy in 
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response to nutrients and growth factors, while upregulation of autophagy is observed during 
starvation or in response to oxidative stress.[59]  
In adipose tissue, the activation of mTORC1 increases the number and size of adipocytes, 
while fasting, as well as rapamycin, leading to fat mass reduction. In addition, mTORC1 facilitates 
the accumulation of triglycerides, promoting adipogenesis as well as lipogenesis, and preventing 
lipolysis and β-oxidation.[60,61]  
mTORC1 also seems to be an important regulator of mitochondria function. Inhibition of 
mTORC1 modifies mitochondrial phosphoproteome, reduces mitochondrial membrane potential, 
oxygen consumption and therefore cellular ATP levels and reactive oxygen species (ROS) 
production rate, which contribute to oxidative stress.[62] 
So, the mTOR kinase, which is part of two complexes, mTORC1 and mTORC2, has a 
central role in the regulation of metabolism, integrating numerous environmental signals and 
indicating whether conditions are favourable for anabolic processes. In fact, this pathway responds 
to stimuli, including insulin and IGF-1, amino acids and glucose levels, cellular energy status and 
oxygen levels. These data again support the idea that intense anabolic activity is responsible for 
accelerating ageing and age-related diseases (see Figure 1).[28,42] 
2.3 Sirtuins pathway  
Sirtuins, orthologues of Sir2 yeast protein (where Sir stands for silent information regulator 
since it silences certain genes), are a family of histone deacetylase enzymes, involved in the 
regulation of cellular mechanisms, identified as anti-ageing molecules in model organisms. Their 
action was, in fact, linked to some cellular processes, such as cellular metabolism, apoptosis, DNA 
repair, development, inflammatory response and neuroprotection.[63]  
The sirtuin role was first investigated in yeast, in which the overexpression of the SIR2 gene 
leads to an increased lifespan. In Saccharomyces (S.) cerevisiae, Sir2 is involved in changes of 
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cellular metabolic pattern, in the improvement of the genomic stability and in the extension of the 
lifespan.[29,42,64] 
Sirtuin activation seems to contribute to CR-induced longevity in model organisms, including, S. 
cerevisiae, C. elegans and Drosophila (D.) melanogaster. In fact, some studies showed that the 
induction of sirtuin activity could mimic the beneficial effects of CR, reducing insulin/IGF-1 
downstream signalling and decreasing proteins ubiquitination. Moreover, CR, in itself, up regulates 
Sir2.[65-67]  
In mammals, there are seven yeast homolog sirtuins (SIRT1-SIRT7). SIRT1, 6, and 7 are 
localized in the nucleus; SIRT3, 4 and 5 in the mitochondria and SIRT2 in the cytosol. No clear 
data exist about SIRT5 and 7, activated by p53. All sirtuins contain 275-aminoacids catalytic 
subunits and use NAD+ as a co-substrate. It is converted to nicotinamide, whose concentration is 
determined by the nutritional state of the cell.[42]  
In particular, in humans, SIRT1, 2, 3, and 6 are activated by CR, while it inhibits SIRT4. 
SIRT1 modulates responses to oxidative stress by FOXO3A deacetylation. In addition, it has a 
protective role in endothelial function, preventing cardiovascular diseases. Similarly, SIRT3 is 
implicated in metabolism and mitochondrial function, including ROS detoxification. Moreover, a 
study on the Italian population revealed a correlation between a high rate of its activity and 
longevity.[29,68] On the contrary, the overexpression of SIRT7 is observed mainly in cancer cells, 
while its depletion contributes to prevention of ageing. Whereas SIRT2, especially active in the 
cytoplasm, has anti-inflammatory effects, in activating NF-κB.[29,69] Recently, SIRT6 has been 
identified as a critical regulator of transcription, genome stability, telomere integrity, DNA repair, 
and metabolic homeostasis, with an important effect on the ageing process.[70] 
So, sirtuins, which sense low energy states by detecting high NAD+ levels, acts as 
transcriptional effectors by controlling the acetylation state of histones, signalling nutrient scarcity 
and catabolism.[71] Thus, their action is in opposition to the two previous NSPs, hence favouring 
healthy ageing and longevity (see Figure 1).[42] 
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3. Therapeutic interventions to modulate NSPs
To delay ageing and to achieve successful ageing it is necessary to identify new therapeutic 
targets. As we illustrated, NSPs are one of these and different approaches are possible to modulate 
them (see Figure 1). 
3.1 Dietary intervention approaches 
In model organisms and humans, the possibility to modulate ageing, with a non-invasive 
method, has been identified in the dietary restriction (DR), defined as “Dietary regimen in which 
specific food groups or micronutrients are reduced or removed from the diet”.[72] Accordingly, a 
clinical trial demonstrated that an increased consumption of low GI fruits improves glycaemic 
control among people with diabetes and low GI foods are related to a reduction in the risk of 
coronary heart diseases and T2DM. Moreover, foods rich in soluble fibres slow glucose absorption 
and, consequently, the subsequent insulin response.[73-75]  
The most well defined dietary intervention to delay ageing is CR. It is a process involved in 
lifespan extension, acknowledged for almost 80 years, consisting in the reduction of total calorie 
intake by 20-40% without malnutrition.[26,76] In models, CR leads to lifespan extension and 
involves the insulin/IGF-1 and mTOR signalling reduction, the modulation of glycaemia and 
insulinemia, as well as the increase of insulin sensitivity, and the activation of sirtuins 
pathways.[26,77,78] In humans, CR, combined with a low GI diet, has been shown to improve 
cardiovascular parameters and weight loss.[79] 
Page 12 of 32
URL: http://mc.manuscriptcentral.com/eott  Email: Adam.Hall@informa.com
Expert Opinion On Therapeutic Targets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
13
Page 13 of 32
URL: http://mc.manuscriptcentral.com/eott  Email: Adam.Hall@informa.com
Expert Opinion On Therapeutic Targets
On the other hand, on the basis of theoretical models, it has been predicted that the large 
increases in mean life span and maximum life span potential observed in laboratory rodents subject 
to caloric restriction will not been obtained in human beings.[80,81] However, recently, data 
accumulated from observational and randomized clinical trials indicate that, in humans, CR 
results in some of the same metabolic and molecular adaptations that have been shown to improve 
health and slow the accumulation of molecular damage in models of animal longevity. In particular, 
moderate CR in humans improves multiple metabolic and hormonal factors that are implicated 
in the pathogenesis of T2DM, cardiovascular diseases, and cancer, that lead to morbidity, 
disability and mortality.[82] 
Alternative approaches that mimic CR are being investigated, i.e. intermittent (IF) and 
prolonged fasting (PF). IF involves caloric intake on every other day for long period of time; in PF 
only water is consumed for two or more consecutive days. Both IF and PF have been shown to 
extend lifespan in animal models. In particular, in mice, IF seems to prevent or delay age-related 
diseases, and, in humans, preliminary clinical studies seem promising. Concerning the mechanisms, 
CR and fasting promote resistance to damage, activating FOXO (and other transcription factors), 
down regulating insulin/IGF-1 and mTOR pathways, and up regulating sirtuin pathways.[2,83] 
Studying deeper the benefits attributed to CR in more depth, the scientists argued that 
protein restriction (PR) or the restriction of particular amino acids is sufficient to reduce IGF-1 
concentrations and mTOR signalling, more than the simple CR.[36,72,77] In fact, rats fed by soy 
proteins have a higher lifespan than those fed by casein.[84] In addition, in D. melanogaster, the 
effect of CR is lost in presence of essential amino acids.[85] In particular, methionine and 
tryptophan, contained more in animal than plant proteins, seem to have more detrimental effects 
than other amino acids, and their reduction in the diet of various model organisms, extends their 
lifespan, though an as yet unclear molecular process.[2,77] Nevertheless, a few studies were 
performed on the potential benefits of PR on the human ageing process and one of the main limitations 
is the age stratification of analysed groups. In a case-control study, an association 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
14
between decreased protein consumption, reduction in IGF-1 levels and cancer in 50-65 years people 
but not in older population was demonstrated, suggesting that, in elderly, a higher protein intake, 
mostly from vegetables, should be recommend.[11,86]  
However, although CR and fasting may be desirable on account of their health benefits, they 
are severe dietary regimens and not always applicable. An alternative approach may be a close 
adherence to the Mediterranean Diet (MedDiet), which also includes healthy lifestyle.  
The MedDiet is one of the most studied dietary patterns. It is an alimentary regimen with 
low GI and low animal protein intake. It contains phytochemical compounds found in vegetables, 
fruits, red wine, olive oil or nuts with anti-inflammatory and anti-oxidant effects. Moreover, it 
mimics a sort of CR. In fact, studies on Sicilian centenarians demonstrated that their diet contains 
about 1200-1300 Kilocalories.[3,87] One explanation of its pro-longevity properties is the 
inhibition of mTOR, the downregulation of insulin/IGF-1 cascade, and the upregulation of sirtuins 
by the energy sensors AMPK and NAD+, the low GI, the low animal protein intake and, 
consequently, the low consumption of methionine and tryptophan.[4]  
A similar alimentary pattern may be represented by Asiatic diets, in particular by diet of 
Okinawa, an island with an high prevalence of centenarians. The Okinawan diet is characterized by 
relatively high consumption of unrefined, low GI sugars from vegetables, legumes and fruits, with 
moderate fish and marine food consumption.[88,89] 
So, these diets represent an interesting starting point to delineate new or revised dietary 
patterns to reduce the activation of insulin/IGF-1 and mTOR pathways and, consequently, to extend 
healthy lifespan.  
3.2 Nutraceutical approaches  
Nutraceuticals are defined as “Naturally derived bioactive compounds found in foods, 
dietary supplements and herbal products, that have health promoting, disease preventing, or 
medicinal properties”.[90] These are constituents of different dietary patterns, such as the 
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Mediterranean and the Asiatic diets, and can modulate NSPs.[30] They explicate their action as 
hormetins, activating cellular stress response pathways, like the nuclear factor erythroid 2-related 
factor 2 (Nrf2), and leading to the transcription of antioxidant genes.[91]  
In two clinical trials, it was seen that US men and women that consumed  a large amount of 
fruit with purple skin, containing anthocyanidins (plant pigment belonged to flavonoids family), 
such as blueberries, grapes and strawberries, had minor risk of T2DM. In general, human 
intervention trials have shown that berries significantly improve insulin sensitivity, reduce fasting 
plasma glucose and the postprandial glucose response to a sucrose load. In vitro, the anthocyanidins 
interact with molecular targets and affect signalling pathways like NF-κB, reducing inflammageing. 
Moreover, in an animal model of T2DM, anthocyanins significantly decreased blood glucose 
concentrations and improved insulin sensitivity. In diabetic mice, bilberry extract reduces glucose 
production in the liver, acting on AMPK that increases the glucose uptake and its utilization in 
white adipose tissue and skeletal muscle.[92-94] 
Resveratrol, an antioxidant polyphenol contained in grape skin, induces the down regulation 
of IGF-1 signalling in mice consuming a high-fat diet.[95] Interestingly, it induces apoptosis in 
human colonic cancer cells, even in presence of IGF-1, used in combination with other grape 
extracts.[96] In addition, it belongs to a group of substances that inhibit mTOR, as well as: the 
quercetin, a flavonoid found in fruits and vegetables, like apples and capers, the polyphenol 
epigallocatechin gallate, present in green tea, and the ethylxanthine caffeine, in coffee.[4] In 
particular, it was seen that quercetin, mainly present in tea, onions, red grapes, and apples, acts as 
anti-cancer agent by the inhibition of mTOR signalling, activating AMPK.[97] 
Moreover, resveratrol is a part of a class of SIRT1-activating compounds (STACs), plant- 
derived metabolites such as flavones, stilbenes, chalcones and anthocyanidins that directly activate 
SIRT1 in vitro through an apparent allosteric mechanism. In mice, STACs activate SIRT1, binding 
it to a conserved N-terminal domain.[2,98] The discovery of natural STACs prompted the 
production of synthetic SIRT1 activators that are considerably more potent, soluble, and 
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bioavailable. In many in vitro and model organisms studies, resveratrol and synthetic STACs mimic 
the anti-ageing properties of CR, inducing gene expression changes and, in vivo, extending  lifespan.
[2,99] In addition, third generation STACs molecules have been discovered. Compared to 
resveratrol, these show more specificity and sensitivity and are much more potent. They include 
benzimidazoles, thiazolopyridines, and urea- ased scaffolds classes.[98] 
Flavonols, contained particularly in cocoa products, indirectly act on insulin sensitivity with 
a particular effect on the vascular endothelium, promoting nitric oxide production, with anti- 
atherogenic and anti-thrombotic functions.[100,101] Moreover, isoflavones, another class of 
flavonol compounds, plentiful in soybeans, have inhibitory effect on mTOR pathway via 
PI3K/AKT. In this regard, however, little data has been collected.[102] 
Curcumin, a hydrophobic polyphenol produced by Curcuma longa, has also attracted 
considerable interest because of its ability to interact and regulate multiple molecular targets. In 
particular, curcumin has been shown to inhibit the mTOR pathway and the phosphorylation of S6K, 
resulting in the inhibition of proliferation and in the induction of autophagy.[103] In addition, it can 
also activate Nrf2.[104] 
3.3 Pharmacological approaches 
The possibility to identify an anti-ageing or, better still, a pro-longevity drug is one of the main 
goals of  pharmaceutical companies.[105] Because NSPs constitute the most interesting target for the 
achievement of healthy ageing, much research has been conducted with the aim to pharmacologically 
modulate insulin/IGF-1, mTOR, and sirtuin pathways. 
Concerning the aim to decrease blood IGF-1 levels, a number of available drugs have been 
designed for human use. These can block IGF-1 signalling pathway, targeting cells and tissues 
involved in the production of, or in response to, GH and IGF-1 signals. In particular, somatostatin 
analogues control serum IGF-1 levels through the suppression of GH secretion by pituitary 
releasing factor. However, they also suppress the secretion of other endocrine hormones. On the 
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contrary, pegvisomant, an antagonist of the GH receptor, used for acromegaly treatment, might have 
positive effects on healthy ageing, lowering serum IGF-1, and increasing insulin sensitivity. Only a 
few serious adverse effects have been reported concerning the use of pegvisomant. Nevertheless, the 
effect of these drugs on health and lifespan is currently being investigated in several different 
experimental models.[4,27] 
Rapamycin (or Sirolimus) is the most well-known TOR inhibitor. It was isolated from S. 
hygroscopicus and shows anti-proliferative and immunosuppressive activity. In female mice, it has 
shown to extend lifespan up to 30% at high doses and to a lesser extent in males.[106] This 
molecule allosterically inhibits mTORC1 kinase activity by the interaction with the mTOR 
carboxyl-terminus.[107] It doesn’t binds mTORC2, so it selectively blocks only mTORC1.[108] 
Trials testing rapamycin in healthy elderly people are ongoing, hence, in a few years, it will be 
possible to determine its possible role as an anti-ageing drug.[2] 
Sirtuin pathways can be triggered using NAD+ precursors to increase NAD+ levels, by 
activating NAD+ biosynthetic enzymes or inhibiting NAD+ hydrolase. In fact, the enzymatic 
reaction, catalysed by sirtuins, requires NAD+ as a substrate, which is converted to nicotinamide. In 
vivo, nicotinamide acts as an inhibitor of the reaction, and provides negative feedback for the 
sirtuins.[71] The synthetic isonicotinamide can activate sirtuins by competing with its endogenous 
inhibitors. Unfortunately, its action depends on specific concentrations within the cell that limit the 
possibility to use this approach.[2,109] It is noteworthy that a precursor to NAD+, called 
nicotinamide riboside, can be transformed by the organism into NAD+ and put to use. Using this 
precursor, a supplement was created. 
Metformin is one of the most widely used anti-diabetic agents but it was also identified as a 
possible anti-ageing drug, targeting a number of age-related mechanisms. It is a safe oral anti- 
hyperglycemic drug, belonging to the biguanide family that decreases blood glucose concentration, 
using different mechanisms to insulin. It acts by enhancing insulin sensitivity, inducing greater 
peripheral uptake of glucose, and decreasing hepatic glucose output. Nevertheless, although these 
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aspects are relevant for diabetes treatment, the same are not pertinent with ageing.[110] In addition, 
it acts specifically on NSPs involved in ageing process, decreasing insulin levels and IGF-1 
signalling, inhibiting mTOR pathway, and activating AMPK energy sensor, hence positively affecting 
inflammation and autophagy.[111-114]. Other anti-ageing effects seemingly unrelated to NSPs have 
been described.[110] So, there is growing evidence that metformin increases healthy lifespan in 
model animals and epidemiological retrospective studies suggest that chronic treatment with 
metformin is associated with a decreased cancer incidence and with a decreased mortality rates. It is 
not surprising that a big study has been planned to elucidate the effect of metformin on ageing 
process, by measuring a composite outcome that includes cancer, dementia, cardiovascular diseases 
and mortality.[110]  
Moreover, in cells treated with LPS, metformin has been shown to inhibit SASP through 
NF-κB inhibition. In particular, metformin was demonstrated to block NF-κB translocation to 
nucleus, and to inhibit the phosphorylation of some factors of the pathway.[115] In a model of high- 
fat-diet induced obesity mice, it has been suggested that the modulation of microbiota (through an 
increase of Akkermansia (A.) muciniphila populat on) by metformin may contribute to its 
antidiabetic effects.[116,117] In a cross-sectional study of the microbiota in women with T2DM, 
metformin treatment was accompanied by a marked increase in the bacterium A. muciniphila and an 
associated increase in mucin-producing goblet cells.[118] It is noteworthy that A. muciniphila 
adheres to the intestinal epithelium and strengthens enterocyte monolayer integrity in vitro, 
suggesting an ability to fortify an impaired gut barrier.[119]  
4. Conclusion 
Age-associated diseases are the biggest challenges in both developed and developing 
countries. In fact, the overall increase in average life expectancy is far greater than that of healthy 
life expectancy, as evidenced by their incremental burden of them. This is already 
overwhelming the healthcare and welfare systems of developed nations, and if present trends 
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continue, the challenges could cause even larger problems. A long life in a healthy, vigorous, 
youthful body has always been one of humanity’s greatest dreams. Recent progress in genetic 
manipulations and calorie-restricted diets in laboratory animals hold forth the promises that 
someday science should enable us to exert total control over our own biological ageing. In 
particular, up regulation of some NSPs and down regulation of others ones are associated with age- 
related diseases, whereas their manipulation, in model animals, has been associated with extension 
of maximum lifespan and longevity. 
At present, there is a scarcity of data on the efficacy of pharmacological treatment, whereas 
a dietetic approach seems to be feasible as a prevention for many age-related diseases. 
5. Expert opinion 
Our approach is directly to show possible interventions on NSPs, involved in ageing 
processes, to delay ageing and to get older more healthily. Because ageing is an ineluctable process, 
the strategies to live longer in a healthy condition have been the main goal of recent researches. 
Nutrition represents the most concrete way to act on ageing. Accordingly, several kinds of 
dietary interventions, effective in model animals, have been outlined. However, they are not easily 
applicable to human beings. So, alternative approaches should be pursued. A feasible diet that reduces 
the risk of ageing-related diseases, favouring health ageing and longevity, should down regulate NSPs. 
The Insulin/IGF-1 pathway is activated by refined sugars, the mTOR pathway by amino acids and that 
of sirtuins, by nutraceuticals such as resveratrol. So, a diet with low GI, with healthier vegetable 
proteins, and rich in nutraceuticals, is to be recommended. However, it is not necessary to determine 
the ideal composition of this diet, because it does already exist in the traditional “poor” MedDiet.  
The low content of animal protein and the low GI of the MedDiet modulate the insulin/IGF-
1 and the mTOR pathways, with a down-regulation of the signals that lead to the inhibition of 
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• The global aged population is growing and the achievement of healthy ageing is  
the main challenge of the recent research. So, the identification of new therapeutic targets, 
supporting healthy lifespan, constitutes the main goal of ageing studies.  
Page 20 of 32
URL: http://mc.manuscriptcentral.com/eott  Email: Adam.Hall@informa.com
Expert Opinion On Therapeutic Targets
FOXO, thus favouring the transcription of homeostatic genes involved in survival and longevity. 
The down-regulation of both IGF-1 and mTORC1 also induces an anti-inflammatory effect. In 
addition, nutraceuticals from vegetables act both as hormetins and sirtuin activators (i.e. 
reseveratrol).  
In addition, Okinawan centenarians follow a vegetable-rich, low GI, and low-calorie diet, 
rich in nutraceuticals, with low assumption of meat, dairy products, and fat intake, and with the 
moderate intake f fish products. Compared to Western diets, this diet does not over stimulate 
mTOR, insulin, and IGF-1 receptors.  
With regards pharmaceutical interventions, some drugs appear promising but further clinical 
studies are mandatory. We are ready both to consider several therapeutic options for the treatment 
of age-related diseases and to initiate clinical trials with the goal of increasing the healthy lifespan 
of human beings.  
Rapamycin and somatostatins are already in use for other clinical indication, however they 
have notable side effects, which limit their consideration as an anti-ageing therapy. Moreover, the 
more safe safer pegvisomant has not yet been tested in clinical trials for healthy ageing, and neither 
has nicotinamide riboside. 
The antidiabetic drug metformin appears to target a number of ageing-related mechanisms. 
In fact, it modulates the biology of ageing and health span in model organisms. It has been used 
with an excellent safety record for over 60 years, so it is the ideal drug to test in clinical trials to 
further understand its effect on healthy ageing and longevity. The trials are ongoing and hopefully 
in a few years the results will be available.  
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• NSPs like insulin/IGF-1, mTOR and sirtuins, play a central role in the modulation of 
lifespan in various organisms. Their modulation influences ageing and longevity processes. 
• At present, dietary interventions represent the only possibility to modulate ageing, with a
non-invasive method. 
• Nutraceuticals have already been identified as possible molecules with bioactive effects on 
ageing process. 
• Drugs or supplements may hold the key to the future creation of a longevity elixir. 
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Legend to Figure 
Figure 1. Overview on NSPs and their role in healthy ageing.  
The figure shows molecular events involved in insulin-IGF-1, mTOR and sirtuin pathways, known 
as NSPs, and the possible effects due to their modulation by dietary interventions, nutraceuticals, 
and drugs. These act inhibiting insulin/IGF-1 and mTOR pathways and increasing that of sirtuins,  
favouring longevity, autophagy and the activation of the homeostatic genes, and reducing 
inflammation and anabolic processes. Microbiota and physical activity are external factors that 
influence successful ageing, through inflammation control.  
See the text for the acronyms. 
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Figure 1. Overview on NSPs and their role in healthy ageing. 
The figure shows molecular events involved in insulin-IGF-1, mTOR and sirtuin pathways, known as NSPs, 
and the possible effects due to their modulation by dietary interventions, nutraceuticals, and drugs. These 
act inhibiting insulin/IGF-1 and mTOR pathways and increasing that of sirtuins one, favouring longevity, 
autophagy and the activation of the homeostatic genes, and reducing inflammation and anabolic processes. 
Microbiota and physical activity are external factors that influence successful ageing, through inflammation 
control. 
See the text for the acronyms.  
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Abstract
Background: The aim of this study was to analyse the nutraceutical properties of table green olives Nocellara del
Belice, a traditional Mediterranean food. The Mediterranean Diet has as key elements olives and extra virgin olive oil,
common to all Mediterranean countries. Olive oil is the main source of fat and can modulate oxidative stress and
inflammation, whereas little is known about the role of olives. Moreover, emerging evidences underline the association
between gut microbiota and food as the basis of many phenomena that affect health and delay or avoid the onset of
some age-related chronic diseases.
Methods: In order to show if table green olives have nutraceutical properties and/or probiotic effect, we performed a
nutritional intervention, administering to 25 healthy subjects (mean age 38,3), 12 table green olives/day for 30 days. We
carried out anthropometric, biochemical, oxidative stress and cytokines analyses at the beginning of the study and at
the end. Moreover, we also collected fecal samples to investigate about the possible variation of concentration of
Lactobacilli, after the olives consumption.
Result: Our results showed a significant variation of one molecule related to oxidative stress, malondialdehyde,
confirming that Nocellara del Belice green olives could have an anti-oxidant effect. In addition, the level of interleukin-6
decreased significantly, demonstrating how this food could be able to modulate the inflammatory response. Moreover,
it is noteworthy the reduction of fat mass with an increase of muscle mass, suggesting a possible effect on long time
assumption of table olives on body mass variation. No statistically significant differences were observed in the amount
of Lactobacilli, although a trend towards an increased concentration of them at the end of the intervention could be
related to the nutraceutical effects of olives.
Conclusion: These preliminary results suggest a possible nutraceutical effect of daily consumption of green table olives
Nocellara del Belice. To best of our knowledge, this is the first study performed to assess nutraceutical properties of this
food. Of course, it is necessary to verify the data in a larger sample of individuals to confirm their role as nutraceuticals.
Keywords: Table green olives, Mediterranean Diet, Nutraceuticals, Dietary intervention, Oxidative stress, Inflammatory
status
Background
Nowadays, ageing process and the related diseases
constitute one of the bigger challenges in Western
countries. The general increase of lifespan does not
go, hand in hand, with the increase of healthy life-
span, the so-called “healthspan”. This constitutes a
worldwide problem, in particular due to age-related
chronic diseases [1].
It is well known that the pathogenesis of age-related
diseases is characterized by a low-grade inflammation. In
particular, the visceral adipose tissue is a source of in-
flammatory mediators produced by adipocytes and infil-
trating monocytes [2].
Abdominal obesity with dyslipidaemia, elevated blood
pressure and impaired glucose tolerance characterizes
metabolic syndrome (MS) that predisposes to the onset
of age-related diseases. As many studies demonstrate, a
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dietary Mediterranean regimen can positively influence
these parameters. Large intervention trials showed, in
fact, that Mediterranean Diet (MedDiet) could prevent
and or delay the onset of age-related diseases with a
great implication in the health social system [3–7].
The traditional MedDiet is a common dietary pattern,
adopted by inhabitants of countries within Mediterra-
nean basin where the olive tree, Olea europaea, is widely
cultivated for the production of table olives and oil. They
are the essential components of the MedDiet with a very
significant economic value. Besides of the economical
contribution to national economies, these are important
in terms of nutritional value. Extra virgin olive oil
(EVOO) has been claimed to play a key role in the pre-
vention of age-related diseases and in the attainment of
longevity. This is due to the high levels of monoun-
saturated fatty acids, likely responsible for the de-
creased low density lipoprotein levels, and phenolic
compounds claimed to play a role as antioxidants and
anti-inflammatories [6, 8, 9].
Foods with bioactive molecules can be considered
“nutraceuticals”, defined as “Naturally derived bioactive
compounds that are found in foods, dietary supplements
and herbal products, and have health promoting, disease
preventing, or medicinal properties”. The term was coined
in 1989 by Stephen De Felice and was born from the con-
junction between nutrition and pharmaceutics [10].
As reported in a recent review, table olives are ex-
tremely rich sources of polyphenols, especially oleuro-
pein and hydroxytyrosol, comprising 1–3 % of the fresh
pulp weight. Despite the high levels of hydroxytyrosol in
both table olives and EVOO, in humans its bioavailabil-
ity was proved only in oil. Accordingly, to the best of
our knowledge, there are no human studies on health ef-
fects of table olives [11]. However, the amount of poly-
phenols is strongly influenced by the variety and the
geographical origin. Greek Koroneiki have a very high
level of them, while the polypenol content of the Spanish
Arbequina is low and that of Sicilian Nocellara is
medium-high [12]. So, a possible anti-inflammatory and
anti-oxidant effect of these Sicilian olives is conceivable.
The development of strategies aimed at counterbalan-
cing the frailty in the elderly is a major challenge for the
medicine of 21st century [1]. As recently reviewed, age-
ing affects the gut microbiota composition and its influ-
ence in immune response. Age-related gut microbiota
changes are associated with immunosenescence and
inflamm-ageing. Hence, the gut ecosystem shows the po-
tential to become a promising target for strategies able
to contribute to the health status of elderly. In this con-
text, the consumption of pro/prebiotics may be useful in
both prevention and treatment of age-related patho-
physiological conditions, favouring the attainment of
longevity [13].
Probiotics are defined as “Live microorganisms which
when administered in adequate amounts confer a health
benefit on the host”. Lactobacilli (L.) and Bifidobacteria
are the most commonly used bacterial probiotics [14].
Nutritional supplementation in aged people might help
to maintain good immune-inflammatory responses by
re-equilibrating the gut microbiota.
Fermentation is one of the oldest methods to preserve
olives. It has applied worldwide for thousands of years.
The microbiota of olives during fermentation, that varies
somewhat from cultivar to cultivar, has been recently
reviewed, showing that L. are the major constituents of
Nocellara del Belice olives microbiota [15, 16]. So, a pos-
sible probiotic-like effect of these olives is feasible.
The aim of this pilot study was to evaluate the effect
of green table olives Nocellara del Belice on clinical and
biological parameters of healthy individuals at baseline
(T0) and after the assumption of 12 olives/day for
30 days (T1) (this amount was chosen to assure the ad-
ministration of 2x107 L./die, see below).
Results and discussion
Hematochemical tests
At the end of the intervention, all hematochemical pa-
rameters did not experienced variations, with the excep-
tion of alkaline phosphatase that significantly increased
(Table 1).
However, the increased values were in normal range.
This means that a regular consumption of 12 green ol-
ives/day for 30 days does not have a detrimental effect
on liver and kidney function and on lipid values.
Anthropometric measurements
At T1, in analysed subjects the fat mass significantly de-
creased together to an increase of muscle mass (Table 1).
The possible explanation could be linked to the capacity
of conjugated linoleic acid (CLA) to reduce the body fat
levels [17]. This molecule is present both in EVOO and
Table 1 The Table shows the arithmetic average values at T0
and T1, the p-value and the variation in percentage (+ indicates
an increase of the variable at T1; - a decrease at T1)
Variable T0 ± SD T1 ± SD p-value %
Alkaline phosphate (IU/L) 49.95 ± 13.26 53.73 ± 16.81 0.022 +7.57
Fat mass% 29.70 ± 7.92 28 ± 7.24 0.004 −5.72
Muscle mass % 66.97 ± 7.62 68.36 ± 6.85 0.003 +2.09
IL-6 (FI) 31.52 ± 29.37 20.89 ± 11.93 0.027 −33.73
MDA (μmol/L) 2.72 ± 0.64 2.33 ± 0.49 0.005 −14.24
Weight (Kg) 70.44 ± 14.07 69.93 ± 13.77 0.08 −0.72
BMI (Kg/m2) 24.37 ± 4.19 24.24 ± 4.16 0.22 −0.53
T0 baseline, T1 the end of the nutritional intervention (30 days), BMI Body
Mass Index, IL-6 interleukin-6, IF indirect fluorescence, MDA malondialdehyde,
SD standard deviation
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table olives, and can also be produced during their di-
gestion. In experimental models, acting as signalling me-
diators, CLAs inhibit lipogenesis, increase fat oxidation,
and reduce adipocytes size [18, 19].
Cytokines analyses
The serological analysis of the levels of the main pro and
anti-inflammatory cytokines was conducted. Although it
was not possible to evaluate the absolute concentration
of interleukin (IL)-6 because it is too low, a significant
variation was measured in the indirect fluorescence (IF).
In fact, its levels significantly decreased at the end of the
dietary intervention (Table 1).
IL-6 is a pleiotropic cytokine capable of regulating
proliferation, differentiation and activity in a variety of
cell types. In particular, it plays a pivotal role in acute
phase responses and in the balancing of the pro and
anti-inflammatory pathways. It is involved in impaired
lipid metabolism and in the production of triglycerides.
Moreover, it decreases lipoprotein lipase activity and
monomeric lipoprotein lipase levels in plasma which con-
tributes to increased macrophage uptake of lipids [20].
This datum suggests that a regular consumption of green
olives can have anti-inflammatory effects linked to poly-
phenols, known to have anti-inflammatory properties [6].
Oxidative stress analyses
At the end of intervention, the values of malondialde-
hyde (MDA) significantly decreased (Table 1), while par-
aoxonase (PON) plasma levels and reduced glutathione
in the red blood cells were not changed (data not
shown). MDA is the main product of the polyunsatur-
ated fatty acids peroxidation and is an important index
of oxidative stress [21]. So, its reduction should be
linked to the increased assumption of mono-unsatured
oleic acid by olives.
Microbiological analyses on feces
The amount of L./g of feces was quantified before and
after the intervention. No statistically significant differ-
ences were observed, although a trend towards an in-
creased amount of L. was highlighted in some subjects
at T1 (data not shown). Thus, we can speculate that a
more durable dietary intervention and a bigger sample
of people could give more interesting results.
Conclusions
The traditional MedDiet is a common dietary pattern that
identify a lifestyle and a culture. It was proven that it con-
tributes to better health and quality of life. Concerning its
healthy effects, low content of animal protein and low
glycaemic index may directly modulate the insulin/insu-
lin-like growth factor-1 and the mammalian target of
rapamycin pathways, known to be involved in ageing, age-
related diseases and longevity. In addition to the influence
on nutrient sensing pathways, many single components of
MedDiet are known to have positive effects on health, re-
ducing inflammation, oxidative stress and other important
risk factors of age-related diseases [6].
This pilot study demonstrates an anti-inflammatory
and anti-oxidant effect of daily consumption of green
table olives Nocellara del Belice. Moreover, it is note-
worthy the reduction of fat mass with an increase of
muscle mass. Although no statistically significant pro-
biotic effect was observed, the positive trend related to
L. amount at T1 could represent a starting point for fur-
ther studies.
It is to note that the study presents limitations. One is
strictly related to the intrinsic complexity of human as
study model and to the inter/intra-individual variability.
These features are more evident in ageing than in youn-
ger people. This is the reason why we chose middle age
people. So, our choice represented the second limitation
of the study because we did not analyze the effects of
the intervention in elderly. Thirdly, it is necessary to ver-
ify these data in a larger sample of individuals to confirm
the role of table green olives as nutraceutical foods. Also
the duration of the intervention could be inadequate. In
fact, we developed a short-term dietary regimen (30 days).
This is a good choice in terms of compliance to the study
because the more is the time of intervention the more is
the drop out effect. But, a long-term dietary intervention
could be stronger in terms of variation of analyzed param-
eters (e.g., L. amount in feces).
However, these new knowledges give an important
achievement for the food and farming industry, espe-
cially in Sicily, where the olives represent a great poten-
tial resource. No approved healthy property and claim
exist for them. Therefore, adding such a common prod-
uct to the class of nutraceuticals could represent a big
deal.
In the era of many expansive and mysterious longevity
elixirs, the olives could represent a traditional, cheap
and accessible to everyone “healthy food”.
Methods
Study design
The trial consisted in the assumption of 12 olives/day
for 30 days. They belonging to the variety Nocellara del
Belice, were processed in salt solution without any
chemical additives.
See Fig. 1 for the flow chart of the study design.
Study population
Twenty-five randomized volunteers (mean age 38,3),
both men and women, were recruited from April 2015
to July 2015. The subjects included were: healthy, with
age between 18 and 65 years and Caucasian. The
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exclusion criteria provided: a history of the absence of
pathologies (obesity, MS); a history of use of any pre or
probiotics as dietary supplements within 3 months prior
to the study; a history of treatment with statins or simi-
lar and with lyposoluble drugs; the onset of gastrointes-
tinal disorders or the use of antibiotics during the
nutritional intervention. No restriction related to sex
was considered. Two subjects dropped out of the trial.
All participants signed an informed consent before the
enrolment. To respect the privacy, everyone was identi-
fied with an alphanumeric code. Height and weight were
measured wearing light clothes and barefoot. The body
composition was registered using specific hardware and
software. Body mass index was calculated as weight (in
kilos) over height squared (in square metre) (Table 1).
Dietary habits were assessed through a food frequency
questionnaire, officially validate by the EPIC study.
Blood tests, oxidative stress and cytokines analyses were
carried out for all subjects at T0 and T1. Molecular ana-
lyses were conducted on L. DNA obtained from fecal
samples to measure the variation of its amount. A data-
base was created to insert all participants’ data and to
handle the collected information.
Hematochemical tests
The recruited people underwent to venipuncture at T0
and at T1. Blood samples were collected in specific
blood collection tubes containing ethylenediaminetetra-
acetic acid (EDTA) for plasma analyses and in serum
tubes with no additives. Plasma and sera were separated
from whole blood by low-speed centrifugation at
2,500 rpm for 15′ at 4 °C. After separation, the samples
were stored at −80 °C for further tests. We also obtained
gruel of red blood cells from blood collected in tubes
with EDTA through three washes with physiological so-
lution (centrifugation at 2,500 rpm for 15′ at 4 °C).
Evaluation of parameters of oxidative stress
These analyses were conducted in collaboration with the
University of Sassari. Thiobarbituric acid reactive sub-
stances (TBARS) were determined according to the
method described by Esterbauer and Cheeseman [22].
TBARS methodology measures MDA and other alde-
hydes produced by lipid peroxidation induced by hy-
droxyl free radicals. For the measurements, plasma was
mixed with 10 % trichloroacetic acid and 0.67 % thiobar-
bituric acid and heated at 95 °C in thermoblock heater
for 25′. TBARS were determined by measuring the ab-
sorbance at 535 nm. A calibration curve was obtained
using standard MDA and each curve point was sub-
jected to the same treatment as that of the samples.
PON activity was determined by measuring the
increase in absorbance at 412 nm (formation of 4-
nitrophenol), using paraoxon (O, O diethyl-O-p-nitro-
phenyl phosphate) as a substrate [22]. The enzyme
activity was calculated by using the molar extinction co-
efficient of 17,100 M−1cm−1 and one unit of PON activ-
ity was defined as 1 nanomole of 4-nitrophenol formed
per minute. For red blood cell glutathione quantification,
200 μl (μL) of thawed packed cells were lysed by adding
600 μL of cold water and keeping the samples at 4 °C
for 15′. 200 μL of lysed samples were deproteinized by
adding 200 μL acetonitrile and centrifuged at 2,000 × g
for 5′. Samples were then derivatized by mixing 100 μL
of supernatant with 100 μL of sodium phosphate buffer
(60 μmol (mmol)/L, pH 12.5), and 25 μL of 5-
Fig. 1 The figure shows the flow chart of the study design
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Iodoacetamidofluorescein (4.1 mmol/L). After vortex
mixing, samples were incubated for 15′ at room
temperature. Derivatized samples were diluted 100-fold
in water and analysed by capillary electrophoresis with
laser induced fluorescence detection [23].
Pro and anti-inflammatory cytokines analyses
These analyses were conducted using Luminex assays,
coupled to Bio-Plex Manager software.
Data obtained have been checked by technical depart-
ment and quality control parameters. Values of the
standard curve were compared to the values provided by
the manufacturer of the kits used and must not exceed a
CV of 15 %. All of above parameters were applied on, at
least, the 90 % of the standard curve values.
Microbiological and molecular analyses of Lactobacilli
In order to quantify the amount of L. in each olive, 1 g
of pulp was suspended in phosphate-buffered saline so-
lution (1 mL), homogenized for 2′ at maximum speed,
and then serially diluted. Decimal dilutions were plated
and incubated on de Man, Rogosa and Sharpe at 30 °C
for 48 h to observe the L. growth. The colonies’ count
was performed in triplicate and the L. DNA was ex-
tracted from them to perform molecular analyses. Moro-
ever, colony suspension were used as a template for Real
Time PCR. The primers and probes used to detect L.
species (spp) were based on 16S rRNA gene sequences
retrieved from the NCBI databases (Table 2). The ampli-
fication reactions were carried out in a total volume of
25 ml containing 1X SSoFast Probe mix (BIORAD),
primers (each at 200 nM concentration), 100 nM Taq-
Man MGB probe, 60 ng purified target DNA. Amplifica-
tion (1 cycle of 5′ at 95 °C, 45 cycles of 15″ at 95 °C and
1 cycle of 1′ at 60 °C) and detection were carried out on
a CFX Real Time system (BIORAD).
Fluorescent probe was labeled at 5′ end with the re-
porter dye 6-carboxyfluorescein and at 3′ end with a
quencher dye. A negative and a positive control were in-
cluded on the reaction plate.
In order to perform the quantification of L. in each
feces sample, the QIAamp DNA Stool Minikit (Qiagen)
was used to extract DNA from an appropriate amount
of frozen stool sample, according to the manufacturer’s
instructions. The Real Time PCR was performed as pre-
vious described and the cycle threshold of each sample
was compared to a standard curve made by diluting gen-
omic DNA (10-fold serial dilution) from cultures of
known concentrations of L. (106 CFU/ml).
Statistical analyses
The paired comparisons were performed with the Stu-
dent’s t-test or the Wilcoxon signed rank test, according
to the normality of samples. Statistical analyses were
performed with the IDE RStudio for the R (version 3.2.2)
software [24, 25].
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1.Summary: Recent interest in intestinal hormones has risen with the idea that they modulate
glucose tolerance and food intake through a variety of mechanisms, and such hormones like peptide
YY (PYY), ghrelin, glucagon-like peptide (GLP)-1 and 2, and cholecystokinin (CKK) are therefore 
excellent therapeutic candidates for the treatment of diabetes and obesity. Furthermore, in the recent 
years, multiple studies suggest that the microbiota is critically important for normal host functions, 
while impaired host microbiota interactions contribute to the pathogenesis of numerous common 
metabolic disorders. In this study, we considered the nutraceutical effects of β-glucans added to 
pasta at the concentration of 6g\100g. Ten participants have been recruited and hematochemical
analyses and intestinal hormones tests have been performed before and after 30 days of pasta intake. 
Stool specimens have been studied for Lactobacillus Fermentum, Lactobacillus acidophilus, 
Lactobacillus salivarius, Bifidobacterium longum, and Enterococcus faecium presence before and 
after 30 days of nutritional intervention. After 30 days of regular intake of pasta enriched by β-
glucans results have been evaluated. In conclusion, pasta prepared from barley flour enriched with 
β-glucans at 6% exhibit promising responses on glucose metabolism, on intestinal hormones 
responses and on microbiota modification. 
Key words: β-glucans; entero-endocrine system; intestinal hormones; microbiota; nutritional 
intervention 
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2. Introduction 
The β-glucans are soluble fibres commonly found in the cell wall of yeasts, fungi, bacteria, 
algae and cereals. All the β-glucans are polysaccharides consisting of linear molecules of D-glucose 
joined together by glycosidic bonds linear β (1-3) and β (1-4) and differ between them for the length 
and branched structures. The branches derived from the nuclear chain glycoside are highly variable 
and the two main groups are branching chains glycosidic β (1-4) and β (1-6). These ramifications 
appear to be specific. For example, the β-glucans of mushrooms have side branches 1→6 while 
those of bacteria have side branches 1→4 [1, 2]. The presence of the bond β (1-3) leads to the 
formation of folds in the linear chain that allow water to enter; for this reason the β-glucans are 
classified as soluble fibres. Characteristics of β-glucans are their effect on cholesterol that depends 
on the ability to form a viscous layer on the surface of the small intestine that reduces the absorption 
of cholesterol and the bile acids. The inhibition of the reabsorption of bile acids can increase their 
synthesis from endogenous cholesterol thus reducing the blood levels of low density lipoprotein 
(LDL)-cholesterol [3]. This action has already been investigated using breakfast drinks [4], biscuits 
and crackers added with less of 3% of β-glucans [3]. A minimum dose of 3g/day has been 
demonstrated to reduce the blood levels of cholesterol and consequently it decreases the risk of 
cardiovascular diseases [4]. In fact, the β-glucans viscous layer may have beneficial effects on 
glycaemia and sensations of hunger and satiety [4,5]. In a recent report, some of us considered the 
nutraceutical effects of β-glucans added to pasta (6%). After 30 days of pasta intake, we obtained 
encouraging results with a significant decrease of LDL-cholesterol, interleukin (IL)-6 and advanced 
glycation end-product levels [6]. Therefore, the nutraceutical use of β-glucans seems to be an 
interesting perspective [7].  
On the other hand, the effects of β-glucans on satiety have been reported in many studies, 
but no consensus has been reached. In a recent report, it was examined the effects of breakfasts 
varying in the dose of oat bran (4g or 8g β-glucans). The sensations associated with hunger and 
satiety were evaluated using visual analogue scales before and after ingesting the test  breakfasts 
and every 30 min until 210 min. Oat bran addition in breakfasts increased postprandial satiety [8].  
However, the effects of regular intake in human of higher amounts of β-glucans on intestinal-
hormones, that concur to regulate appetite/satiety, have not been defined.  
Moreover, many studies demonstrated the role of gut microbiota in many inflammatory 
diseases, including type 2 diabetes mellitus and obesity. Two groups of beneficial bacteria are 
dominant in the human gut, the Bacteroidetes and Firmicutes. The relative proportion of 
Bacteroidetes is decreased in obese people by comparison with lean people, and this proportion 
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increases with weight loss, indicating that obesity has a microbial component [9]. Thus, the 
alteration of microbiota homeostasis can be involved in the pathogenesis of diseases but it is not 
clear if this process is a consequence or a cause of it. In animal model modification of intestinal 
microbiota seems to affect insulin resistance and post prandial glucose response perhaps due to 
reduced gut permeability and therefore influencing intestinal hormones concentration. More 
interestingly, mice model treated with prebiotics showed increased levels some intestinal-hormones 
[10].  
Microbiota has been already identified as a metabolic organ that could ferment non 
digestible dietary components. In fact, microbiota generates short chain fatty acids (SCFAs), which 
could affect host energy metabolism and could develop obesity by changing the hormonal secretion 
in the intestine. So, microbiota cyclical fluctuation in composition may trigger intestinal hormones 
release. In addition, in obese rats and high-fat diet-fed mice an intervention with prebiotics 
stimulates Bifidobacteria and reduces weight, by increasing intestinal-hormone PYY and reducing 
ghrelin [11]. In obese people during weight gain it is observed a decreased level of GLP-1, which is 
normally regulated by gut microbiota. GLP-1 influences the expression of the proglucagon (its 
precursor), which causes insulin resistance independent of fatty acids circulating level [12].   
Thus, in the present pilot study we investigated the modification of serum concentrations of 
orexigenic peptide ghrelin, anorexigenic active form of GLP-1, GLP-2, CKK, and PYY. Those 
hormones were evaluated in the postprandial period after a challenge with a test meal constituted by 
pasta supplemented with 6% β-glucans. 
This study was performed in overweight and healthy individuals, before and after 30 days of 
pasta intake. In addition, we quantified the variation of some bacterial strains in faeces samples at 
the baseline and after 30 days of nutritional intervention. 
3. Material and Methods 
3.1. Study Design 
This was a 30±3 days longitudinal, intervention study on the effect of consuming 100 g of 
pasta supplemented with 6% of β-glucans four times a week, in 10 overweight young Sicilians, 
otherwise healthy. It was not recommended other changes in dietary habits. We took blood for 
hematochemical test at baseline (day 0), as a control, and after 30 days (day 30) to register possible 
variation. In addition, we evaluated intestinal hormones after a challenge with test meals at day 0 
and at day 30; we also collected stool samples in sterile containers for the analysis of some bacterial 
species of the intestinal microbiota. Moreover, anthropometric measurement (height in cm, weight 
in kg) were collected and BMI (kg/m2) was calculated.  
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The study protocol was conducted in accordance with the Declaration of Helsinki and its 
amendments, and was approved by the local review board. Suitable subjects were identiﬁed from 
computerized clinic registers, according to the inclusion and exclusion criteria and were contacted 
by the clinicians personally or by telephone. All eligible candidates had to provide signed informed 
consent before enrolment in the study. 
 
3.2. Test Meal 
The intestinal hormones evaluation consisted of 100g of pasta with β-glucans administered 
to the selected people after night fasting of day 0 and of day 30 as sort of breakfast. Immediately 
after test meal blood samples were collected after 15, 30, 60, 90 and 180 min. Intestinal hormones 
measured were the following GLP-1, ghrelin, PYY, CCK, and GLP-2 (Figure 1). 
 
 
3.3. Subjects 
Inclusion criteria were: age range 20-30 years, overweight (BMI, 25-29.9 kg/m2;), normal 
glucose tolerance (fasting plasma glucose <100 mg/dL; glycated haemoglobin <5.7%), slight 
dyslipidemia (total cholesterol 200-240 mg/dL, LDL 130-160 mg/dL, triglyceride level ≤170 
mg/dL). Exclusion criteria were: any diagnosis of systemic disorder (including heart disease, 
hypertension, rheumatologic disease, liver, kidney and enterological disorders), any drug treatment, 
eating behaviour disease based on the VAS Questionnaire [13], any hypocaloric dietary treatment in 
the last six months. Enrolled people underwent a complete medical evaluation by a trained 
physicians (SB). All the subjects ended the pilot study (100% of trial completion), none abandoned 
the study before completion.  
Participants were asked to maintain their usual diet and physical activity level throughout 
the study period. Body weight, height and blood pressure of all participants were measured and 
blood samples and faeces were collected at day 0 and at day 30. Baseline and after 30 days tests 
were performed between 8:00 and 9:00 a.m., in post-absorptive fasting from at least 10 hours, 
without any strenuous physical activity in the last three days. An indwelling venous cannula was 
placed in the forearm 10 min before the first blood sample. Blood samples were collected before 
and 15, 30, 60, 90, 180 min after the ingestion of the test meal and immediately centrifuged to 
collect serum samples, and stored at -80°C. Furthermore, faeces were stored at -80°C for 
subsequent determinations . 
 
3.4. Nutritional Intervention 
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β-glucans extraction, characterization and pasta have been prepared according to 
Montalbano et al [14] by pasta factory Tomasello (Casteldaccia, Italy). 
3.5. Haematochemical Tests 
Plasma and serum samples were used for hematochemical test, total cholesterol, LDL-
cholesterol, HDL-cholesterol, alanine aminotransferase, aspartate aminotransferase, glucose, 
triglycerides, creatinine, gamma-glutamyl transferase, total protein, uric acid, high sensitivity c-
reactive protein. 
3.6. Intestinal Hormones Tests 
For intestinal hormones measurement, plasma was obtained from peripheral blood sample 
by centrifugation at 5°C for 10 min at 3000 rpm; plasma samples were collected in prechilled 
EDTA-containing tubes with apoprotein (0.6 TIU/ml blood) and dipeptidyl peptidase IV inhibitor 
(10 µl/ml blood). All samples were immediately stored at -80°C until analyzed. Results were 
obtained from all the study participants (see flow chart Figure 1). Samples were analyzed using the 
following enzyme immunoassay kit: EGLP-35K for active GLP-1, EZGRT-89K for total ghrelin, 
EZHPPYYT66K for total PYY, EZGLP-237K for GLP-2, all from Millipore (EMD Millipore, 
MERCK KGaA, Darmstadt, Germany); CCK (26-33) for CCK from Phoenix (PHOENIX 
PHARMACEUTICALS, INC.) These kits are enzyme immunoassays developed for the detection 
and quantization of the different hormones in plasma, serum or other tissue culture methods. Each 
kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown 
sample. The detection method is fluorescent and/or colorimetric. 
3.7. Microbiota Analysis 
In order to perform the quantification of microbiota in faeces samples at the baseline and 
after 30 days of nutritional intervention, the total DNA amount (bacterial and human) was extracted 
with the QIAamp DNA Stool Minikit (Qiagen), from a frozen stool sample of 200 mg, quantified 
by a spectrophotometric assay. The total DNA was used as a template to perform the PCR 
Real_Time to identify the possible variation in the amount of the following bacterial strains 
Lactobacillus fermentum, Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium 
longum, Enterococcus faecium, Clostridium difficile. We have chosen Lactobacilli and 
Bifidobacterium as markers of healthy status of gut because they are considered reference 
probiotics (15, 16). Instead, we have selected Clostridium difficile, either as marker of intestinal 
inflammation (17) either because Lactobaccilli inhibit its growth (18). Finally, Enterococcus 
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faecium was preferred as marker of dysbiosis in overweight subjects (19). The amplification 
reactions were carried out starting from 1 µl DNA, 25µg/µl and Qiagen kits were employed, 
according to the manufacturer’s procedure. Each assay contained a negative (without DNA) and a 
positive control (quantified DNA, specific for each strain). Moreover, specific primers and 
fluorescent probe labelled with the reporter dye 6-carboxyfluorescein (FAM) were used. In 
particular, the kits have the following catalog number: BBID00188A for Lactobacillus fermentum; 
BBID00184A for Lactobacillus acidophilus; BBID00196A for Lactobacillus salivarius; 
BBID00067A for Bifidobacterium longum; BBID00143A for Enterococcus faecium; BBID00100A 
for Clostridium difficile. The variation of DNA amount before and after the nutritional intervention 
was calculated considering the cycle threshold (CT) of each sample. 
 
3.8. Statistical Analysis 
Results are shown as mean ± S.E.M. for intestinal hormones data, S.D. used for 
haematochemical tests. The comparison of hematochemical tests before and after the 30 days of 
pasta intake was performed by Wilcoxon test. The comparison between the levels of gut hormones 
after test meal at baseline and after 30 days was performed by ANOVA followed by Bonferroni’s 
post-test test using Prism Version 6.0 Software (Graph Pad Software, Inc., San Diego, CA, USA). 
The AUC values were calculated using the trapezoidal rule. In the field of pharmacokinetics, the 
AUC is the area under the curve  in a plot of concentration of drug in blood plasma against time. In 
this case, it determines whether the same standardized two formulations of test meal, before and 
after 30 days treatment within pasta added with β-glucans, release the same dose of hormones. A p 
value <0.05 was considered to be statistically significant.  
 
4. Results  
 
4.1. Hematochemical Tests 
Anthropometric and biochemical measurements are presented in Table 1. In particular, 
biochemical values did not change following the 30 days intervention with β-glucans with the 
exception of glucose concentrations and total and LDL cholesterol, as reported in Table 1. Body 
weight and body mass index (BMI) were not significantly changed at the end of the study. Thus, as 
observed ex-vivo in the previous study [6], the treatment with β-glucans induced a reduction of 
serum LDL-cholesterol concentrations.  
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Instead, in this study there were no significant alterations of high density lipoprotein (HDL)-
cholesterol and triglycerides concentrations or the other considered parameters, probably, due to the 
small sample size.  
On the other hand, we have observed a significant reduction of glycaemic levels after the 
treatment, datum not observed in the previous study, likely because previously only healthy normal 
weight subjects were studied. 
 
 
4.2. Gut Hormone Responses  
GLP-1 (Figure 2). The consumption of test meal induced an increase in plasma GLP-1 
concentrations, starting from 15 min up to 90 min, peaking at 30 min. The consumption of the β-
glucans enriched pasta for 30 days significantly increased the levels of GLP-1 at 0, 30 and 60 
minutes after intake. As shown by area under the curve (AUC), on the whole after 30 days 
treatment we observed an increased release of GLP-1.  
 
 
Ghrelin (Figure 3). Plasma ghrelin concentrations were higher in fasting state and they were 
reduced following the test-meals. The consumption of the β-glucans enriched pasta for 30 days 
significantly increased the levels of ghrelin at 0, 15 and 30 minutes after intake. As shown by AUC, 
on the whole after 30 days treatment we observed an increased release of ghrelin. 
 
PYY (Figure 4). The consumption of test meal induced an increase in plasma PYY 
concentrations starting from 15 min up to 90 min, peaking at 90 min. The consumption of the β-
glucans enriched pasta for 30 days significantly increased the levels of PYY at 0, 15, 30, 60 and 90 
minutes after intake. As shown by AUC, on the whole after 30 days treatment we observed an 
increased release of PYY.  
 
 
GLP-2 and CCK (Figure 5). Plasma CCK concentrations were lower in fasting state and 
they were increased following the test-meals whereas no difference were observed for GLP-2 
plasma concentrations. However, the consumption of the β-glucans enriched pasta for 30 days did 
not affect plasma concentrations of GLP-2 and CCK in fasting state or after the meal test.  
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Figure 5.(A) Plasma concentrations of GLP-2 at day 0 and after 30 days of consumption of 
enriched β-glucans pasta. (B) Plasma concentrations of CKK at day 0 and after 30 days of 
consumption of enriched β-glucans pasta. (C) The AUC of GLP-2 during a 3-hours 
monitoring period. (D) The AUC of CKK during a 3-hours monitoring period. Data are 
mean values ± S.E.M. (n=10/group). 
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4.3. Analysis of microbiota in faeces  
The analysis of microbiota in stool samples was carried out to identify a possible variation 
between the baseline and the end of the nutritional intervention. No PCR inhibitors were detected in 
the reactions. At the end of the intervention, after 30 days, Bifidobacterium Longum, one of the 
most important probiotic bacterium in human intestine, increases in 80% of subjects analysed 
(8/10), from 2 to 36-fold than the baseline, while did not show variation in 10% (1/10) and an 8-fold 
decrease in the other 10% (1/10). Enterococcus faecium, a human pathogen responsible of many 
nosocomial diseases, surgical wound infection, endocarditis and urinary tract infection, showed a 
decrease in 90% (9/10), while no result was detected for one sample. However, these results, 
although interestingly, were not significant. 
5. Discussion 
The intestinal tract is the largest endocrine organ in the body secreting a wide array of 
hormones and neuropeptides that regulate the endocrine-metabolic answer to food ingestion within 
as well as outside the gut. Recent interest in gut hormones has risen with the idea that they modulate 
glucose tolerance and food intake through a variety of mechanisms, and such hormones are 
therefore excellent therapeutic candidates for the treatment of type 2 diabetes and obesity [20]. The 
most widely studied appetite modulating intestinal hormones are GLP-1, GLP-2, CCK, PYY and 
the peptide ghrelin [21-23]. So far, ghrelin is the only known circulating orexigenic satiety-related 
hormone and exogenous administration of ghrelin has been shown to stimulate appetite and food 
intake both in rats and in humans [24]. In contrast to ghrelin, GLP-1, GLP-2 and PYY are secreted 
into the circulation following meal ingestion and decrease with fasting [25]. The administration of 
GLP-1 decreases hunger and energy intake both in animals and humans [26]. The post-prandial 
production of GLP-1 is blunted in severely obese people but controversy exists if GLP-1 
concentrations tend to normalize following body weight reduction [27, 28]. Pharmacological 
activation of the GLP-1 system has beneficial effects on obesity-induced alterations of lipoprotein 
metabolism. The role of GLP-2-related pathways on lipid levels and metabolism are less clear, but 
some effects are opposite to GLP-1 [29, 30]. The PYY is another intestinal hormone that is 
stimulated by food ingestion, especially by the fat content of meal. The infusion of PYY seems to 
reduce food intake in normal-weight and obese humans; in rodents, repeated infusion of PYY 
attenuates weight gain [31, 32]. Also CCK is anorexigenic, leading to decrease in food intake [33]. 
In the present study, we demonstrated that pasta enriched by 6% of β-glucans strongly 
modified short-term hormones release by intestinal tract. In response to 30 days of pasta intake we 
observed different postprandial responses of ghrelin, CCK, PYY, and GLP-1. In particular, 30 days 
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of regular intake of enriched β-glucans pasta significantly increased the endogenous levels of GLP-
1 compared with day 0 as well as those of plasma PYY levels. Furthermore, plasma ghrelin 
concentrations were higher in fasting state and they were reduced following the test-meals. So, food 
stimulated postprandial secretion of the anorexigenic hormones PYY, and GLP-1 and repression of 
concentrations the orexigenic hormone ghrelin that have been proposed to increase satiety and 
decrease short-term food intake [34]. As stated in the Introduction, it has been claimed an effect on 
satiety by products prepared from barley flour enriched with β-glucans, but in that study no 
hormonal measurement was performed. Thus, to the best of our knowledge, the present study is the 
first one to demonstrate an effect of intestinal hormones. 
Due to the known effects of these hormones in weight regulation, we can suggest that the 
regular intake of pasta added with  β-glucans should be a promising tool to prevent obesity. 
On the other hand, it is well known that harmful metabolites, produced by the human 
microbiota, likely participate to ageing process, contributing to inflammageing and 
immunosenescence. Although the intestinal microbiota is relatively stable throughout adulthood, 
age-related modifications in the intestinal tract, as well as changes in diet and host immunity 
reactivity, inevitably affect bacteria population composition. The prolonged retention time leads to 
an increase in bacterial protein fermentation and consequently putrefactive processes in the gut with 
a greater susceptibility to inflammatory diseases [35]. Hence, the gut ecosystem shows the potential 
to become a promising target for strategies able to contribute to the health status of elderly. In this 
context, the consumption of prebiotics as β-glucans fibres might be useful in both prevention and 
treatment of age-related pathophysiological conditions, favouring the attainment of longevity [20]. 
Accordingly, we observed changes in microbiota composition in our subjects, after 30 days 
treatment with pasta added with β-glucans, however, the brief period of time of our study did not 
allow us to reach significant changes. 
It is to note that our study presents some limitations. One is strictly related to the intrinsic 
complexity of human as study model and to the inter/intra-individual variability. More important, 
we can consider this study only a pilot one due to the small size sample (10 people) ), which is not 
enough to completely cover the genetic and individual variability. Also the lack of a real control 
group can be considered a weakness of our study but the possibility to administrate a placebo (pasta 
without β-glucans) couldn’t be an option because of the totally different organoleptic properties (in 
particular taste and colour). Thus, here we presented preliminary results but further analyses are 
needed to confirm our data.  
However, present and previous results clearly suggest that the regular intake of this food might 
useful for the prevention of obesity, type 2 diabetes and metabolic syndrome [6]. So, The use of 
Page 11 of 21
https://mc.manuscriptcentral.com/iji
International Journal of Immunopathology and Pharmacology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
11 
pasta added with 6% β-glucans seems exhibit promising responses on glucose metabolism, LDL-
cholesterol values, intestinal hormones responses and  microbiota modification. 
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day 0 day 30 P
1
Gender (Females/Males) 5/5 5/5 
Age (years) 26.5±2.5 
Body weight (kg) 84.8±8.1 84.2±6.5 
BMI (kg/m2) 27.4±3.4 27.3±3.3 
Fasting blood measurements: 
Glucose (mg/dl) 99 ± 2 89 ± 9 = 0.05 
Total cholesterol (mg/dl) 175 ± 24,7 160 ± 13,3 = 0.03 
HDL-cholesterol (mg/dl) 52 ± 7,5 52 ± 5,1 = 0.8 
LDL-cholesterol (mg/dl) 103 ± 20,7 91 ± 10,4 = 0.03 
Triglycerides (mg/dl) 96 ± 32,7 82 ± 26,3 = 0.3 
Table 1. Characteristics of the cohort and blood measurements at day 0 and 30 days after 
regular consumption of pasta added with β-glucans 
All data are presented as means ± S.D.  
1
 Wilcoxon test. 
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Figure 1. The flow chart of study design. 
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Figure 2. (A) Plasma concentrations of active GLP-1 at day 0 and after 30 days of consumption of enriched 
β-glucans pasta. (B) The AUC of active GLP-1 during a 3-hours monitoring period. Values are mean ± S.E.M. 
*p <0.05. (n=10/group).
569x364mm (96 x 96 DPI)  
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Figure 3.(A) Plasma concentrations of ghrelin at day 0 and after 30 days of consumption of enriched β-
glucans pasta. (B). The AUC of ghrelin during a 3-hours monitoring period. Data are mean values ± S.E.M. 
*p<0.05. (n=10/group).
209x140mm (300 x 300 DPI) 
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Figure 5.(A) Plasma concentrations of GLP-2 at day 0 and after 30 days of consumption of enriched β-
glucans pasta. (B) Plasma concentrations of CKK at day 0 and after 30 days of consumption of enriched β-
glucans pasta. (C) The AUC of GLP-2 during a 3-hours monitoring period. (D) The AUC of CKK during a 3-
hours monitoring period. Data are mean values ± S.E.M. (n=10/group). 
248x213mm (300 x 300 DPI) 
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VIII. Pasta with Opuntia Ficus
Indica: a functional food with anti-
inflammatory, hypoglycemic and 
antioxidant effects 
148
VIII.I Introduction
The increased interest in the health benefits of food has 
stimulated research studies to look beyond the basic nutritional 
values of foodstuffs towards disease prevention. In this regard, 
the beneficial effects of plant remedies are generally accepted 
and dependant on the presence of bioactive compounds from 
the whole plant, part of plant or processed foods obtained with 
plant extracts.  
OFI, belonging to the family Cactaceae, is commonly 
known for its nutritionally rich edible fruits, the prickly pears, 
often investigated for their antioxidant and anti-inflammatory 
properties. However, its leaves, the cladodes, are also used as 
fresh green vegetable and in salads.  
This cactus plant is well adapted to arid lands and to diverse 
climates, including Mediterranean basin, Middle East, South 
Africa and America, Australia and India, and in some countries 
is utilized in the food and cosmetic industries (Saenz, 2000). 
OFI, fruits and stems, have traditionally been used for 
several medicinal purposes (Hunt et al., 2006) and, nowadays, 
a lot of pharmacological interventions have suggested its health 
benefits for the prevention of some chronic diseases (Osuna et 
al., 2014). Recently, the interest in the role of OFI in the 
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control of obesity and other metabolic parameters, such as 
glycaemia and lipid profile has increased. However, although 
some of these results have been proven in animal tests (rabbits, 
mice) and mainly concern the properties of prickly pears, they 
are disputable in human studies. Indeed, a recent meta-analysis 
showed that few clinical trials evaluating the effects of OFI on 
human beings have been published. The supplementation with 
OFI generates no statistically significant effects on body 
weight in these trials but its consumption would seem to be 
associated with a reduction of body fat, blood pressure and TC 
(Onakpoya et al. 2014). Nevertheless, some studies appear 
inconsistent and further clinical interventions are necessary to 
evaluate the real contribution of OFI to human health. 
The aim of our study was to evaluate the effect of a 
pasta, made by University of Palermo, with OFI cladode 
extracts on hematochemical, anti-inflammatory, antioxidant, 
anthropometric and microbiological parameters, to test its 
potential hypoglycemic, hypocholesterolemic and weight loss 
properties and its possible modulator action on gut microbiota 
(prebiotic like effect).The idea was to manufacture a processed 
food commonly used by Mediterranean people with added 
cladode extracts that represent a source of phytochemical 
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compounds, such as phenolic acids (malic acid) and flavonoids 
(Ginestra et al., 2009). The cladodes are mainly comprised of 
water (80-95%), carbohydrates (3-7%), fibers (1-2%), and 
protein (0,5-1%). The carbohydrate component includes 
polysaccharides like mucilaginous, whose role is to regulate 
the plant cellular water, and pectins (Zhao et al., 2007). Their 
utilization in food, medical and industrial applications was also 
documented. In Mexico, the cactus pads are commonly served 
with meals, similar to green beans (Feugang et al., 2006; 
Stintzing et al., 2005). Moreover, the reported heat-resistance 
of cactus pear extract antioxidants, suggests the capability of 
these antioxidants to maintain their activity well after harvest 
and during adequate storage (Siriwardhana and Jeon, 2004).  
The statistical data analysis, shown in part in this thesis, 
is ongoing and the results displayed are preliminary.  
VIII.II Materials and methods
Study design 
The trial consisted in the consumption of 500 g/week of 
pasta with 3% of OFI cladode extract, for 30 days. The pasta 
was made by University of Palermo, using Vertola wheat with 
a small amount of Pietra Fitta wheat. OFI extract was used in 
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the gel form, replacing all of the water used for the pasta 
dough. Extract and pasta characterization was conducted 
respectively by Professor Bonina (University of Catania) and 
Professor Cirrincione (University of Palermo). The extract was 
composed of 30% insoluble polysaccharides and had a strong 
antioxidant power (data unpublished). See Figure 10 for the 
flow chart of the study design. 
Subjects recruited 
We have performed a nutritional intervention on 42 
randomized volunteers (mean age 47,05), both men and 
women, recruited from September 2015 to December 2015. 
The subjects included were: aged between 19 and 69, 
Caucasian, and with metabolic syndrome. Inclusion criteria 
were: slight dyslipidemia (TC190-240 mg/dL, triglyceride 
level ≥150 mg/dL); waist circumference ≥102 cm in men and 
≥88 cm in women; altered glucose tolerance (fasting blood 
glucose ≥100 mg/dl); any treatment for specific disease, 
including drugs to treat metabolic disorders. Exclusion criteria 
were: a diagnosis of a severe systemic diseases; a history of use 
of any pre or probiotics as dietary supplements within 3 months 
prior to the study; a history of treatment with statins or similar, 
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and with lyposoluble drugs; the onset of gastrointestinal 
disorders or the use of antibiotics during the nutritional 
intervention; restrictive dietary requirements. No restriction 
related to sex was considered. Enrolled subjects underwent a 
complete nutritional anamnesis with trained nutritionists. Two 
subjects dropped out of the trial. One was excluded. All 
participants signed an informed consent before the enrolment. 
To respect the privacy, everyone was identified with an 
alphanumeric code. Height and weight were measured wearing 
light clothes and barefoot. The body composition was 
registered using specific hardware and software. Body mass 
index was calculated as weight (in kilos) over height squared 
(in square metre). Dietary habits were assessed through a food 
frequency questionnaire, officially validated by the EPIC 
study. Blood tests, complete lipid profile, oxidative stress, 
cytokines analyses were carried out for all subjects at T0 and 
T1. Molecular analyses were conducted on total DNA obtained 
from faecal samples to measure the variation of its amount. A 
database was created to insert all participants’ data and to 
handle the collected information. 
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Hematochemical tests 
See Accardi et al., 2016b. 
Pro and anti-inflammatory cytokines analyses 
Cytokines analysis of high sensitivity IL-6, IL-10, IL-
1B, IL-17A, and high sensitivity tumor necrosis factor (TNF)-α 
were measured. See Accardi et al., 2016 b for the methods. 
Evaluation of parameters of oxidative stress 
These analyses were conducted in collaboration with 
the University of Sassari. Oxidative stress markers 
(thiobarbituric acid reactive substances, TBARS, and plasma 
proteins SH, PSH) and antioxidants (paraoxonase, PON, and 
glutathione, GSH, activity) were measured in 39subjects with 
metabolic syndrome. TBARS were determined according to the 
method described by Esterbauer and Cheeseman (Esterbauer 
and Cheeseman, 1900).TBARS methodology measures MDA 
and other aldehydes produced by lipid peroxidation induced by 
hydroxyl free radicals. Plasma was mixed with 10% 
trichloroacetic acid and 0.67% thiobarbituric acid and heated at 
95°C in a thermoblock heater for 25 min. TBARS were 
determined by measuring the absorbance at 535 nm. A 
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calibration curve was obtained using standard MDA and each 
curve point was subjected to the same treatment as that of the 
samples. PON activity was determined by measuring the 
increase in absorbance at 412 nm (formation of 4-nitrophenol) 
using paraoxon (O,O diethyl-O-p-nitrophenyl phosphate) as a 
substrate (Gan et al., 1991). Enzyme activity was calculated by 
using the molar extinction coefficient of 17.100 M
−
1cm
−
1 and
one unit (U) of PON activity was defined as 1 nmoL of 4-
nitrophenolformed per minute. Plasma PSH determination was 
performed by spectrophotometry with 5.5'-dithiobis-2-
nitrobenzoic acid (DTNB) as titrating agent by measuring the 
absorbance of conjugate at 405 nm (Ellman, 1959). 
Concentration in samples was determined from a GSH standard 
curve. 
Microbiological and molecular analyses on feces 
Total DNA was purified from faecal samples using the 
QIAamp DNA Stool Minikit (Qiagen, Germany) following 
manufacturer’s instructions. The purified DNA was 
spectrophotometrically quantified at 260nm by means of 
NanoDrop 2000c (Thermo Scientific) and stored at -80°C until 
use. 
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The relative abundance of Lactobacilli and Enterobacteriaceae 
16S rRNA gene was measured by quantitative PCR (qPCR), 
using the primer pairs described in Table 3. A known amount 
of exogenous Anemoniaviridis (Cnidaria) DNA was added to 
template faecal DNA and the single copy gene AvHSP28.6 was 
amplified as internal reference sequence to overcome the lack 
of unbiased target among samples (Nicosia et al., 2014; 
Gagliano et al., 2016). The 25 µl of qPCR mixtures contained 
12.5 µl of Power SYBR Green PCR Master Mix (Applied 
Biosystems, Foster City, CA, USA), 0.5 µM each of the 
forward and reverse primers, 20 ng of faecal DNA and 5 ng of 
exogenous DNA. The reactions were carried out on a 
ABIPRISM 7500 System (Applied Biosystems, Forster City, 
USA) with initial denaturation at 95 °C for 10 min and 40 
cycles of 95 °C for 30 s and 60 °C for 60 s, followed by a 
melting curve from 60 to 95 °C. All qPCRs were run in 
triplicate. Melting curve and gel electrophoresis analyses were 
performed to confirm the specificity and the appropriate size of 
the amplified products. Data analysis was performed according 
to the 2
−ΔΔCT
 method (Schmittgen and Livak, 2008). All data
represented relative mRNA expressed as the mean ± standard 
deviation (n=3). Significant differences between values of 
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different treated groups and the reference control groups were 
determined by one-way ANOVA with Tukey's post-test. 
Table 3. Oligonucleotide primers used in this study. 
Statistical analyses 
The multiple logistic regression analyses are ongoing. 
However, the preliminary comparisons were performed with 
the Student’s t-test or the Wilcoxon signed rank test, according 
to the normality of samples.  
VIII.III Preliminary results and discussions
Hematochemical tests 
Physical characteristics and statistically significant 
biochemical parameters are shown in Table 4. In particular, at 
T1, in analyzed subjects, uric acid significantly decreased, 
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together with a decrease of nitrogen, probably due to an 
increase of fiber intake during the nutritional intervention that 
facilitates the elimination of the waste from the intestine. Uric 
acid, the last product of purine metabolism, is a biomarker of 
inflammation. Its reduction suggests a supposed anti-
inflammatory properties of this pasta. We also noted a 
significant decrease of glycaemia that suggests a hypothetic 
hypoglycemic effect. All these values, increased or decreased, 
were in normal range. All the other biochemical values did not 
statistically change following the 30-days consumption of pasta 
added with OFI, although a trend towards a decreased TC was 
observed (212 at T0 vs 206,07 at T1), according to literature 
data. 
Anthropometric measurements 
At the end of the intervention, body weight and body 
mass index (BMI) did not vary as well as fat and muscle mass 
along the 30 days. However, in the analysed subjects, the 
abdominal and the thoracic waist decreased, suggesting a 
reduction of localized adipose tissue probably due to the over 
intake of fibers. After all, few study showed the anti-obesity 
effect of OFI extracts and, to the best of our knowledge, no 
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studies were conducted regarding the role of processed food 
realized with these extracts. 
Cytokine analysis 
The serological analysis of the levels of the main pro 
and anti-inflammatory cytokines was conducted. At the end of 
the intervention, no significant changes were observed, 
suggesting that pasta with Opuntia does not have any effect on 
cytokines status probably due to the short duration of the 
intervention. 
Oxidative stress analysis 
The antioxidant effect of OFI was demonstrated but 
only a few studies showed this property on humans. Most of 
them have utilized OFI supplement and no functional food. 
Thus, we have analysed the effects of pasta added with 
Opuntia extracts intake on some oxidative stress parameters. In 
particular, we noted that the PON plasma levels and GSH in 
red blood cells significantly increased, confirming the anti-
oxidant power of OFI cladode extracts also in processed foods. 
This is probably due to high polyphenol presence. However, 
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MDA levels, the main product of the PUFA peroxidation and 
an important index of oxidative stress, was unchanged.  
Microbiological analysis on feces 
The development of real-time quantitative PCR 
procedures provides useful tools for the accurate assessment of 
specific components of microbial communities and their ratios. 
In order to overcome any random variation in qPCR efficiency 
and sensitivity due the occurrence of inhibitors, such as 
bilirubin and bile salts, which could impair the analyses 
outcome, serial dilutions of pooled faecal DNAs from both T0 
and T1 subject were prepared and mixed with fixed amount of 
exogenous Anemoniaviridis DNA. The amplification efficiency 
of AvHSP28.6 was evaluated and a template amount ensuring 
reproducibility was identified (data not shown). As a result, in 
our experiments 16S DNA amplifications was obtained for all 
the subjects except for 4 probands. The amount of Lactobacilli 
in faecal samples was evaluated and a significant reduction was 
noticed before the intervention in 30 probands, while an 
increased amount, ranging from 2.3- to 95-fold higher than 
corresponding controls (T0), was detected in five subjects. 
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Moreover, in order to evaluate the specificity of the 
observed pattern, similar assays were carried out to evaluate 
the amount of Enterobacteriaceae in the same specimens. As 
previously observed, the qPCR analyses revealed a decrease of 
Enterobacteriaceae among probands at T1. Thus, it could be 
hypothesised that an overall reduction in the 
amount/composition of the intestinal microbiota maybe 
associated to dietary supplementation of compounds from OFI 
(data not shown). 
Extended dietary interventions and larger cohort will be 
useful to confirm the Lactobacilli increase in responding 
probands. 
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Table 4. The table shows the arithmetic average values at T0 and T1, the p-
value and the variation in percentage (+ and – indicate, respectively, an 
increase and a decrease of the variables at T1).  
VIII.IV Discussion and conclusions
It is well known that the MedDiet and Mediterranean 
functional foods can positively influence the health of each 
individual. In particular, it is know that fibers have an 
important role. In the present study, we preliminary 
demonstrated that the daily intake of pasta made with 3% of 
OFI extracts, rich in fibers and bioactive compounds, has a 
strongly antioxidant effect. Moreover, this pilot study has 
shown the hypoglycemic property of this processed food as 
well as its effect on the abdominal and thoracic waist. It also 
was observed an anti-inflammatory effect linked to the uric 
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acid reduction and a positive decrease trend of TC. Further 
analyses are necessary to confirm the Lactobacilli increase and 
the reduction of Enterobacteriaceae in responding subjects, 
probably associated to dietary supplementation of OFI. 
It must be stressed that the study presents limitations, 
concerning: the average age of recruited people, the small size 
of population analysed and the short duration of the 
intervention. This is a good choice in terms of compliance to 
the study because the longer the duration of the intervention the 
greater the drop out effect. But, a long-term dietary 
intervention could be stronger in terms of variation of analysed 
parameters (e.g., prebiotic effect). 
According to the results of this pilot trial, we might 
speculate that a system of well-balanced diet of carbohydrates 
and fibers like OFI, as the Mediterranean diet would appear to 
be, may be suitable for helping accumulation due to age and 
foods or for maintaining normal glycaemic values.  
For all its proven properties, pasta with OFI extracts can 
be considered a functional food and it will present an important 
opportunity for the food and farming industry, especially in 
Sicily, where the OFI represent a widespread, economic 
resource. 
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IX. Antioxidant effects of extra
virgin olive oil polyphenol extracts on 
peripheral blood mononuclear cells  
164 
IX.I Introduction
As we have extensively explained in this thesis, several 
epidemiological studies have shown a relationship between the 
MedDiet and the reduction of the onset of age-related 
pathologies such as CVDs, cancers, and diabetes. Several of 
these reports attribute these health benefits to high 
consumption of bioactive molecules, greatly present in this 
dietary pattern that has, as common element between all 
Mediterranean countries, EVOO. It is rich in phenols and 
flavonoids, bioactive compounds also related to healthy ageing 
(Rigacci and Stefani, 2016; Tripoli et al., 2005).  
Among these, the most studied and potentially promising are 
oleuropein and its hydrolysis products, such as 3, 4-dihydroxy-
phenylethanol (hydroxytyrosol) that have established anti-
oxidant properties. These compounds are present in olive 
leaves, drupes and virgin olive oils, and are responsible for 
olive oil’s characteristic bitter taste and its stability (Andrewes 
et al., 2003). Oleuropein is the most studied phenolic 
compound found in EVOO. It shows anti-oxidant activity and 
antimicrobial effect especially on a broad range of Gram-
positive bacteria (Fleming et al., 1973; Kruk et al., 2005). 
Hydroxytyrosol is the main polyphenol present in free form in 
165 
EVOO. It acts as a scavenger of ROS and exerts beneficial 
cardiovascular effects through the decrease of oxidized LDL 
and platelet aggregation. It would seem that hydroxytyrosol 
stimulates Sirt1 activation and increases antioxidant defences 
via nuclear factor-E2-related factor 2 (Nrf-2) induction in mice 
fed with a diet rich in olive oil phenolics (Bayram et al., 2012). 
Furthermore, oleuropein mediates Sirt activation but it acts by 
reducing adipogenesis and inducing autophagy via AMP-
activated protein kinas (AMKT) activation or, directly, through 
the modulation of insulin/IGF1/protein kinase B and mTOR 
pathways. This determines forkhead box O (FOXO) 3A 
stimulation with ensuing transcription of homeostatic genes 
that favor longevity and reduce inflammatory states (Rigacci et 
al., 2015; Svobod et al., 2014). In this way, these polyphenols 
act as CR mimickers. 
Moreover, oleuropein and its derivatives can act as anti-
inflammatory molecules, positively contrasting the chronic 
low-grade inflammation and the accumulation of ROS, typical 
of age-related diseases (González-Correa et al., 2009). In a 
study, oleuropein has been shown to enhance NO production in 
macrophage cells, thus to fight against endotoxins and facilitate 
the elimination of pathogens (Durlu-özkaya and Özkaya, 
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2011). Several studies have demonstrated that these 
compounds are able to inhibit proliferation and induce 
apoptosis in different tumor cell lines (Fabiani, 2016) .So, for 
all these reasons, they arouse a great interest in the scientific 
community. 
Although several studies have shown the effects of 
EVOO polyphenols on cell lines or animal models, few 
interventions have been conducted in humans both in vivo and 
ex vivo studies. Since the beneficial effect of  EVOO is 
associated to the simultaneous action of all compounds that it 
contains, to study the single effect of the oleuropein or its 
derivatives, their extracts and derivatives are used. In 
particular, it has been reported that some acetyl derivatives of 
phenols maintain biological antioxidant activity, compared to 
that of the unprotected compound, probably because of the 
massive deacetylation by carboxylesterases. Moreover, it was 
demonstrated that this chemical modification improves the 
capacity of the molecule to permeate the cellular membrane 
(Procopio et al., 2008).  
The aim of this study will to test the antioxidant and 
anti-inflammatory activities of oleuropein, hydroxytyrosol and 
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their paracetylated derivates on PBMCs, using an ex vivo 
cellular screening system. 
IX.II Materials and methods
Subjects recruited 
We recruited fourteen healthy randomized Caucasian 
volunteers (aged 23-65), from April to July 2016. No 
restriction related to sex was considered. All participants 
signed an informed consent before the enrolment. To respect 
their privacy, everyone was identified with an alphanumeric 
code. A database was created to insert all participants’ data and 
to handle the collected information. 
Isolation of PBMCs 
Donor PBMCs were isolated from leukocyte-enriched 
human peripheral blood collected in specific blood collection 
tubes containing ethylene diamine tetra acetic acid (EDTA). 
The cells were separated using Ficoll density gradient 
centrifugation, washed twice in PBS, and stored in 10% heat-
inactivated fetal bovine serum (FBS) and dimethyl sulfoxide 
(DMSO) at -80 °C for further tests. For the analyses, the viable 
cells (95–98% of the preparation) were re-suspended at the 
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concentration of 1×10
6
/ml in complete medium composed of
Roswell Park Memorial Institute (RPMI) 1640 (Euroclone, 
Devon, UK) supplemented with 10% heat-inactivated FBS, 1% 
penicillin/streptomycin, 25mM 4-2-hydroxyethyl-1-piperazine 
ethane sulfonic acid (HEPES), and 1 mM L-glutamine. 
Tested compounds 
On PBMCs we already aglicone oleuropein 
paracetylated (AOP). We tested, partly, oleuropein, 
hydroxytyrosol, and hydrossytyrosol paracetylated (HP). These 
compounds were obtained as described Procopio et al., 2009. 
Paracetylated derivatives were achieved after chemical 
modiﬁcation of oleuropein following a patented synthetic 
method (Procopio et al., 2008). Before cell cultures tests, the 
lyophilized extracts were suspended in ethanol. 
PBMCs viability assay in ethanol and in polyphenols 
The cells were subjected to a viability assay in ethanol 
to identify the non-toxic ethanol concentration for the PMBCs 
to use to suspend lyophilized polyphenol extracts. The PBMCs 
were cultured in 96-well flat-bottom plates at 150.000 cells per 
well in complete RPMI with different ethanol concentrations 
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(5, 2.5, 1, and 0.5%). We evaluated cell viability using Trypan 
blue dye exclusion assay. After 24, 48, and 144 hour 
treatments, the PBMCs was counted in the Burker chamber. 
Cell growth rate was calculated as percent of non-stained (live) 
cells over control. Cell mortality was calculated as the 
percentage of stained cells over total cells and expressed as a 
ratio between treated and untreated (control). 
Then, cells were cultured and incubated with the polyphenol 
extracts. We used three different polyphenol concentrations (1, 
10 and 100 M), and we treated the cells for 24 and 48 hours. 
Subsequently, we added, to each well, 250 M hydrogen 
peroxide (H2O2), to induce oxidative stress, for 30 minute and, 
immediately after, we evaluated the ROS production by 
Synergy-HT plate-reader (Ex/Em 488/528nm), after a 
treatment with 20mM of 2’,7’-dichlorofluorescin diacetate. 
IX.III Preliminary results and discussion
At the time of writing of this thesis, the experiments 
were ongoing and only some anti-oxidant tests were conducted. 
For the re-suspension of lyophilized polyphenols 
extracts, we chose 0.5% ethanol concentration because after 
144 hours the cell viability was greater than 100%, suggesting 
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that this ethanol amount probably stimulates cell growth 
(Figure 11). 
Figure 11. The histograms show the PBMCs viability after the EtOH 
assays. 
About anti-oxidant tests with polyphenol extracts, 
preliminary results demonstrate that the AOP works in a dose-
dependent manner, scavenging the ROS after 24 hours of 
treatment (Figure 12). The same is not true after 48 hours, 
when the most efficient concentration is the 10 M (Figure 
13A).  
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Figure 12. The figure shows the percentage over the control of the ROS 
accumulation in one sample treated with H2O2 and AOP at 24 and 48 hours. 
As the bars show, the effect of AOP is dose-dependent, at 24 but not at 48 
hours. 
An interesting observation is that after one hour of 
reading of the fluorescence in the 24 hour treated sample, the 
100 M concentration works less than the 1 M an 10 M 
(Figure 13B) but the effect became dose-dependent after 2 
hours reading (Figure 12) (data unpublished). 
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Figure 13A. The figure shows the result obtained in one sample of PBMCs 
treated with H2O2 and AOP at different concentrations for 48 hours, after 1, 
2 and 3 hours of fluorescence emission. 
Figure 13B. This figure shows the intensity of dichlorofluorescin diacetate 
fluorescence dependent on the time. The figure also shows the result 
obtained in one sample of PMBC treated with H2O2 and AOP at different 
concentrations for 24 hours, after 1 hour of fluorescence emission.   
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IX.IV Conclusions
Although it is necessary to verify these data in a larger 
sample of individuals, these preliminary results are very 
interesting. 
Some studies have demonstrated the antioxidant activity 
of olive oil phenols in several in vitro systems but few and 
conflicting studies analysed their role in ex vivo model 
(Fabiani, 2016). In a study was investigated the potential 
protective activity of different olive oil phenols on oxidative 
DNA damage induced by H2O2. The authors showed a potent 
DNA damage preventive activity of olive oil phenols, 
providing new evidence to support a possible role of these 
compounds in the prevention of cancer (Fabiani et al., 2008). 
Another investigation demonstrated that the hydroxytyrosol has 
a promising antioxidant potential in protecting the PBMCs 
against 2,3,7,8-tetrachlorodibenzo-p-dioxin, a substance that 
induced oxidative stress (Ilavarasi et al, 2011).  
It was previously reported that the acetyl derivatives of 
phenolic compounds maintain biological antioxidant activity 
compared to that of the parent compound, probably because of 
extensive deacetylation of hydroxytyrosyl acetate by 
carboxylesterases (Mateos et al., 2005). Such deacetylation can 
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take place either within the cell, upon absorption of the 
acetylated molecule, or in the extracellular space by secreted 
esterases, generating free hydroxytyrosol, which is the 
effective antioxidant compound. Procopio et al. demonstrated 
that peracetylation of oleuropein and its derivatives may 
improve their capacity to permeate the molecular membrane 
and their “drug likeness” (Procopio et al., 2009). The authors 
investigated the antiproliferative and antioxidant effects of 
peracetylated oleuropein, peracetylated aglycone and 
peracetylated hydroxytyrosol, compared to unprotected 
oleuropein, on two lines of human breast cancer cells, showing 
antiproliferative and antioxidant effects. 
According to Procopio, in our pilot study we showed 
that paracetylated molecules are chemically more stable 
derivatives that are able to be biochemically converted in vivo 
into their original active forms. However, this hypothesis this 
requires further analyses.  
Nowadays, the use of oil-based supplements is widely 
popular but the real effects on humans are not always tested. 
Their application in terms of strengthening of therapies or 
prevention is interesting but, because they are chemical 
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molecules, it is important to characterize their possible positive 
and adverse effects using human models, firstly ex vivo ones.  
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Abstract
During the last two centuries the average lifespan has increased at a rate of approximately 3 months/year in both
sexes, hence oldest old people are becoming the population with the fastest growth in Western World. Although
the average life expectancy is increasing dramatically, the healthy lifespan is not going at the same pace. This
underscores the importance of studies on the prevention of age-related diseases, in order to satisfactorily decrease
the medical, economic and social problems associated to advancing age, related to an increased number of
individuals not autonomous and affected by invalidating pathologies. In particular, data from experimental studies
in model organisms have consistently shown that nutrient signalling pathways are involved in longevity, affecting
the prevalence of age-related loss of function, including age-related diseases. Accordingly, nutrigerontology is
defined as the scientific discipline that studies the impact of nutrients, foods, macronutrient ratios, and diets on
lifespan, ageing process, and age-related diseases. To discuss the potential relevance of this new science in the
attainment of successful ageing and longevity, three original studies performed in Sicily with local foods and two
reviews have been assembled in this series. Data clearly demonstrate the positive effects of nutraceuticals,
functional foods and Mediterranean Diet on several biological parameters. In fact, they could represent a prevention
for many age-related diseases, and, although not a solution for this social plague, at least a remedy to alleviate it.
Thus, the possibility to create a dietary pattern, based on the combined strategy of the use of both nutraceuticals
and functional foods should permit to create a new therapeutic strategy, based not only on a specific bioactive
molecule or on a specific food but on a integrated approach that, starting from the local dietary habits, can be led
to a “nutrafunctional diet” applicable worldwide.
Keywords: Ageing, Longevity, Mediterranean Diet, Nutraceuticals, Nutrigerontology, Phytochemicals
Background
Nutrigerontology is defined as the scientific discipline
that studies the impact of nutrients, foods, macronutri-
ent ratios, and diets on lifespan, ageing process, and age-
related diseases. Its goal is to investigate about com-
pounds, foods, and diets that can reduce the risk of
ageing-related diseases and increase the healthy lifespan,
so achieving successful ageing and longevity [1].
Many definitions of longevity and successful ageing
have been proposed but none has been accepted yet. In
May 2012, a group of scientists and clinicians met in
Athens (Greece) to consider the relevance of ageing,
longevity, exceptional longevity and related genetic and
non genetic markers. The workshop led to the creation
of a consensus statement to highlight the importance of
a common view related to these processes, since they
represent phenotypes that are rapidly spreading world-
wide [2].
As reported in this panel: “Successful ageing involves
avoidance (or late onset) of age-related diseases includ-
ing cardiovascular disease which is the main cause of
death, and other organ specific diseases, disability, pres-
ervation of desirable cognitive and physical function and
social activities throughout the lifespan”. Moreover, it
proposes the definition of exceptional longevity in rela-
tive and absolute terms, on the basis of demographic
data. It quotes that: ““Relative” suggests that longevity is
concept country/population specific and must take into
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consideration the life expectancy of the different popula-
tions/countries, which show great variability owing to his-
torical, anthropological and socio-economic differences.
In “absolute” terms longevity could be defined according
to the maximum lifespan attained and scientifically vali-
dated by human beings in the planet” [2].
Also, the statement reported the main genes related to
longevity and ageing. Such genes and their encoded pro-
teins are included in a variety of signalling pathways, i.e.,
the nutrient sensing insulin/insulin-like growth factor-1
(IGF-1) or mammalian target of rapamicin (mTOR), the
oxidative stress and anti-oxidant ones and that involved
in the control of immune-inflammatory responses [2].
In addition, it is becoming clear that epigenetic
changes linked to environmental/life style factors (such
as physical activity, diet and emotional stress) play a role
in longevity attainment [2, 3].
In particular, a nutrient-sensing pathway is activated
by nutrients that trigger signals that lead to a down-
stream activation of genes involved in ageing processes.
The complex relationship among nutrition and healthy
ageing is not fully understood, but evidences have
already demonstrated that both in animal models and
humans, dietary intervention can positively modulate
ageing process, preventing or decreasing various age-
related diseases and their generalized pro-inflammatory
status, the inflammageing [4, 5]. So, healthy diets that
not overstimulate mTOR and insulin/IGF-1 pathways
because poor in refined sugars and animal proteins can
substantially reduce the risk of age-related diseases,
hence favouring successful ageing and longevity [6, 7].
On the contrary, a bad dietary lifestyle accelerates the
ageing process, activating the pathways with nutrients,
growth factors and mitogenic stimuli, so accelerating
ageing phenotype [1].
Mediterranean Diet (MedDiet) is one of the most
studied healthy dietary patterns. It is an alimentary regi-
men with low-glycaemic index and low animal protein
intake that contains phytochemical compounds found in
vegetables, fruits, red wine, olive oil or nuts, with anti-
inflammatory and anti-oxidant effects. This pattern, that
more than a diet could be defined a lifestyle, owes its
health properties also to the nutraceuticals [1, 8–11], de-
fined as “naturally derived bioactive compounds that are
found in foods, dietary supplements and herbal prod-
ucts, and have health promoting, disease preventing, or
medicinal properties”. The term, coming from the con-
junction among nutrition and pharmaceutics, was
coined in 1989 by Stephen De Felice [12].
Dietary phytochemicals belong to this group. They are
non-nutrients compounds from a wide range of plant-
derived foods. Despite the translational gap among basic
and clinical research, the current understanding of the
molecular interactions between phytochemicals and
immune-inflammatory and oxidative stress pathways
could help in designing effective nutritional strategies to
delay ageing and age-related diseases. In particular, it
has been claimed that dietary phytochemicals trigger a
condition defined hormesis [1, 8, 13, 14]. This process is
due to low-doses of bioactive compounds that act as
mild stressors to induce adaptive expression of stress-
protective genes and enhance resistance to mechanisms
that determine ageing. The signal passes through the
modulation of kinases, leading to the activation of down-
stream targets, among which FoxO3A and sirtuins. In
this last case, it is to note the known effect of resvera-
trol, phytochemical contained in the grape, that, down-
stream, inhibits the NF-kB pathway, with interesting
anti-inflammatory effects, although it is not totally clear
and contrasting results exist [15]. In vitro and in vivo ev-
idences suggested that many phytochemicals can affect
the expression of numerous genes encoding pro-survival
proteins, including antioxidant enzymes, neurotrophic
or anti-apoptotic factors [1, 8].
Extra-virgin olive oil (EVOO) is full of these com-
pounds, such as hydroxytyrosol, tyrosol and secoiridoids.
It is extracted from olive fruits of Olea Europea and its
health beneficial effects are well established. An exten-
sive literature demonstrated that they can be attributed
to many different substances belonging to the phenolic
fraction of EVOO. However, the concentration of these
molecules is strongly affected by belonging to a particu-
lar cultivar, by agronomic and environmental factors,
and by the extraction and storage conditions [8, 16, 17].
Interestingly, experimental evidence suggests that
hydroxytyrosol is not only effective in removing reactive
oxygen species generated by impaired redox balance but
it may also be a potent inducer of phase II detoxifying
enzymes and an enhancer of mitochondrial biogenesis.
Indeed, its effect is mostly observed at the transcrip-
tional level through modulation of the redox-sensitive
nuclear factor-E2-related factor 2 (Nrf2), which regulates
gene expression of several phase II detoxifying enzymes
and supports the structural and functional integrity of
the mitochondria. For instance, in a study performed on
rats, hydroxytyrosol supplementation improves neuro-
genesis and cognitive function through increased activity
of the transcription factors FoxO1 and FoxO3, as well as
Nrf2, resulting in decreased oxidative stress and in-
creased mitochondrial function [18].
Several health claims for EVOO and its derivatives
have been assessed in recent years but only one was au-
thorized in Europe. It relates the impact of olive phen-
olic compounds on the protection of blood lipids from
oxidative stress: “A daily intake of 20 g of olive oil, which
contains at least 5 mg of hydroxytyrosol and its deriva-
tives (e.g., oleuropein and tyrosol) provides the expected
beneficial effects” [19].
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Phytochemicals are also ingredients of many dietary
supplements commercially available to prevent or ameli-
orate specific diseases, including age-related ones. The
majority of these products are not substantiated by solid
scientific evidences and have not been approved yet by
the EFSA and/or FDA. Beyond them, functional foods
are widely used, especially in Japan and in USA. Al-
though a universal definition of them does not exist,
they are often considered as foods with healthy proper-
ties that contain bioactive compounds naturally or added
to obtain processed foods.
However, further observational studies and dietary
intervention trials in large cohorts of healthy subjects
are essential to evaluate whether these foods and com-
pounds can help to prevent age-related disorders.
The series
To discuss the potential relevance of nutrigerontology in
the attainment of successful ageing and longevity, three
scientific studies and two reviews have been assembled
in this series.
As discussed by Passarino et al., on the whole, al-
though the genetic factors account for only 25 % of hu-
man lifespan, the knowledge of the genetic basis of
longevity may give significant hints on modulating life-
style, in order to extend health span. That is, a few sub-
jects can attain successful ageing and longevity thanks to
a lucky combination of polymorphisms, which allow
them to have an efficient metabolism or an efficient re-
sponse to different types of stress. Most of the others
can reach similar results by targeting the same pathways
with appropriate lifestyle or interventions to slow ageing.
In this context, the importance of epigenetic factors,
both as biomarkers of ageing and target of interventions
will certainly grow in the forthcoming studies [20].
The aim of the study of Accardi et al., was to analyse the
nutraceutical properties of table green olives Nocellara del
Belice, a traditional Mediterranean food, since little is
known about the role of olives as nutraceutics. After the
intake of 12 olives a day for 30 days, a significant decrease
of malondialdehyde, a molecule related to oxidative stress,
was observed. In addition, the level of interleukin-6 (IL-6)
underwent a significant reduction, demonstrating how this
food could be able to modulate the inflammatory re-
sponse. Moreover, it was noteworthy the reduction of fat
mass with an increase of muscle mass, suggesting a pos-
sible effect on long time assumption of table olives on
body mass variation [9].
In Barera et al. study, the authors considered the nutra-
ceutical effects of β-glucans, alimentary fibers, added to
pasta, in order to produce a functional food. After 30 days
of pasta intake, they obtained encouraging results with a
significant decrease of low-density lipoprotein cholesterol,
IL-6 and advanced glycation end-product levels. In fact,
MedDiet is also characterized by a large intake of fibers,
which contribute to lowering cholesterol and are positively
associated with colon cancer prevention. However, in
Mediterranean towns most people do not have a close ad-
herence to MedDiet, hence adding fibers to pasta would
achieve the same effects [21].
Data from dietary intervention studies of Carruba et al.
underlined some interesting aspects related to mechanisms
underpinning both biological and clinical effects of nutri-
tion and specific activities of Mediterranean food compo-
nents. In particular, the authors provided evidence that
MedDiet may regulate oestrogen metabolism in postmeno-
pausal women. In fact, it seems that the formation of po-
tentially harmful genotoxic oestrogen compounds is
remarkably reduced by the adoption of a traditional Medi-
terranean dietary model, while the levels of parent hormone
estradiol become slightly increased. So, this result would
imply that traditional Mediterranean food reduce the risk
of developing breast cancer, while limiting the side effects
of oestrogen withdrawal in menopause. Technological
innovation and prototypical industrialization of either,
processes or products, could be used to obtain traditional
Mediterranean food with high health potential and market
capacities. Precisely, the production of monocultivar
EVOOs revealed that they may have differential activity on
cellular and metabolic processes, eventually leading to pro-
duce highly characterized EVOOs with a preferential use
for the prevention and care of various chronic diseases [22].
The review of Davinelli et al., attempted to summarise re-
cent evidences about phytochemicals as anti-oxidants and
anti-inflammatories. In fact, as previous mentioned, they
may act as positive modulators of inflammation and oxida-
tion by attenuating pro-inflammatory signalling associated
with the redox imbalance that occurs in brain ageing. They
also discussed the need to initiate long-term nutritional
intervention studies in healthy subjects. In fact, their manu-
script highlighted crucial aspects but that require further
studies to determine the effective physiological concentra-
tions and to explore the real impact of dietary phytochemi-
cals in preserving brain health before the onset of
symptoms leading to cognitive decline and inflammatory
neurodegeneration [23].
Discussion
As stated by Kolovou et al. [3] during the last two centuries
the average lifespan has increased at a rate of approximately
3 months/year in both sexes. The most important steps in
prolonging human lifespan were the decrease of child and
maternal deaths, the lowering of infant and juvenile mortal-
ity rate due to, respectively, vaccination and treatment of
infectious diseases. Moreover, in the last decades, the sur-
vival of elderly people improved thanks to secondary and
primary prevention of ageing-related diseases and, particu-
larly, coronary heart one [3].
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So, all the factors above mentioned contribute to the
fact that oldest old people are becoming the population
with the fastest growth in Western World. Although the
average life expectancy is increasing dramatically, the
healthy lifespan is not going at the same pace. Hence,
ageing and age-associated diseases are emerging as
among the greatest challenges and financial burdens,
faced by developed and developing countries [7].
Data from experimental studies in model organisms
have consistently shown that both chronic dietary restric-
tion, affecting nutrient signalling pathways, and mutations
in nutrient and growth signalling pathways can extend
longevity by 30–50 % [6, 7]. Also, they can lower the
prevalence of age-related loss of function, including
immunosenescence and multiple diseases, such as cancer,
cardiovascular disease, and neurodegeneration [6, 7, 24].
In addition, several experimental data clearly demon-
strate the hormetic effects of phytochemicals by inducing
cellular stress resistance mechanisms [1, 8]. In designing
human intervention studies to provide high-quality evi-
dence for their health benefits, the following factors have
to be considered: 1) the phytochemicals need to be suffi-
ciently characterised, as well as its optimal physiologic
dose, 2) the characteristics of targeted populations includ-
ing their nutritional status, health condition, and genetic
background have to be taken into account, 3) clinically
relevant, sensitive, reproducible, and feasible endpoints
have to be identified, 4) length of the intervention have to
be commonly agreed [24–26]. However, even though ex-
perimental data have not always translated to a definitive
clinical effect, the antioxidant and anti-inflammatory
properties of phytochemicals have been widely accepted.
Conclusion
The new findings presented in the experimental studies
of the series give a great achievement for the food and
farming industry, especially in Sicily, where local prod-
ucts represent a great potential resource. No approved
healthy property and claim exist for them. Therefore,
adding such products to the class of “healthy food” could
represent a big deal. In the era of many expansive and
mysterious longevity elixirs, they could represent a trad-
itional, cheap and accessible “healthy food” to everyone.
But more than for the single food, the Accardi’s study
[9] highlights the importance to analyse local products
that are traditional and easy to find. So, in Italy one
should find phytochemicals in table green olives, in
China in the Goji berries. In fact, the key is not a specific
molecule in a specific food but its beneficial effect and
the possibility for everyone to benefit.
The interesting effects of nutraceuticals and functional
foods could represent a prevention for many age-related
diseases, and, if not a total solution, at least a piece of
their puzzle.
So, the possibility to create a dietary pattern, based on
the combined strategy of the use of both nutraceuticals
and functional foods, should permit to create a new
therapeutic strategy based not only on a specific bio-
active molecule or on a specific food but on a integrated
approach that, starting from the local dietary habits, can
be led to a “nutrafunctional diet” applicable worldwide.
Additional longitudinal observations on community-
based cohorts are needed to confirm these data and in-
vestigate the biological mechanisms, including epigenetic
ones, through which effects are induced, and to fully ex-
plore their therapeutic potential.
Nevertheless, nutrigerontology, putting together branches
strictly related to ageing process, as biogerontology, medi-
cine and nutrition, should be the key for achieving success-
ful ageing and longevity.
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XI. Discussion and conclusions
The present thesis confirms the widely discussed role of 
the MedDiet and functional foods on health. 
As it was demonstrated, a close adherence to a 
Mediterranean-style diet permits one to avoid some 
cardiovascular disorders and cancers and is responsible for the 
high rate of long-living individuals scattered throughout the 
world. In 2011, five places: Okinawa in Japan, Sardinia in 
Italy, Ikaria in Greece, Loma Linda in California, and Nicoya 
in Costa Rica, have been recognized to have a very high 
prevalence of healthy octogenarians. These countries have been 
identified as “Blue-Zones”. The term given to these areas 
defines them as limited regions whose population shares a 
common lifestyle and environment, and whose exceptional 
longevity has been accurately verified (Buetner, 2011). Among 
the lifestyle habits, the adopted nutritional patterns are similar 
to that of the Mediterranean, since their diets are characterized 
by a high/quality consumption of fruit, wild plants and 
vegetables, and low consumption of meat products. Other 
common features to these populations are high levels of daily 
physical activity, positive attitudes, and work hours spaced out 
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with periods of calm and mid-day siesta (Chrysohoou et al., 
2011; Chrysohoou and Stefanadis, 2013).  
Using nutritional interventions as means to study the 
effects of Mediterranean functional food on humans, we 
showed that some Mediterranean plant-foods or derivatives, 
like olives, pasta with β-glucans, and pasta with OFI cladode 
extracts, have antioxidant and anti-inflammatory effects on 
healthy or non-healthy subjects. We also showed that an over 
intake of fibers through processed functional foods can act on 
gut hormones, exhibiting promising responses on glucose 
metabolism and on microbiota modification. 
We mainly recruited young and middle age people to 
study, at the best of our ability, the inter/intra-individual 
variability, and to evaluate the role of healthy eating on healthy 
ageing. We also demonstrated that several molecular pathways, 
like NPS ones, affecting metabolism, growth, inﬂammation, 
and epigenetic modiﬁcations, which alter the rate of ageing and 
incidence of age-related diseases, can be modulate by nutrition. 
The well-known are insulin/IGF-1, mTOR and sirtuins 
pathways. Their association with ageing and longevity 
processes was widely approved (Fontana et al., 2010; Wątroba 
and Szukiewicz, 2016) (see V.). In particular, it was seen that 
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the downregulation of IGF-1 and mTOR cascade or the up-
regulation of sirtuins one, through a low GI and low animal 
protein intake, in synergy with bioactive compounds, can 
extend lifespan in various model organisms, including 
mammals (Ziv and Hu, 2011). As previously reported, these 
effects were also obtained by the presence of specific single 
nucleotide polymorphisms (SNPs) in genes encoding proteins 
involved in NSPs, such as IGF-1 receptor or FOXO 3A. For 
example, some FOXO3A SNPs were associated with longevity 
in different populations. Certain variants were found with 
higher frequency in centenarians, highlighting their role in SA 
probably due to an increased activity of FOXO3A and the 
consequent interaction with sirtuins (Di Bona et al., 2014; 
Kenyon, 2005; Suh Y et al., 2008).  
In the same way, it was suggested that the beneficial 
effect of CR on lifespan was linked to decreased circulating 
IGF-1 levels and, consequently, to the activation of FOXO3A 
and the inhibition of mTOR Complex 1. On the other hand, the 
downregulation of insulin/IGF-1 signaling pathway inhibits the 
NF-B signalling, a known pathway involved in immune 
inflammatory mechanisms, with interesting anti-inflammatory 
effects (Gilmore and Wolenski, 2012; Newton and Dixit, 2012). 
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A recent review underlines that one of the best human models 
of CR without malnutrition is the Okinawa diet. Okinawans 
consume approximately 17% fewer calories than the average 
adult in Japan. The Okinawa diet is also reported to be lower in 
protein and rich in fresh vegetables and fruits, sweet potatoes 
and soya (Pallauf et al., 2013, Willcox et al., 2007, 2014). 
Polyphenols (such as resveratrol in grapes and red wine, 
and secoiridoids in olives and EVOO) can also regulate NF-
B, reducing the expression of inflammatory cytokines and
activating sirtuins (in particular SIRT1) pathway (Martín-
Peláez et al., 2013). In this regard, we demonstrated that table 
green olives Nocellara del Belice have anti-inflammatory 
effects on healthy subjects because the levels of IL-6 were 
significantly decreased (see VI.). Recently, Longo also used 
green olives in FMD, probably for their positive effects on 
health.  
In addition, it must be stressed that several insights 
evidenced that the induction of a mild stress is a promising 
strategy to slow down ageing and prevent or postpone the onset 
of age-related disabilities. This induces hormesis (Davinelli et 
al, 2012; Rattan, 2012). Its role in ageing has already been 
examined by Rattan (Rattan, 2008) but it also has relevance to 
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explain the anti-ageing and life-extending actions of CR in 
long-lived species (Masaro, 2007). 
Hormesis is a process triggered by exogenous agents or 
environmental conditions and it is likely identified as an 
integral part of the normal physiological function of cells and 
organisms. Hormetins are molecules, like the phytochemicals 
of fruits and vegetables produced by plants as protection 
against microorganisms, which can activate the hermetic 
process. Polyphenols belong to this category. These molecules 
induce cellular stress response and, subsequently, adaptive 
stress resistance (Mattson, 2008). Stress resistance involves 
molecular adaptations and induces many of the nutrient-
sensing longevity pathways like Nrf2. It is a central regulator 
of the adaptive response to oxidative stress but very few studies 
have investigated its role in the modulation of ageing and 
longevity (Scapagnini et al., 2011). However, it was seen that 
when Nrf2 is translocated into the nucleus, it binds Nrf2-
antioxidant response element (ARE), determining the 
activation of genes that encode antioxidant enzymes, resulting 
also in endothelial protective effects. Molecules that act in this 
way are, for example, is othiocyanates in Brassicaceae like 
broccoli, cabbage, and cauliflower, (Accardi et al., 2016a; 
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Ungvari et al., 2010). Moreover, interesting experimental 
evidence suggests that also hydroxytyrosol has positive effect 
on the modulation of the transcription of Nrf2. For instance, in 
a study performed on rats, hydroxytyrosol supplementation 
improves neurogenesis and cognitive function through 
increased activity of the transcription factors FOXO1 and 
FOXO3, while Nrf2 results in decreased oxidative stress and 
increased mitochondrial function (Zheng et al., 2015). 
In our research, we showed that AOP, a semisynthetic 
peracetylated oleuropein derivative, works in a dose-dependent 
manner, scavenging the ROS in PBMCs medium, in presence 
of hydrogen peroxide, after 24 hours of treatment, probably 
activating AREs. This confirmed its antioxidant activity 
(Figure 12, 13, 14). Indeed, the antioxidant compounds are 
able to modulate the production of free radicals. The role of 
free radicals as mediators of tissue damage is recognized in 
many pathophysiological processes such as inflammaging, 
atherosclerosis, ischemia, tumors, and other age-related 
disabilities (Kehrer JP and Klotz, 2015). In this regard, we 
showed that a functional food, processed with OFI cladode 
extracts, has antioxidant power. It improves some healthy 
parameters, causing PON and GSH, antioxidant molecules, 
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increase. Also green olives have demonstrated antioxidant 
activity, as a matter of fact that MAD, a marker of lipid 
oxidation, significantly decreases (see VI.).  
Moreover, although the beneficial effects of 
Mediterranean nutraceuticals on the cardiovascular system 
have long been known, only recently have scientists focused 
their attention on the role of nutraceuticals and, in general, of 
“nutritional therapy” on endothelial function. In particular, the 
possibility to improve endothelial state and to modulate 
inflammation is achievable by modulating the functional 
activity of endothelial progenitor cells (EPCs). We showed that 
the MedDiet is able to decrease ROS production and, so, to 
reduce endothelial damage, by determining lower apoptosis 
rate in endothelial cells. Moreover, in vitro studies 
demonstrated that antioxidant bioactive compounds from olive 
oil, by decreasing oxidative stress by the modulation of Nrf2 
pathway, restore the EPCs function and reduce the number of 
senescent cells (Accardi et al., 2016a). 
According to several interventional studies, like 
PREDIMED, the largest randomized primary prevention trial 
showing that an intervention to promote a Mediterranean diet is 
beneficial against the CVDs (http://www.predimed.es), we also 
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showed that the functional food pasta with Opuntia has 
beneficial effects on TC and on abdominal and thoracic waists 
(see Table 4). This is in agreement with the literature that 
evidences that the supplementation with OFI generates effects 
on body fat and TC (Onakpoya et al. 2014). In addition, at the 
end of the table green olives intervention, we observed a 
reduction in fat mass with an increase in muscle mass probably 
linked to the activity of CLA. Also Lehnen et al. demonstrated 
that CLA supplementation could also increase lipolysis and 
reduce the accumulation of fatty acids on the adipose tissue; 
the putative mechanisms involved may be its action in reducing 
the lipase lipoprotein activity (Lehnen et al., 2015). Although 
other studies made in humans have shown some benefits of 
CLA supplementation for weight loss, the results are still 
discordant. In line with these data, our group showed that pasta 
enriched with β-glucans is able to implicate a significant 
decrease of LDL-cholesterol, IL-6 and AGEs levels, 
confirming the promising role of fibers intake in Mediterranean 
dietary pattern (Barera et al., 2016). If further analyses will 
confirm this, pasta with β-glucans may be used in the 
prevention of diabetic disease, for its role on glucose 
metabolism and gut hormones linked to sense of satiety. It 
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must be stressed that the effects of regular intake of higher 
amounts of β-glucans on gut hormones in humans, that concur 
to regulate appetite/satiety, have not been defined. 
Another aspect that we investigated during our 
nutritional interventions was the possible prebiotic effect of 
functional foods and the consequently microbiota modulation.  
The relationship between diet, microbiota and, in turn, health 
and longevity, is yet obscure. However, a large number of 
recent studies have investigated the importance of diet, among 
lifestyle factors, that influence the composition of the gut 
microbiota (Sonnenburg and Bäckhed, 2016). 
The human microbiota is the set of the 10-100 trillion 
symbiotic microbial cells present in gastro-intestinal tract 
(GIT) of each person, primarily bacteria; the human 
microbiome consists of all microbes genes and it can be 
considered a counterpart to human genome (Turnbaugh et al., 
2007). Such compounds, considered as prebiotics, defined as 
non-digestible food ingredients that beneficially affect the host 
by selectively stimulating the growth and/or activity of a 
limited number of bacterial species in the colon, thus 
improving host health (Gibson and Roberfroid, 1995). Many of 
the health-promoting effects attributed to prebiotic substrates 
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are due to their suitability to be fermented by the colonic 
microbiota producing short-chain fatty acids (SCFA). 
The correlation between diet and microbiota was analysed both 
in mice and in humans but more studies are necessary to 
evaluate the prebiotic effect of foods and food constituents, 
especially fruits, vegetables, and phytochemicals. However, it 
was ascertained that specific dietary pattern is associated with 
the increase or the decrease of specific bacterial population 
(Clarke et al., 2012; Graf et al., 2015).  
Nowadays, several research groups have also 
investigated the contribution of gut microbial communities to 
old people and their role on healthy ageing because of it has a 
strong impact on human metabolism and immunology. The 
microbiota composition is not stable over the whole life-time 
of an individual. It is affected by ageing. Age-related gut 
microbiota changes are mainly associated with 
immunosenescence and inflammageing, and with changes in 
diet and in host immunity reactivity. For example, the 
prolonged retention time leads to an increase in bacterial 
protein fermentation and consequently putrefactive processes 
in the gut with a greater susceptibility to inflammatory diseases 
(Woodmansey, 2007). Changes with age in specific bacterial 
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genera and species have been identified, with a considerable 
inter-individual variation that continues into old age. Many 
studies have demonstrated a decline, with the increased age, in 
counts of Bacteroides and Bifidobacteria, both in the total 
numbers and in the species diversity that is amplified 
consequently to the antibiotic therapy (Biagi et al., 2013; 
Jeffery et al., 2013). 
In our pilot studies, after the consumption of 12 table 
green olives/day, in middle-aged people we did not observe 
statistically significant differences in the Lactobacilli amount 
in feces, although a positive trend towards an increase was 
observed. It is plausible that a long-term dietary intervention 
could be stronger in terms of variation of this analysed 
parameter. In the second study, we noted that the dietary intake 
of foods rich in oligosaccharides had beneficial effects on 
intestinal functions. The prebiotic effect of mucilage and 
pectic-derived oligosaccharides from Opuntia have yet been 
reported in literature, and resulted in relevant increase in 
Lactobacilli and Bifidobacteria populations (Guevara-Arauza 
et al., 2012). In contrast, our results showed that dietary 
supplementation with OFI cladode extracts, embedded in pasta, 
resulted in an overall decrease in Enterobacteriaceae and 
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Lactobacilli populations, where the latter was more heavily 
affected. This could suggest a possible negative effect of the 
Opuntia dietary supplementation on microbiota, probably due 
to the high anti-microbiological property of OFI cladode 
extracts or to the bacterial competition for adhesion to the gut 
mucosa. Our data about bacterial reduction remain difficult to 
explain, even considering that neither “trapping” effect nor 
specific attachment of Lactobacilli to dietary fibers (which 
could explain a decreased number due to reduced mucosal 
colonization) have been reported to date. Moreover, the 
different route of intake has to be highlighted, since the 
inclusion of Opuntia into wheat pasta (consisting mainly in a 
protein and starch matrix) might alter the availability of 
different components and, in turn, the overall effect. On the 
contrary, a positive promising link between fibers-food intake 
and microbiota was seen for β-glucans consumption. Indeed, in 
our pilot study we showed that, at the end of the intervention, 
Bifidobacterium Longum increased in 80% of subjects 
analyzed (8/10), from 2 to 36-fold greater than the baseline, 
while Enterococcus faecium showed a decrease in 90% (9/10) 
(see VII.). 
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In conclusion, the healthcare costs in many countries 
are very high because of the increased number of unhealthy 
populations and the consequent increase of age-related 
disabilities. However, experiments in laboratory organisms 
have shown that ageing is not an immutable process. Indeed, 
interventions to slow or postpone ageing and to increase the 
active life expectancy are available. Pharmacological therapy is 
one of these. However, our data strengthen the possibility that 
nutrition could be the alternative to pharmacological 
approaches to improve SA. 
As we discussed, some dietary interventions should be 
pursued. A feasible diet that reduces the risk of ageing-related 
diseases, promoting health ageing and longevity, should be one 
that delivers refined carbohydrates and amino acids in a pro-
ageing way, in activating or reducing NSPs. It is not necessary 
to determine the ideal composition of this diet, because it does 
already exist. It is the traditional “poor” MedDiet, which more 
than nutrients or single foods, can act on ageing. In fact, the 
key for anti-ageing therapies is not found in a specific molecule 
in a specific food but it is found in the beneficial dietary pattern 
from which everyone can benefit. 
195 
Nutritional education could be the way to improve 
health and quality of life of mid and old people, increasing the 
potential relevance of “dietary therapy”. In this regard, we 
believe that nutrigerontology, putting together branches strictly 
related to ageing process, as biogerontology, medicine and 
nutrition, should be the key for achieving SA and longevity. 
Furthermore, the new findings presented in the 
experimental studies of this thesis could present a great 
opportunity for the food and farming industry, especially in 
Sicily, where local products like EVOO, green olives, barley 
and OFI, represent a great potential resource.  
In the era of many expensive and mysterious longevity 
elixirs, these resources could represent traditional, cheap, and 
accessible “healthy foods” for everyone. However, it is 
important to highlight that the interesting effects of 
nutraceuticals and functional foods could represent a 
prevention for many age-related diseases, and not a solution. 
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